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Abstract 
Breast cancer is one of the most common cancers in the developed world, and it is 
rapidly increasing in developing countries, such as Saudi Arabia. Early stage 
diagnosis of breast cancer is an aim that would enable better outcomes, especially 
survival. The impact of early presentation of breast cancer on prognosis is so 
profound that the investigation into factors influencing late presentation of female 
breast cancer in Saudi Arabia is vital to attain timely diagnoses.  
A mixed methods research design was used to gain insight into the factors associated 
with late presentation and the reasons for their association; quantitative and 
qualitative data were collection, analysed, and integrated from various data sets and 
perspectives.  
Phase I of this thesis comprised a review of Middle East studies in the published 
literature about factors associated with late-presentation breast cancer. The review 
confirmed the need to conduct this research and the originality of such research.  
Phase II comprised collection of breast cancer-related data from the Saudi National 
Cancer Registry. In total, 10,663 records for female breast cancer were analysed to 
investigate the relationship between stage at diagnosis and five independent 
variables: age, year of diagnosis, nationality, place of residence, and marital status. 
Analysis found all variables except marital status to be significant.  
The quantitative findings were used for sampling participants in Phase III, which 
comprised semi-structured interviews with 19 women diagnosed with breast cancer 
at early and late stages. The analysis found an interaction between factors associated 
with late presentation, in particular with age. Furthermore, the results provided 
insight into contextual factors influencing time to seek medical care and diagnosis 
following symptom recognition.  
Phase IV comprised a reanalysis of quantitative data to investigate the interaction 
between variables and stage at diagnosis, which was prompted by the qualitative 
findings. The analysis illustrated the characteristics of women who typically receive 
a late-stage diagnosis. These include living in regions with less oncology care and 
age older than 58 years or younger than 42 years. In further analysis, inference was 
then generated by integrating findings: explaining the factors found in the 
  - V - 
 
quantitative results through integration with the qualitative findings and then 
comparing these results with findings in the literature.  
This thesis presents an innovative platform for investigating a complex health 
problem and offers answers to what factors might associate with late presentation of 
female breast cancer in Saudi Arabia and why.  
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Chapter 1: Introduction 
Worldwide, breast cancer is the most common cancer for females, accounting for 
25% of all female cancer cases. An estimated 1.68 million new cases of female 
breast cancer were diagnosed in 2012. Among men and women, breast cancer 
accounts for 12% of all cancer diagnoses worldwide and is the most common type of 
cancer after lung cancer (13%) Cancer Research UK (2014). The incidence of female 
breast cancer is highest in developed countries, with more than 80 cases per 100,000, 
and lowest in developing countries, with fewer than 40 cases per 100,000 (Ferlay et 
al., 2010). The incidence of breast cancer, however, is rising in developing as well as 
developed countries; in developing countries, the upward trend is thought to be due 
to population aging, population growth, and life-style changes. An estimated 60% of 
breast cancer deaths now occur in developing countries (Jemal et al., 2011).  
Early-stage diagnosis of cancer yields better female breast cancer outcomes; 
treatment is more effective and survival higher than with later-stage diagnoses (De 
Angelis et al., 2014). Best outcomes are achieved when patients start treatment 
before the onset of breast cancer symptoms, such as when the female patient is 
diagnosed in a mammography screening, or as soon as possible after the first 
appearance of symptoms (Richards, 2009a). Upon diagnosis, those who begin 
treatment as soon as possible have a better prognosis than those who delay (Smith et 
al., 2013); but breast cancer in women in Saudi Arabia is not always diagnosed in the 
early stages. The following sections of this chapter introduce the research problem 
and the aim and objectives of this thesis. 
1.1 Cancer in the Gulf Countries  
As elsewhere in the world, the most common type of cancer among women in Arab 
countries is breast cancer, and its incidence is expected to rise (Salim et al., 2010). A 
ministry decree in Gulf Cooperation Council (GCC) countries (Saudi Arabia, the 
United Arab Emirates, Oman, Kuwait, Qatar and Bahrain) requires that hospitals and 
laboratories report all cancer cases to the Gulf Centre for Cancer Registration 
(Brown et al., 2012). The most common types of cancer in the GCC are breast and 
thyroid cancers in female patients, and lung and prostate cancers in males (Al-
Madouj and Al-Zahrani, 2009). Whilst early detection of cancer in the GCC is 
  - 2 - 
 
improving with advancements in healthcare provision (Brown et al., 2012), late 
presentation is a critical issue for the treatment of cancer (Silbermann, 2012) as 
treatment success is lower for women who present at advanced stages (Salim et al., 
2010). Breast cancer screening varies among GCC countries, ranging from the 
routine screening done in the United Arab Emirates to an absence of standard 
national screening in Saudi Arabia (Brown et al., 2012). Brown et al. (2012) have 
emphasised the need to expand and integrate current research on barriers to early 
detection of breast cancer into the domain of cancer care delivery in the GCC 
countries. Currently, there is a dearth of research on the role of international and 
local contexts in cancer care delivery, and consequently, on potential differences 
arising from variations in needs, social factors, culture and biology. Such research is 
important because breast cancer outcome has multifactorial influences, some of 
which are non-modifiable, such as biology, and others which are modifiable, such as 
patient behaviour, the healthcare system, and interactions between patients and the 
healthcare system (Wheeler et al., 2013). Accordingly, research addressing these 
differences could improve the early detection of cancer and cancer control.  
This thesis seeks to address this gap in the literature, looking into the much-
neglected reasons for late-presentation breast cancer among females in Saudi Arabia. 
It adopts innovative mixed methods research to do so, employing quantitative and 
qualitative approaches that take into consideration the perspective of Saudi female 
breast cancer patients—an approach that has not been systematically undertaken in 
previous research in this area.  
1.2 Breast cancer in Saudi Arabia  
The reasons for studying late presentation of female breast cancer in Saudi Arabia: 
(i) breast cancer is the most common type of cancer in Saudi nationals (males and 
females), and highest among women, (ii) the incidence of female breast cancer is 
estimated to increase , and (iii) stage at presentation is later in Saudi Arabia than in 
developed countries.  
In 2009, breast cancer was the most common type of cancer and comprised 14.5% of 
all cancer diagnoses among adult Saudi nationals (males and females); among Saudi 
females alone, incidence rose to 26.5%. Breast cancer thus affects males and females 
more than other cancers: colorectal cancer (12%), thyroid cancer (7.4%), non-
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Hodgkin’s lymphoma (7.2%), and liver (4.6%). Table 1 illustrates the significant 
differences between the most commonly occurring cancers in male and female adult 
Saudis (Al-Eid and Garcia, 2012).  
Breast cancer incidence varies among the Kingdom’s administrative regions, with 
the Eastern region reporting the highest number of cancer cases, followed by the 
Riyadh and Makkah regions (Al-Eid and Garcia, 2012). The variation in breast 
cancer incidence among the regions may indicate variation in stage at diagnosis, and 
more importantly, variation in the availability of advanced oncology care (see 
Chapter 2). Thus, this thesis will examine place of residence by region in relation to 
stage at diagnosis and the impact of late-stage presentation.  
Table 1: Distribution of cancer type by gender during 2009 
Cancer type 
Female 
Cancer type 
Male 
Frequenc
y 
% 
Frequenc
y 
% 
Breast 1308 26.5 Colorectal  616 14.4 
Thyroid  537 10.9 Non-Hodgkin’s 
lymphoma 
386 9 
Colorectal  492 10 Prostate 294 6.9 
Non-Hodgkin’s 
lymphoma 
277 5.6 Liver 290 6.8 
Uterine cancer 253 5.1 Lung 274 6.4 
Total 4927 Total 4269 
Source: (Al-Eid and Garcia, 2012) 
The Age Standardised Incidence Rate (ASIR) for breast cancer among females in 
Saudi Arabia was 22.7/100,000 in 2009 (Al-Eid and Garcia, 2012) compared to 
125.9/100,000 in the United Kingdom (UK) (Cancer Research UK, 2012) and 
123.8/100,000 in the United States (US) (Howlader et al., 2012).  
Another reason for choosing to study female breast cancer is that the incidence in 
Saudi Arabia, among the lowest in the world, is estimated to increase 350% by 2025 
due to aging of the population (Ibrahim et al., 2008), with future reproductive and 
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socioeconomic changes (Babay, 2004) highlight the urgent need to address this 
problem.   
Anderson et al. (2011) have cautioned that developing countries must prepare for the 
expected increase in breast cancer rates by designing and implementing appropriate 
breast cancer programmes. 
The third reason for choosing to study female breast cancer concerns its generally 
late presentation in Saudi Arabia compared with developed countries. Although the 
incidence of breast cancer is currently lower in Saudi Arabia than in the US, for 
example, most diagnoses were made at an advanced stage, in contrast to at an early 
stage in the US (See Table 2). A worldwide comparison of breast cancer stages at 
diagnosis shows the magnitude of late presentation in Saudi Arabia. The Saudi 
National Cancer Registry (SNCR) categorises cancer stages based on disease 
progression – localised, regional and distant – as defined in the Surveillance, 
Epidemiology, and End Results (SEER) Summary Staging Manual – 2000 (Al-Eid 
and Garcia, 2012). Methods of categorising the stages of cancer vary across the 
world (Walters et al., 2013a), but comparisons with countries that use a staging 
system similar to the one used in Saudi Arabia show that although the proportion of 
late-stage breast cancer diagnoses in Saudi Arabia is similar to in other Gulf states 
and the Middle East, it varies substantially from in developed countries such as the 
US,
1
 where the percentage of cases diagnosed at the early, localised stage is 
significantly higher, and the percentage of those diagnosed at later stages is thus 
considerably lower (Table 2). 
Early-stage cancer is localised, while advanced stages are regional and distant. When 
the cancer is limited to a specific organ and has not spread to other parts of the body, 
it is diagnosed as localised (Young et al., 2001). The regional stage occurs when 
cancer cells have spread to nearby lymph nodes, organs or tissues; the distant stage, 
when cancer cells have spread to distant organs or lymph nodes (Young et al., 2001).  
 
 
 
 
                                                 
1
 The US was selected for breast cancer comparisons because the tumour-staging system used there is 
similar to that used in Saudi Arabia. 
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Table 2: Stage of breast cancer development at diagnosis 
Stage at 
diagnosis 
Gulf Countries 
Middle 
East 
Developed 
countries 
Saudi 
Arabia 
(2009)
1 
Gulf 
Countries 
(1998-2005)
2 
Egypt 
(2000-
2002)
3 
US 
(2003-2009)
4 
Localised 31% 20.9% 25.5% 61% 
Regional 42.2% 47% 58% 32% 
Distant 18.4% 11.4% 16.5% 5% 
Unknown 8.4% 20.9%  2% 
1 
(Al-Eid and Garcia, 2012), 
2 
(Al-Madouj and Al-Zahrani, 2009), 
3 
(World Health 
Orgnization, 2009) and 
4 
(Howlader et al., 2012). 
Figure 1, constructed from data in Table 2, clearly illustrates the problem of late-
stage breast cancer diagnoses in Saudi Arabia. The higher discovery of cancer in the 
localised stages in the US than in Saudi Arabia may be due to the higher prevalence 
of mammography screening, which also detects breast cancers that are 
asymptomatic. The percentage of breast cancer in the distant, metastatic stage, 
however, is 3.3 times higher in Saudi Arabia than in the US, and this cannot be 
attributed solely to better screening methods and technologies. 
Evidence on late-stage at diagnosis of breast cancer has been reported previously 
(Al-Eid and Arteh, 2009, Al-Eid and Manalo, 2011), however, trends over time since 
the SNCR began its registration of cancer are unclear. Thus, this thesis will report 
year of diagnosis to investigate its association with late-stage at diagnosis. 
The fourth reason for choosing this research problem is to reduce the proportion of 
late-stage diagnoses by helping guide the effective implementation of current 
healthcare services and inform future policy on screening services (see Chapter 2) to 
reduce treatment delays and increase the proportion of women who survive more 
than five years.                 
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Figure 1: Stages of breast cancer at diagnosis 
Source: (Al-Eid and Garcia, 2012, Al-Madouj and Al-Zahrani, 2009, Howlader et 
al., 2012, World Health Orgnization, 2009). 
One explanation for the higher incidence of breast cancer in regional and distant 
stages among Saudi Arabian women compared with patients in the US may be 
biological. Increasing evidence suggests that differences in breast cancer incidences 
and outcomes are related to ethnicity (Januszewski et al., 2014), with disparities 
being noted within specific countries, such as the UK and the US (Januszewski et al., 
2014). Although differences in tumour biology are recognised, this alone does not 
describe where and why differences exist in breast cancer outcomes (Januszewski et 
al., 2014).  
A consecutive breast cancer series analysis of 204 Saudi Arabian breast cancer cases 
and 2,197 Swiss cases found a notable biological difference between Saudi and 
Swiss patients (Al-Kuraya et al., 2005). Saudi patients had a higher percentage of 
grade III tumours (65%) compared to Swiss patients (32%). In addition, lower grade 
tumours (Grade I) were seen in 6% of Saudi patients compared to 27% of Swiss 
patients (Al-Kuraya et al., 2005). The authors concluded that Saudi women have a 
greater tendency to develop high-grade tumours than do Swiss women. However, 
Saudi women had a 14-fold lower risk of developing grade I tumours than Swiss 
women. The authors suggested that the higher-grade tumours among Saudi breast 
cancer patients might be explained in two ways: either Saudi women have a higher 
tendency to develop higher-grade tumours, or they have a lower risk of developing 
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lower-grade tumours, and genetic and/or lifestyle differences might explain the 
molecular differences between Saudi and Swiss breast cancer patterns (Al-Kuraya et 
al., 2005).  
Al-Kuraya et al. (2005) study thus provides supporting evidence for ethnic 
variability in the disease progression of breast cancer (Januszewski et al., 2014). 
Although this thesis will not examine ethnicity as the study population comprises 
Saudi nationals, the quantitative study will examine potential differences in stage at 
diagnosis between Saudi and non-Saudi nationals.   
The research literature shows that the risk of developing breast cancer increases as 
women age (Irminger-Finger, 2010), with the risk of breast cancer increasing 
substantially for women over age 50 in Western nations (Howlader et al., 2012). 
Breast cancer patients, however, tend to be younger in Arab nations
2
 than in Western 
ones, with an average age at diagnosis of 45.4 years; 66% of Arab cases of female 
breast cancer are under 50 (Najjar and Easson, 2010). In Saudi Arabia, the mean age 
at diagnosis of patients with female breast cancer is 48; 65% of the cases at diagnosis 
are under 50 (Al-Eid and Garcia, 2012), and these patterns are similar in all Arab 
nations (Najjar and Easson, 2010).  
Other research examining the characteristics of breast cancer patients in Saudi 
Arabia provides evidence of a younger average age at diagnosis of breast cancer in 
Saudi Arabia than that seen in Western nations. A review of 867 breast cancer 
records for patients diagnosed in the King Faisal Specialist Hospital and Research 
Centre (KFSH&RC) between 1986 and 2002 showed that patients age 40 and under 
represented 33.2% of all breast cancer diagnoses (Elkum et al., 2007). This age 
range, 40 and younger, is a critical prognostic factor for disease-free survival among 
women in Saudi Arabia (Elkum et al., 2007).  
A study conducted in Saudi Arabia’s Eastern province compared age at breast cancer 
diagnosis in Saudi Arabia and the US (Rudat et al., 2012). The retrospective study 
compared 262 breast cancer diagnoses made between 2004 and 2011 in Saudi Arabia 
with the published US data from the SEER program. The results confirmed both a 
younger average age at diagnosis and a higher prevalence of advanced stages at 
diagnosis among Saudi Arabian patients compared to US patients, with 57.5% of 
                                                 
2
 Saudi Arabia, Bahrain, Qatar, Kuwait, Emirates, Oman, Yemen, Iraq, Syria, Jordan, Lebanon, 
Egypt, Libya, Algeria, Tunis, Morocco, and Sudan. 
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patients  diagnosed at under age 50 in Saudi Arabia compared to 12.5% in the US 
(Rudat et al., 2012).  
The younger age at diagnosis and the low incidence of breast cancer in Saudi Arabia 
raises questions about whether the menopause is a factor associated with breast 
cancer outcomes. A review of 130 breast cancer patients diagnosed between 1981 
and 1991 by a health institution in the Eastern province examined the association 
between age, menopause and survival (Al-Idrissi et al., 1992). Of these patients, 82 
were pre-menopausal and 48 post-menopausal. However, neither unadjusted nor 
adjusted analyses could identify any significant differences in survival attributable to 
either age or menopause (Al-Idrissi et al., 1992).  
The differences in breast cancer diagnoses between the Arab states and the West in 
general, and in age at diagnosis between Saudi Arabia and the West, have caught the 
attention of breast cancer experts, and are the reason that a regional committee, the 
Middle East and North Africa Breast Cancer Regional Guidelines Committee has 
proposed modifying the clinical practice guidelines for breast cancer to meet the 
unique needs of breast cancer patients in the Gulf States and the Middle East 
(Abulkhair et al., 2010a). Thus, this thesis examines the association between age at 
diagnosis and late-stage diagnosis for female breast cancer; the thesis also includes a 
literature review since the literature, in particular, shows a strong association 
between age and delayed presentation of breast cancer (Ramirez et al., 1999).  
1.3 Concerns about late-stage diagnosis of breast cancer in Saudi 
Arabia  
From a public health viewpoint, early presentation and diagnosis of breast cancer can 
both save lives and reduce healthcare costs, because it is more cost effective to treat 
breast cancer in early stages than in advanced ones. Groot and colleagues (2006) 
found that treating early stage (stage I) breast cancer and implementing extensive 
breast cancer programmes
3
 are the most beneficial interventions for breast cancer 
control (Groot et al., 2006). Moreover, early diagnosis can also improve a patient’s 
quality of life (Unger-Saldana and Infante-Castaneda, 2009).  
                                                 
3
 An extensive breast cancer programme involves the treatment of all stages of the disease, together 
with breast cancer awareness and early case detection through bi-annual mammographic screening for 
women age 50–70 years. 
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In the absence of mammography screening, breast cancer detection relies mainly on 
patients seeking healthcare for observed abnormalities. The patient thus plays a 
crucial role in early-stage detection, especially in the absence of routine 
mammography screening provision. 
Studies that investigate the problem of delayed presentation usually consider 
presentation to be delayed when the time between self-recognition of breast cancer 
symptoms and seeking medical advice exceeds three months (Ramirez et al., 1999, 
Richards et al., 1999b). Although the SNCR does not provide estimates of the 
intervals between symptom recognition and the seeking of healthcare, several studies 
using institutional data have indicated that there is a problem of late presentation of 
breast cancer in Saudi Arabia. 
Ibrahim (1990) retrospectively reviewed the records of 75 female breast cancer 
patients in a single healthcare institution and estimated the interval between 
symptom recognition and treatment seeking to be a median of 5.5 months (range 1–
72 months), with 17% of those surveyed having had symptoms for more than a year. 
There was, however, no significant association between symptom delay and breast 
cancer prognosis (Ibrahim, 1990).  
The birth rate in Saudi Arabia is estimated to be an average of 2.9 children per 
woman (Ministry of Health, 2012b). Many pregnancies occur in younger women, 
and this prompted a research group from the KFSH&RC to investigate the 
association between pregnancy and breast cancer outcome. They reported a mean of 
6 months between symptoms discovery and diagnosis among 28 pregnant women 
compared to a mean of four months among 84 non-pregnant women. They did not 
find significant difference in term of survival between the two groups (Ezzat et al., 
1996). The length of the delay at presentation in breast cancer diagnoses during 
pregnancy can show whether health professionals play a significant role in speeding 
up diagnosis, as pregnant women will often be in frequent contact with healthcare 
providers (Petrek, 1994).  
A later study analysed data from 1991 to 1996 on 72 breast cancer patients who had 
been diagnosed during pregnancy and 216 breast cancer patients who had not been 
pregnant when diagnosed; all patients had been treated at the same institution, 
KFSH&RC. The researchers identified a significant difference in average 
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presentation, with pregnant women being diagnosed in a shorter period (median 5.6 
months) than non-pregnant women (median 9.4 months). Although pregnant women 
have shorter durations of medical-care seeking than non-pregnant women before 
diagnosis, the cancer stage at the time of diagnosis was similar, with no significant 
between-group differences in time between definitive diagnoses and treatment. The 
authors attributed the physiological changes in the breast during pregnancy to the 
delays in diagnoses (Ibrahim et al., 2000), which means that pregnant women are 
more likely to be diagnosed by chance. 
Abdelhadi (2008) described late presentation and delay in breast cancer management 
in a single institution in Saudi Arabia. Using 303 breast cancer records of diagnoses 
made between 1997 and 2007, three instances of delay were identified: patients, 
Primary Health Centres (PHCs), and hospitals (advanced care). The author attributed 
the primary factor in delay to patient misconceptions about breast cancer; some 
patients presented with a tumour of 4–6 centimetres, ulceration, and metastases. The 
problem of late presentation increased when primary care physicians did not provide 
support for early detection due to a lack of training and knowledge, and/or when the 
patient was not seen soon enough by a specialist due to health system referral 
procedures, and this led to more diagnoses being made at advanced stages 
(Abdelhadi, 2008).  
1.4 Late-presentation breast cancer and survival 
The stage of cancer at diagnosis partially explains disparities in breast cancer 
survival rates in Europe (Sant et al., 2003) and internationally (Sankaranarayanan et 
al., 2010, Walters et al., 2013b). Cancer stage at diagnosis (its disease extent) is 
recognised as a prognostic factor in breast cancer survival (Coleman, 1999), with an 
advanced stage of cancer at diagnosis correlating with decreased survival times in 
breast cancer patients (Sant et al., 2004, Sant et al., 2003). A collaborative cancer 
survival study by the International Agency for Research on Cancer (IARC) found 
that differences in cancer survival correlated with level of healthcare provision and 
early detection (Sankaranarayanan et al., 2010).  
A retrospective review of the causes of death in 427 patients at a teaching hospital in 
Saudi Arabia during 2008 identified malignancy as the most common cause of death 
(Ansary et al., 2012). Between 1994 and 1999, the observed survival rate in Saudi 
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Arabia after five years of breast cancer was 66.4%, and this did not improve in 
2000–2004, when the survival rate was 63.1% (Al-Eid and Manalo, 2011). 
Ravichandran et al. (2005) observed five-year survival rate in the Riyadh region 
based on stage of cancer at diagnosis for women diagnosed with breast cancer during 
1994–1996. They found the rates to be 67.5% for localised cancer, compared to 
55.6% for regional, and 57.6% for distant cancer. Although these findings were not 
statistically significant—based on only 316 cases—the trend of lower survival rates 
in advanced stages is clear (Ravichandran et al., 2005).  
The five-year observed survival rate for female breast cancer patients in Saudi 
Arabia during 1994–2004 was 64.4% (Al-Eid and Manalo, 2011), which is 
significantly lower than the relative survival rates of 98% seen in the US during 
2002–2008 (Howlader et al., 2012) and 85.1% in the UK during 2005–2009 (Cancer 
Research UK, 2012). But direct comparison of survival rates for breast cancer in 
Saudi Arabia with those of other countries can be misleading without considering the 
difference between observed and relative survival rates. Ries et al. (2003) explain 
that estimates for relative survival should be higher than those for observed survival 
because observed survival represents the proportion of cancer patients that survive 
during a specific time, and therefore includes both deaths due to cancer and to other 
causes. Relative survival, however, estimates the possibility that cancer patients will 
die as a result of cancer alone (Ries et al., 2003), and is akin to an observational 
survival rate adjusted to account for expected mortality (Ederer et al., 1961, Ries et 
al., 2003).  
The SNCR provides data about the incidence of recorded cancer diagnoses, but does 
not follow up on patients, so it does not routinely collect information on when 
patients die, for example. In order to estimate survival rates, the SNCR determines 
whether a cancer patient is alive either by contacting the National Information 
System (Al-Eid and Manalo, 2011) or by contacting patients directly (Ravichandran 
et al., 2005). Moreover, its latest information on breast cancer did not examine or 
estimate the impact of late stage diagnoses on mortality (Al-Eid and Manalo, 2011), 
which means that the impact of late presentation on breast cancer survival in Saudi 
Arabia remains unclear. The international literature on breast cancer does however 
provide data about the impact that late presentation breast cancer has on survival 
rates (Richards et al., 1999b).  
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One possible explanation of the differences in breast cancer survival rates is 
differences in healthcare quality, including presentation time (Coleman, 1999), 
(Coleman, 1999), and the stage of the cancer at diagnosis and treatment (Sant et al., 
2003). Richards et al.’s (1999) systematic review addressed the impact on survival 
rates of delay before seeking diagnosis and treatment and of the stage of the disease. 
The authors found a reduction in survival among women who waited 3–6 months to 
seek treatment compared to those who waited fewer than 3 months. The effect of 
delay on survival is mediated by stage at diagnosis, with longer delays associating 
with more advanced stages of cancer (Richards et al., 1999b). One of the main 
concerns about diagnosing breast cancer relevant to this thesis is that the survival 
rates for breast cancer have been shown to be better than those for other types of 
cancer because of the availability of early detection and effective treatments (Parkin 
et al., 2005).  
Al Diab et al.’s (2013) review of published studies on breast cancer in Saudi Arabia 
included 80 studies examining epidemiology, knowledge and practice of breast self-
examination, etiological factors, metastases, and survival. None of the reviewed 
studies, however, either directly investigated the problem of late presentation or 
explored the underlying factors contributing to the problem (Al Diab et al., 2013).  
Ravichandran et al. (2010) assessed cancer awareness in the Riyadh region of Saudi 
Arabia. Their study of 1,407 Saudi nationals (688 males and 719 females) indicated 
that awareness about cancer is poor and is significantly associated with age, with 
little knowledge about cancer signs and symptoms, or about the benefits of attending 
PHC and of undergoing screening procedures—the main areas in which knowledge 
is lacking (Ravichandran et al., 2010). A number of studies have addressed the low 
level of breast cancer awareness among women in various regions of Saudi Arabia. 
These studies also found low levels of knowledge about the disease (Alam, 2006, 
Amin et al., 2009, Dandash and Al-Mohaimeed, 2007, Ibrahim et al., 1991b, Jahan et 
al., 2006, Mahfouz et al., 2013, Sait et al., 2010). Furthermore, Al-Amoudi and 
Abduljabbar (2012) explored men’s knowledge about breast cancer in Jeddah, a 
coastal city in Western Saudi Arabia. Their study revealed poor levels of awareness 
among men, with 24% having no knowledge of breast cancer symptoms and 90% 
unaware of the importance of mammography screening (Al-Amoudi and 
Abduljabbar, 2012). The lack of awareness about breast cancer raised concerns that 
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perhaps women may not be aware of the signs of breast cancer, and therefore might 
not seek medical care for symptoms. This concern impelled the in-depth 
investigation into the role of breast cancer awareness on late presentation in the 
qualitative part of this study. 
Al-Alaboud and Kurashi (2006) evaluated barriers to the early detection of breast 
cancer by surveying 79 female General Practitioners (GPs) in PHCs from three cities 
in the Eastern Province. The main barrier that these GPs cited was the lack of a 
national screening programme. A charitable breast cancer screening service was 
launched in Riyadh in September 2007, and the prevalence of breast cancer has been 
assessed using the 1,215 women that utilised the service over one year period 
(between September 2007 and September 2008 (Abulkhair et al., 2010b). Only 16 
women were diagnosed with breast cancer; 39% of the 1,215 women were 
symptomatic, their most common symptom being breast pain (Abulkhair et al., 
2010b). That women are using this service shows encouraging signs that early 
presentation could increase. However, the limited availability of cancer screening 
services across Saudi Arabia makes it unlikely that the majority of breast cancer 
patients will be diagnosed at earlier stages. To achieve this will require tackling late 
presentation for female breast cancer by improving breast cancer awareness.  
In developed countries such as the US, travel time for mammography screening is 
not a determinant of stage diagnosis of breast cancer, as shown by an analysis of 
161,619 women with breast cancer from 10 states’ cancer population-based registries 
in the US; but ethnicity, poverty, and insurance status are all associated with late-
stage diagnosis (Henry et al., 2013). In the UK, despite a free universal health system 
providing national screening, late presentation still occurs due to low awareness 
about breast cancer in ethnic minority groups (Forbes et al., 2011), much like the 
population examined in this study (see Chapter 2 for further details about healthcare 
in Saudi Arabia).  
In 2008, the National Awareness and Early Diagnosis Initiative (NAEDI) was 
launched in the UK as a part of the Cancer Reform Strategy to promote early 
diagnosis (Richards, 2009b). The NAEDI works on the hypothesis that delays in 
seeking medical care result in more advanced stages of breast cancer being recorded 
at diagnosis and that this negatively influences survival rates (Richards, 2009b). It 
has adopted a pathway approach for examining different hypotheses about late 
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diagnosis. The first component of this pathway concerns how low awareness among 
the public (or specific groups of the public) about cancer signs and symptoms and 
the presence of negative beliefs about cancer can lead to late presentation to primary 
care and a low uptake of screening. The second component concerns the role that 
primary care has in avoiding delays in diagnosis by considering patients’ symptoms 
as being potentially cancer-related and facilitating their access to diagnostic tests. 
The third component concerns the delays that can follow referrals to specialists. 
Thus, efforts in the UK have been made to achieve defined time-targets (Richards, 
2009b). 
The approach adopted by the NAEDI could be studied and aspects of it implemented 
in Saudi Arabia to improve the early detection of cancer there. For example, the 
Cancer Awareness Measure – a validated tool for assessing public awareness about 
cancer (Stubbings et al., 2009) – could be used to evaluate cancer awareness at a 
national level in order to promote awareness and early detection, as well as to assess 
the effectiveness of breast cancer promotion campaigns. It would be valuable to 
produce estimates on how many avoidable deaths are likely to be related to the late 
diagnosis of breast cancer in Saudi Arabia.  
1.5 The concept of late presentation  
Late presentation is synonymous with delay in cancer treatment. This goes back to 
Pack and Gallo (1938) work “The culpability for delay in the treatment of cancer”. 
Their work emphasises avoiding delay, a responsibility shared between patients and 
healthcare professionals. Patient delay refers to the time between self-recognition of 
symptoms and first contact with the physician (Pack and Gallo, 1938). The threshold 
for delay is assessed differently in various breast cancer studies, however, less than 
three months is the common rule. The length of patient delay is usually assessed by 
asking the patient directly. Though this raises some concern about validity due to 
recall bias, researchers noticed that women were careful to record the time when they 
first noticed breast cancer symptoms (Facione, 1993).  
The point when a patient seeks medical attention is when the healthcare provider role 
begins. Provider delay reflects the time from diagnosis to the start of treatment. Pack 
and Gallo (1938) consider 1 month between physician contact and subsequent action 
to be an acceptable timeframe. The length of the provider delay is not only patient 
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related due to misdiagnosis leading to diagnosis at advanced ‘non-survivable’ stages 
(Facione, 1993).  
Various methods have been applied in breast cancer delay studies. Quantitative 
methods have assessed the prevalence of delay and factors associated with it, 
pointing out the importance of symptom recognition to overcoming delay (Ramirez 
et al., 1999). Qualitative methods have also been used to understand delay. Smith et 
al. (2005) systematically synthesised concepts and themes in 32 qualitative studies 
that investigated help-seeking experiences in cancer. They found that symptom 
recognition and interpretation, fears related to the consultation, and gender are 
important factors affecting whether patients seek help promptly.  
Facione (1993) argued that researchers tend to describe breast cancer delay without 
judging its appropriateness. This is because assessing delay is complex and seeking 
medical care is not a straightforward process. The great attention given to delay in 
cancer emphasizes the methodological challenges in addressing delay in breast 
cancer and improving our understanding of this problem (Andersen et al., 2009).  
A review of the relevant literature shows that no firm consensus on a definition of 
late presentation has been reached, and that several definitions of late and delayed 
presentation and terms describing factors related to delay are being used. The 
following sections discuss four terms used in the literature to categorise delay or late 
presentation: delay avoidance, time delay, sources of delay, and tumour stages.  
1.5.1 Delay avoidance  
One way to analyse late presentation is by whether the delay was preventable or not. 
According to Kutner (1958), there are two phases in the late presentation of breast 
cancer. First, there is ‘unavoidable delay’, which describes the interval between the 
biological start of the disease and the recognition of the symptom(s). This is the 
silent phase of the disease, in which patients are not aware of any symptoms. If late 
presentation occurs in this period, it is not related to patient knowledge, as patients 
are unaware of any symptoms or changes in their body. The second phase is that of 
‘avoidable delay’, in which patients recognise symptoms but do not seek medical 
care. A synonym for avoidable delay is procrastination (Kutner et al., 1958).  
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1.5.2 Time delay  
Late presentation by breast cancer patients is also assessed in terms of the intervals 
of delay. Qualitative studies may refer to this period of delay as the ‘patient help-
seeking’ period (Smith et al., 2005). In 1938, Pack and Gallo distinguished between 
two periods of delay. They used the term ‘undue patient delay’ when the delay 
period—that is, the time it takes from when a patient first notices symptoms to when 
they actually see a doctor—takes more than three months. They, and others, thus 
consider a period of fewer than three months to be a reasonable time period from 
first noticing symptoms to seeking a doctor’s advice or care (Pack and Gallo, 1938, 
Ramirez et al., 1999, Sharma et al., 2012). Others have argued that one month 
represents a more realistic cut-off point for undue delay (Harirchi et al., 2005). Delay 
can also refer to the period from when symptom(s) are first recognised to the 
patient’s diagnosis, which can obviously vary a great deal between patients 
depending on their presentation and their GP (Wilkinson et al., 1979). But the 
majority of the studies that investigate patient-related delay for cancer treatment do 
so in terms of time delay— that is, the period from first noticing symptoms to seeing 
a doctor about them. 
1.5.3 Sources and phases of delay  
Sources (Hansen et al., 2008) and phases (Burgess et al., 1998, Richards et al., 
1999b) of delay provide another way of understanding late or delayed presentation. 
The terms “sources” and “phases” reflect the importance of the process of help-
seeking for medical attention, diagnosis, and treatment (Burgess et al., 1998, Hansen 
et al., 2008, Richards et al., 1999b). Hansen (2008) categorised delays in cancer care 
in terms of patient, doctor, and health-system delays. “Patient delay” refers to the 
time from symptom recognition to initial contact with healthcare professionals; 
“doctor delay” refers to the time from the patient’s first contact with the doctor to the 
initiation of medical investigations; and “system delay” refers to the time between 
the commencement of medical investigations and the commencement of treatment. 
Thus, delays can be related to patients, doctors, the health system, or any 
combination of them (Hansen et al., 2008). 
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1.5.4 Tumour stages  
The stage of cancer is assessed when a tumour is diagnosed. So, determining what is 
considered to be ‘late-stage’ cancer is also relevant in studies investigating late and 
delayed presentation. The existing literature contains no consensus regarding what is 
considered to be ‘late’ or ‘advanced’ stage cancer. Some studies use the TNM 
Classification of Malignant Tumours (TNM) (Edge and Compton, 2010) and define 
Stage II and onwards as the late stages of breast cancer (Cuthbertson et al., 2009), 
while others define only Stages III and IV as advanced (Downing et al., 2007). 
Moreover, some studies consider advanced cancer to be indicated by nodal or 
metastatic spread (Adams et al., 2004), while those that used SEER Staging define 
advanced cancer as the distant stage of the disease (Clegg et al., 2009, Merkin et al., 
2002). The term “advanced stage” has also been used to discuss and represent late 
presentation of breast cancer and in estimations of breast cancer survival (Allemani 
et al., 2013, Sant et al., 2003). 
1.5.5 Late presentation: definitions used in this thesis  
Examining the various definitions of late or delayed presentation shows that scholars 
have different ways of evaluating the problem. The lack of a standard definition 
affects analyses of how different variables impact late presentation and how these 
variables will be examined. This raises a methodological issue related to the validity 
of measures of late presentation, not only in the context of this thesis but in the wider 
literature as well. Thus, it is important to select a valid and appropriate definition of 
late presentation for this study before deciding which factors most require 
examination.  
The notions of delay and late presentation are thus used to refer to a variety of 
factors, such as the time delay in seeking healthcare or presentation at a late stage of 
the cancer’s development, with “late” being conceived differently in different 
studies. Thus, researchers are increasingly avoiding use of the term “delay” 
(Macleod et al., 2009) because of the confusion it causes regarding whether delay is 
related to time factors or presentation at an advanced stage of cancer. Furthermore, 
the term “delay” may unduly emphasise the patient’s actions and attitudes toward 
healthcare, and imply a lack of motivation or action on the part of the patient 
(Macleod et al., 2009). Thus, generally using “delay” to describe cases in which 
diagnosis was slow or simply made at an advanced stage of cancer is considered 
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inappropriate, as there may be no conscious delay on the patient’s part in seeking 
help (Corner et al., 2006).  
In addition, focusing on delay places more emphasis on the patient and neglects the 
role of the tumour’s characteristics and aggressiveness in determining the stage of 
cancer at diagnosis (Al-Kuraya et al., 2005). Bloom (1965) highlighted the 
importance of considering tumour histology when studying the effect of patient 
delay and found that the histology of the tumour influenced survival, with the 
duration of breast cancer symptoms and survival after hospital admission being 
greater (more than double) for Grade I than for Grade III tumours. But although the 
histology of the tumour is an important determinant of survival, most studies of 
breast cancer delay do not properly investigate it (Bloom, 1965). This thesis does not 
investigate tumour aggressiveness, though it does consider aggressiveness as another 
reason for the inappropriateness of using the term ‘delay’, especially in Saudi 
Arabia. 
It is very difficult to avoid the term “delay” because it is widely used in the literature 
(Macleod et al., 2009) Instead of “delay”, however, this thesis will use the term “late 
presentation” when discussing the seeking of healthcare or presentation at an 
advanced stage of breast cancer. The term “late-stage diagnosis” is often used to 
indicate that a cancer is in an advanced stage at diagnosis (Lannin et al., 1998). Two 
factors categorise late presentation: the interval between the patient noticing 
symptoms and first contact with health professionals, and cancer stage at diagnosis.  
The quantitative study in this thesis uses tumour stage as the relevant aspect of late 
presentation because of its validity in assessing late presentation’s impact on breast 
cancer prognosis, with diagnoses at a later stage increasing the risk of a poor 
prognosis (Howlader et al., 2012, Sant et al., 2003). Using “stage at diagnosis” will 
control for the effects of tumour aggressiveness in developing breast cancer at a later 
stage. The quantitative study analyses data from the cancer registry, the SNCR. The 
SNCR does not normally record the time between noticing symptoms and the first 
medical consultation. Thus, this thesis will use tumour stage as a proxy for time to 
seeking medical care, as those who take longer to seek medical care are at a greater 
risk of being diagnosed at advanced stages of cancer (Arndt et al., 2001). Thus, late 
presentation is defined as diagnosis at advanced stages, as understood in terms of the 
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SEER system of summary staging for cancer, and used by the SNCR (see Chapter 
5). 
The qualitative study in this thesis seeks to understand the causes of delayed 
presentation and focuses on patients’ experiences around late presentation. The 
qualitative study examined late presentation through the experiences of women with 
regard to breast cancer and diagnosis. It is anticipated that those diagnosed at later 
stages are more likely to have taken longer to seek medical care than those diagnosed 
at earlier stages. The time to seek medical care after symptoms are noted is known as 
“patient delay” (Hansen et al., 2008). Late-stage diagnosis is taken to refer to 
diagnoses that are made at advanced stages (Stage III or IV, according to TNM 
clinical staging – see Chapters 6 and 7). Although two tumour staging systems are 
used in this thesis, SEER staging and the TNM staging system for solid tumours, 
they are comparable and an algorithm can convert between the two systems (Walters 
et al., 2013a) (although this conversion was not applied in this thesis due to time and 
resource limitations). To facilitate comparability and consistency, “late stage” is used 
throughout the thesis to describe late presentation and diagnosis at an advanced 
stage.  
Using breast cancer stage at diagnosis in both the quantitative and qualitative studies 
provided the opportunity to integrate evidence from two data sets. It minimises 
validity concerns related to recall bias and overcome the lack of SNCR data on the 
time to present to healthcare facilities. Moreover, it helps in controlling for the effect 
of tumour aggressiveness in categorising advanced stages of cancer. As a result, 
stage at diagnosis is more likely to give an accurate indication of the factors 
associated with late presentation female breast cancer and to better inform the 
clinically applied interventions in the study setting.  
1.6 Aim and objectives of the thesis  
1.6.1 Aim of the thesis  
This thesis aims to investigate the factors influencing late presentation of female 
breast cancer in Saudi Arabia. 
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1.6.2 Objectives  
1- To conduct a systematic review of the reasons for late-presentation female breast 
cancer in the Middle East.  
2- To analyse registry data from Saudi Arabia to find factors associated with late-
stage diagnosis of breast cancer. 
3- To conduct and analyse interviews with Saudi women recently diagnosed with 
breast cancer, guided by the literature review and the findings of the registry 
analysis.  
4- To integrate findings from the systematic review, the quantitative study, and the 
qualitative study to build an overview of what factors influence late presentation 
female breast cancer and their effects. 
The mixed methods approach of this thesis uses a sequence of methods (first 
quantitative, then qualitative, then quantitative) to achieve the thesis objectives. It 
begins with a systematic review of the literature concerning the late presentation of 
female breast cancer in the Middle East. This phase highlights the need for future 
studies and informs the choice of methods.  
After this, a quantitative method will be used to explore factors associated with late-
stage diagnosis of breast cancer. To better understand what prevents early 
presentation, the thesis also assesses factors that influence late presentation using 
qualitative methods.  Based on the findings of this qualitative data, the quantitative 
data is reanalysed to provide a better understanding of the characteristics of women 
who are at a higher risk of late-stage diagnosis. 
Finally, the thesis interprets the quantitative and qualitative data, as well as the 
findings from the systematic review. This will help to build a better understanding of 
the problem and bridge the gap in knowledge in this area, as well as suggest future 
policies and research that should be undertaken to tackle the problem of late-stage 
diagnosis of breast cancer in Saudi Arabia.  
1.7 Thesis structure  
This thesis comprises eight chapters. The next chapter provides information on the 
study setting, Saudi Arabia, while Chapter 3 describes the methods and study design 
adopted for the thesis. Chapter 4 presents the first phase of the research study—the 
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systematic review. Chapter 5 explains the second phase, the quantitative study. The 
third phase of this research—the qualitative study—is split into two chapters, with 
Chapter 6 outlining the methods used and Chapter 7 presenting the results. Chapter 8 
provides interpretation and integration of the quantitative and qualitative aspects of 
the research and relates the conclusions of the thesis, together with recommendations 
for future practice and research.   
1.8 Summary  
The late-stage diagnosis of breast cancer represents a major health problem in Saudi 
Arabia that is expected to grow in the imminent future and requires in-depth 
exploration. This thesis examines the reasons for the differences in stage at 
diagnosis, which may reflect variations in the time it takes for women to seek 
healthcare for breast cancer symptoms in Saudi Arabia, which has a universal health 
system in place that, in theory, should be accessible to all citizens. However, the 
frequency of late-stage breast cancer diagnoses indicates the presence of barriers 
impeding the early detection of the disease. This thesis intends to examine these 
barriers and conceptualise them from various perspectives, including the patients’ 
point of view. This represents an original and unique study in this area. The nature of 
the thesis stresses the need to employ mixed methods because a single research 
approach could not address all thesis objectives. Thus the use of mixed methods in 
this thesis (not usually applied in this field) to undertake a comprehensive analysis of 
late presentation breast cancer is a novel contribution to the literature on late 
presentation of breast cancer. 
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Chapter 2: The study setting—The Kingdom of Saudi 
Arabia 
2.1 Introduction  
This chapter provides information on the study site, and is divided into two main 
sections. The first section provides general information about the country, such as its 
population, demography and culture, whilst the second provides an overview of its 
healthcare system, looking at it strengths and the challenges it faces, together with 
health indicators relevant to the care of breast cancer patients.   
2.2 Overview of Saudi Arabia  
Saudi Arabia, officially the Kingdom of Saudi Arabia, is located in Southwest Asia 
and is the largest country in the Arabian Peninsula (see Figure 2), occupying an 
estimated area of two million square kilometres (Central Departement of Statistics 
and Information, 2010a). It is the birthplace of Islam, where two of Islam’s holiest 
mosques are found. Saudi Arabia is one of the Middle East’s richest countries, and 
one of the largest oil producers in the World (Almalki et al., 2011), and this helps 
fund its welfare state. There has been a huge improvement in the country’s 
infrastructure since the government’s profit-sharing agreement on oil in 1950 (Long, 
2005).  
 
 
 
 
 
 
 
 
 
Figure 2: Map of Saudi Arabia
4
                                                 
4
 Source: GIS base maps, modified by Suad Al Manji in GIS software, 2014. 
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2.2.1 Population demography  
The total population of Saudi Arabia at the latest census in 2010 was estimated to be 
27,136,977, of whom 18,707,576 (68.9%) were Saudi nationals. The male to female 
ratio of the population ratio is 50.9% male to 49.1% female, but males constitute 
70.4% of the non-Saudi population (Central Departement of Statistics and 
Information, 2010c). The population is rapidly increasing, with an estimated annual 
growth rate of 2.7% (Central Departement of Statistics and Information, 2014). In 
terms of age demographics, 10.85% of the population are 0–4 years old, 19.52% are 
5–14, 66.89% are 15–64, and 2.73% are 65 or over (Ministry of Health, 2012b). 80% 
of the population are urbanised, with less than 5% remaining semi-settled or 
nomadic (Al-Yousuf et al., 2002). The government is aiming to reduce the number of 
illegal immigrants, and 601,753 immigrants have recently been deported from the 
country (Al Ahmad, 2014). 
Saudi Arabia is one of the Arab homogeneous populations; all Saudis are officially 
Muslims, with the majority being Sunni Muslims (Long, 2005). Arabs constitute 
90% of the population, with the rest being “nationals’’, mainly comprised of foreign 
immigrants from Afro-Asian countries (Central Intelligence Agency, 2013). 
Education is provided free to all citizens, and an estimated  96.5% of Saudi national 
children in the relevant age group attend primary schools (Central Departement of 
Statistics and Information, 2014), with 17.19% of adults holding bachelor’s degrees 
or higher, and the illiteracy rate among Saudis standing at 5.6% (Central Department 
of Statistics and Inofmration, 2013).  
2.2.2 Distribution of administrative regions in Saudi Arabia  
There are thirteen administrative regions in Saudi Arabia (see Figure 3), and each is 
assigned a regional governor or Prince. Each administrative region varies in space 
and population density. The regions, arranged in population density from highest to 
lowest, are Makkah, Riyadh (Ar Riyadh), Eastern (Ash Sharqiyah), Aseer, Madinah 
(Al Madinah), Jazan, Qassim (Al Qassim), Tabuk, Ha’il, Najran, Jouf (Al Jouf), 
Baha (Al Baha), and the Northern region (Al Hudud ash Shamaliyah) (Central 
Departement of Statistics and Information, 2010b). 
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Figure 3: Administrative regions
5
 
The study was carried out in Riyadh,
6
 which is located in the centre of the country. 
Riyadh is both the capital city of Saudi Arabia and the Riyadh region. It developed 
from a small town to a large modern city, becoming one of the main urban cities in 
the country. In 2010, its total population was estimated to be 6,777,146, which 
represents roughly 25% of the total population. Saudi nationals make up 63.4% of 
Riyadh’s population (Central Departement of Statitsics and Information, 2010).    
2.2.3 Cultural aspects  
It is important to understand the culture of the Saudi population as this may 
influence the way in which Saudi behaviour is interpreted. Long (2005), writing 
about the culture of Saudi Arabia, suggests that “understanding the Saudi behaviour 
requires understanding not only the substance of a situation, but the context in which 
it is being viewed” (Long, 2005 p.25). Two main elements are important for 
understanding Saudi culture: Islam and the family.  
                                                 
5
 Source: GIS base maps, modified by Suad Al Manji in GIS software, 2014. 
6
 Riyadh is a plural of rawdah, it means garden in Arabic  
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2.2.3.1 Islam  
Culture is shaped by different factors, including religion, and Islam is not only the 
official religion in Saudi Arabia, but also a system that regulates life activities. Islam 
means peace and submission to the will of God (Allah) and people who follow Islam 
are Muslims (Long, 2005, Taheri, 2008). Muslims believe that that there is no God 
but Allah and that Muhammad is the Messenger of God. Muslims also believe in 
Allah’s other messengers, such as Moussa and Jesus, with Muhammad being his last 
prophet, peace be upon them all (Al-Shahri and al-Khanizan, 2005). The Islamic 
Holy Scripture is Qur’an which advises Muslims in their religious duties. The 
Prophet Muhammad is considered to be an exemplar by Muslims, and therefore they 
try to follow his deeds in their own lives through following the Qur’an and his 
traditions (Taheri, 2008). There is no division between religious and political 
authority in Islam (Long, 2005). The Islamic law is called Sharia law and the sources 
of the law are the Qur’an (God’s teachings), the Sunna (the prophet Muhammad’s 
teachings) and Muslim scholars’ interpretations and reasoned analogies based on the 
Qur’an and the Sunna (Long, 2005). A distinctive feature of Islamic law that is not 
present in Western legal systems is the fatwa—legal opinion or learned 
interpretation. A fatwa can be issue without bringing a case to court. Saudi Arabia 
applies Islamic or Shari’a law, and the Office of the Grand Mufti, can issue fatwas 
(Long, 2005).  
Islam’s influence on the Saudi culture is obvious, and it is very difficult to isolate it 
from daily activities. People often uses phrases such as ‘insha Allah’, which means 
‘God willing’, and generally understand and explain events in terms of the will of 
God (Long, 2005). In relation to health, patients generally believe in predestination, 
attributing illness to the will of God, but not viewing it as God’s punishment. The 
Prophet Muhammad said: 
No fatigue, no disease, nor sorrow, nor sadness, nor hurt, nor 
distress befalls a Muslim, even if it were the prick he receives from 
a thorn, but Allah expiates some of his sins for that (Al-Shahri and 
al-Khanizan, 2005 p.432). 
This belief does not prevent Saudi people from seeking medical care and treatment 
for illnesses or from using preventative treatments such as immunisation (al-Shahri, 
2002). In fact, Islam encourages taking care of individual health and acting to 
prevent or treat diseases, with the Prophet Muhammad instructing Muslims to: 
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Seek treatment, because Allah did not send down a sickness but has 
sent down a medication for it—known to those who know it and not 
known to others—except for death (Al-Shahri and al-Khanizan, 
2005 p.432). 
An important characteristic of Saudi culture is the consultation, which is a norm 
according to which decisions are made by consensus, and this is rooted in Islam. The 
consultation and the seeking of consensus are used for decision-making within a 
variety of structured hierarchical institutions, including the government, businesses 
and the family (Long, 2005). People might seek consensus from scholars for health-
related issues, and also usually seek family members’ opinions about life matters, 
such as whether to seek medical care or not. 
The cultural norms relating to the appropriate behaviour for Saudis vary with regard 
to context and situation, with the behavioural norms towards family members, for 
instance, being different than those towards non-family members (Long, 2005). 
Another characteristic that often influences the behaviour of Saudi people is personal 
trust, and thus establishing a good rapport is a basis for a successful relationship 
(Long, 2005).  
In Saudi Arabia, it is held that healthcare should be practised in accordance with 
Islam and cultural values (Boyles and Nordhaugen, 1989). Islam generally supports 
the promotion of health (Rassool, 2000) and the use of scientific medicine to solve 
human illness (Chamsi-Pasha and Albar, 2013), and this approach towards 
healthcare is generally adopted within the Saudi healthcare system (Gallagher and 
Maureen Searle, 1985).  
2.2.3.2 The Saudi family  
The main unit of the Saudi society is the family. Each family member contributes to 
the welfare of the family and shares certain family responsibilities, especially with 
respect to elders. Family members generally retain great respect for elders, both male 
and female, whose wisdom and power are accepted by young people as a rule (Long, 
2005), and both Saudi culture and Islam place a high value on children. Children are 
not only a part of the Saudi nuclear family, but of the extended family as well. Due 
to urbanisation, people might move away from their families, but they try to keep as 
close to other family members as possible. For example, family members may live in 
compounds, and when it is difficult for families to keep in close proximity, they 
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sustain a high level of interpersonal communication using phones and the internet 
(Long, 2005).  
Consanguinity is commonly practiced in Saudi Arabia (El-Hazmi et al., 1995). El-
Mouzan et al. (2007) estimate the prevalence of inbreeding to be roughly 56% 
(2004–2005), and it is common in rural and urban areas throughout the country (El-
Mouzan et al., 2007). Genetic disorders such as sickle cell anaemia are ubiquitous in 
the county (El-Hazmi et al., 1995), and the high level of consanguinity may have 
some impact on the genetic predisposition to breast cancer, but this is not explored 
further in the present study.  
Men’s main roles are seen as those of protecting and being responsible for the 
economy and the family, and it is often frowned upon when women work to earn a 
living. Women’s roles are seen to be those of nurturing and managing homes, 
although they also participate in family decisions (Long, 2005). However, the 
percentage of working Saudi women is currently estimated to be 20% of the total 
Saudi labour force (Cental Departement of Statistics and Information, 2013). In 
addition, those Saudi families who can afford to do so use domestic workers to help 
with household chores. Sex segregation is widely practiced in Saudi Arabia, and is 
often portrayed as being based on protection rather than restriction. From the Saudi 
moral point of view, a woman should not associate with a man who is not one of her 
mahram—male relatives, including fathers, husbands, brothers and uncles. Women 
cannot drive in Saudi Arabia, although they can use public transport or ask male 
relatives for transportation (Gallagher and Maureen Searle, 1985). Additionally, 
many families have male drivers, who sometimes live with the family and transport 
family members, including women.   
From the point of view of modesty, women prefer to be seen by female doctors, as 
Islam forbids unnecessary touching between unrelated adults, including handshakes. 
The healthcare system is organised to facilitate these cultural needs, providing 
separate wards and clinics for males and females. The lack of female doctors does 
not stop women seeking medical advice when necessary, however, even when 
women feel very bad about being seen by male doctors (al-Shahri, 2002). Sometimes 
women seek medical advice from well-known doctors regardless of their gender (Al-
Yaemni, 2010).  
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2.2.3.3 Breast cancer and the Saudi Arabian culture  
There are a number of positive aspects of the Saudi culture that help women in 
accepting the diagnosis of breast cancer, especially the strong faith of Saudi people. 
Many Saudi women with breast cancer report trusting in God, and positively 
perceiving their diagnosis of breast cancer as a reward from God (Saati, 2013) rather 
than negatively perceiving having the disease as a punishment (al-Shahri, 2002), 
because Muslims generally view suffering, including illness and death, as part of life 
and test from God (Rassool, 2000). Muslims patients consider suffering as a way of 
atonement for one’s sins and Islamic teaching encourages Muslims to relieve 
suffering (Al-Shahri and al-Khanizan, 2005, Rassool, 2000). Patience and 
satisfaction is commonly seen among Muslim patients, who ask Allah to reduce their 
suffering (Rassool, 2000). 
Another element that helps Saudi people to accept their illness is the family support 
they generally receive (Saati, 2013). Special attention will be given to ill persons, 
particularly if the ill person is a parent or an elder, with family members trying to 
make life as comfortable as possible for their loved ones. Cancer patients are usually 
accompanied by relatives when they seek medical care, especially elder patients, and 
it is uncommon for sick elders to be sent to nursing homes for care as family 
members will accept responsibility for them unless they require professional medical 
care (Almuzaini et al., 1998).  
Cancer is strongly feared by the Saudi public. Two words are used to denote the 
presence of a malignancy—the first ‘waram’ means ‘tumour’, the second ‘saratan’ 
means ‘crab or cancer’. The vast majority of Saudi people assume that a tumour is 
benign when they hear the mention of a ‘waram’, although it can be used to denote 
both the benign and malignant behaviour of a tumour (Younge et al., 1997). The 
word ‘saratan’, however, invokes a fear of cancer  (Younge et al., 1997), and people 
often use euphemisms such as ‘that disease’ or ‘that bad disease’ when they are 
referring to cancer. Cancer experts have attempted to address the public fear about 
cancer by increasing awareness about it, particularly about the fact that it is treatable 
(Bedikian and Saleh, 1985, Ibrahim et al., 1991a). The need to raise awareness about 
breast cancer is no different than the need to raise awareness about other types of 
cancer, as such knowledge improves patients’ understandings of their conditions and 
health-seeking behaviours (Ravichandran et al., 2010, Saati, 2013). 
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2.3 Healthcare in Saudi Arabia  
Levels of healthcare have improved in Saudi Arabia, with the average life 
expectancy rising from 71.4 years in 1998 (Al-Yousuf et al., 2002) to 73.8 years in 
2012 (Ministry of Health, 2012b). There has been a reduction in communicable 
diseases such as measles, which decreased from 3.41/100,000 in 2006 to 
1.01/100,000 in 2012, and this accompanies an increase in immunisation coverage, 
from 95% of the population in 2006 to 98% in 2012. However, the burden of non-
communicable diseases has increased with accelerated development. The five 
leading causes of death in Saudi Arabia in 2012 were from undiagnosed medical 
conditions (29.8%); injury, poisoning and external diseases (21.2%); diseases of the 
circulatory system (18.2%); conditions that originated during the perinatal period 
(6.8%); and neoplasms (4.7%) (Ministry of Health, 2012b). A review of the causes 
of death listed on death certificates in a single hospital suggested the possibility that 
a greater percentage of deaths are due to cancer, as the causes of deaths were 
frequently under-reported (Ansary et al., 2012).  
2.3.1 The organization of healthcare services in Saudi Arabia  
In 1980, following the Alma Alta conference (1978), the Saudi Ministry of Health 
adopted the concept of PHC, which is structured to provide universal access to 
healthcare. The PHC provides the first level of healthcare, including health 
education; comprehensive maternal and child healthcare; vaccination; the treatment 
of common diseases and injuries; the provision of essential drugs and the promotion 
of proper nutrition; the management of chronic diseases, such as diabetes and 
hypertension; dental healthcare; and the promotion of environmental health. It works 
as a gateway for sorting health-related issues and organising referrals to advanced or 
specialised healthcare providers (Al-Yousuf et al., 2002, Almalki et al., 2011). 
Individuals and families are registered to a PHC in their catchment area, and a group 
of PHCs in a specific area is in turn attached to a hospital for referrals and 
coordination. Such hospitals provide secondary care, such as medical, surgical, 
obstetric, gynaecological, dental, and emergency services. Their countrywide 
network depends on geographic location and the population density found in that 
area. The availability of certain services—such as dental clinics, X-ray departments 
and laboratories—are varied among PHCs, however, depending on the populations 
they serve (Al-Yousuf et al., 2002). The number of PHCs has shown an increase 
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over time, with centres serving an average of 13,455 people (Ministry of Health, 
2012b).  
Healthcare is publically funded by the Ministry of Health, which divides Saudi 
Arabia into nineteen health regions for administrative purposes, each region having a 
Regional Director General of Health Services (Al-Yousuf et al., 2002). The Ministry 
of Health is the main healthcare provider for the country, offering 60% of its total 
healthcare services (Almalki et al., 2011), and is responsible for the planning and 
implementation of these services, as well as for monitoring private healthcare and 
providing advice to health institutions about achieving their goals, although the 
administrative regions are themselves reasonably autonomous (Al-Yousuf et al., 
2002, Almalki et al., 2011). Free healthcare is provided to all Saudi citizens and to 
non-Saudi public sectors workers (Almalki et al., 2011), whilst expatriates who work 
in the private sector receive healthcare through their employers’ health insurance 
programmes (Walston et al., 2008).  
The Ministry of Health is the main provider of ambulatory and in-patient care 
(Khaliq, 2012). In 2012, there were 259 hospitals with a total of 35,828 beds 
(Ministry of Health, 2012b), and some government sectors also offer healthcare, 
having a total of 11,043 beds. This latter group comprises Armed Forces Hospitals; 
National Guard Medical services; Ministry of Interior Medical Services; Royal 
Commission Hospitals; The Saudi Arabian Oil Company (Aramco) Hospitals; the 
Ministry of Education; School Health Units; Youth Welfare; the Saudi Red Crescent 
Society; the Institute of Public Administration; and the Saline Water Conversion 
Corporation. In addition, there are University Hospitals and the KFSH&RC in 
Riyadh, which has another hospital in Jeddah (Almalki et al., 2011).  
2.3.2 Healthcare in Saudi Arabia: strengths and challenges  
Access to different levels of healthcare—primary, secondary and tertiary—is a right 
possessed by all citizens in Saudi Arabia. The quality of healthcare in Saudi Arabia 
is improving, which can be seen in indicators such as increasing life expectancy and 
decreasing rates of communicable diseases and infant mortality (Ministry of Health, 
2012b).  
The practice of the healthcare professional is improving as well. In 1992 (2/6/1413 
H), the Saudi Commission Health Specialties was established, with a remit for 
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improving healthcare practice (Saudi Commission for Health Specialities, 2013), and 
this institution regulates the training and license of health professionals. Many 
training programmes and courses are available through it, and an emphasis is placed 
on increasing the number of Saudi healthcare professionals (Khaliq, 2012). Medical 
research is increasing, with the most common journals being the Saudi Medical 
Journal and the Annals of Saudi Medicine, both of which are indexed journals. The 
majority of research is descriptive and survey-based, however, with only a small 
amount of clinical randomised trials being undertaken thus far, the goal of many 
healthcare institutes is to build up biotechnology research through establishing 
infrastructure for research (Khaliq, 2012). 
The Ministry of Health faces many challenges if it is to improve Saudi healthcare. 
One of these challenges is the current lack of detailed, written, disease-specific 
national guidelines and, even where guidelines do exist, they are poorly applied in 
daily practice. Moreover, although there has been an increase in the number of 
healthcare facilities, less attention has been given to the quality and evidence base of 
medical provision, which has led to variations in the quality of healthcare services 
(Ministry of Health, 2012a). 
Al-Ahmadi and Roland (2005) assessed the quality of PHCs through a 
comprehensive literature review of published studies on PHC services in Saudi 
Arabia. They found these services to be generally accessible and effective in 
providing immunisation, maternal healthcare, and the control of endemic diseases. 
However, they found that the quality of clinical care is negatively impacted upon by 
a lack of evidence-based guidelines, inappropriate prescriptions and the under-
referral of patients. Such variations in the quality of healthcare might have a negative 
effect on the timely seeking of medical care for symptoms of breast cancer, as well 
as its subsequent diagnosis. 
In addition, most health professionals are non-Saudi nationals, with the percentage of 
Saudi physicians estimated to make up only 22.6% of total physicians. This means 
that there is a high workforce turnover, and that there are frequent communication 
barriers between health professionals and Saudi nationals (Almalki et al., 2011). The 
Government has considered this issue, and efforts have been made to train and teach 
local healthcare professionals in different health specialities (Almalki et al., 2011).  
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Healthcare funding is also a challenge, especially given the significant population 
increase in Saudi Arabia. The Ministry of Health has decentralised healthcare 
services and offers autonomy to public hospitals, and in order to meet financial and 
health needs and demands, the Cooperative Health Insurance was established in 1999 
to supervise health insurance practises in Saudi Arabia (Almalki et al., 2011). 
Moreover, an electronic health system has been introduced in several hospitals and 
organisations, although its uptake by Ministry of Health facilities has been slow. 
Efforts to improve the current electronic health service are expected to enhance 
quality of care (Almalki et al., 2011).  
Little research in the field of medicine and health has been undertaken with reference 
to the needs of the Saudi Arabian population, which thus represents a further 
challenge for health policy and planning. This shortcoming has been recognised, and 
accredited training programmes are being provided to address it, supported by inter-
institutional cooperation to improve research and knowledge in this area. The latest 
national plan takes these challenges on board in its proposals for improving the 
quality of care and health indicators (Ministry of Health, 2010).  
2.3.3 Options for seeking medical care for breast cancer symptoms  
A woman with a self-identified breast cancer symptom might go to the PHC provider 
she is registered with. However, not all women choose Ministry of Health services as 
their first option. This might be because they are eligible for healthcare offered by 
other governmental health services, and so they may seek medical advice from such 
services. Moreover, some citizens have health insurance provided for them and their 
families by their employers, and so these people may go to a clinic or hospital that is 
covered by their insurance. Any woman who has medical insurance might choose 
this option when she wants to seek medical advice or treatment.  
The private sector (personally financed treatment) is another option for medical care, 
and this option may be chosen because of the convenience of the appointments that it 
provides and the lack of waiting times, as well as the chance to choose one’s own 
health specialist. Moreover, in some cities, such as Riyadh, a woman can go to a 
charity-run cancer screening centre, which can refer patients to an oncology unit for 
further investigations and treatment if they are diagnosed with breast cancer. Finally, 
the Ministry of Health has also launched a breast cancer line that provides advice 
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(Ministry of Health, 2012c). Using this phone service may have an impact on the 
choices that women then make when seeking medical care.  
2.3.4 Breast cancer care  
Comprehensive government cancer care facilities are located in the Riyadh region 
(n=4), the Makkah Region (n=3) and the Eastern Region (n=1). A high quality of 
cancer care is provided in these facilities, with adequate staff, diagnostic equipment 
and treatment. In addition, each of these cancer care facilities has a hospital-based 
registry and research centre, although these vary in their functions and sizes (Ibrahim 
and Ezzat, 2010).  
There are an additional five cancer care facilities that are smaller than those above, 
having fewer oncology staff and facilities. Hospitals in rural and urban areas might 
have medical oncologists, but will lack oncology specialists, whilst private hospitals 
offer modest cancer care, but only three private hospitals provide radiation treatment 
(Ibrahim and Ezzat, 2010).  
There are numerous challenges for the provision of cancer care in Saudi Arabia. As 
comprehensive cancer care facilities are only located in the three main regions listed 
above, this creates a travel burden or barrier for patients living in other regions to 
access this care, especially those living in rural areas. The shortage of oncology 
specialists, especially among Saudi nationals, is also a large hurdle for providing 
high quality cancer care. Finally, the lack of comprehensive cancer care in some 
facilities might interfere with proper healthcare and outcomes, and the lack of public 
awareness might interfere with the timely diagnosis and treatment of cancer (Ibrahim 
and Ezzat, 2010). 
Cancer registration started in the GCC in 1998, with the main branch being located 
in KFSH&RC, Riyadh, which collect local cancer data from the Gulf countries and 
follows IARC recommendations on cancer registration and data analysis (Al-
Hamdan et al., 2009). Cancer registration in Saudi Arabia is conducted by the 
SNCR, which has collected cancer-related data since 1994—before cancer 
registration in the Gulf states—and provides useful epidemiological data that guides 
the future needs of cancer care (Al-Eid and Garcia, 2012). The quality of cancer 
registration is high, which allows data related to breast cancer to be included in 
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international studies comparing cancer survival rates (Sankaranarayanan et al., 
2010). Further details about SNCR are provided in Chapter 5.  
According to data from the SNCR, the ASIR for female breast cancer ranged from 
6–31.8/100,000 women in the different regions of Saudi Arabia in 2008 (Alghamdi 
et al., 2013). Figure 4 shows the substantial variations that exist in breast cancer rates 
across the country, with the regions that have the highest incidence of breast cancer 
being the Eastern, Makkah and Riyadh regions, and those that have the lowest being 
Aseer, Najran and the Northern region. The distribution of cancer services described 
above fits with this variation in the incidence rates of breast cancer. The likelihood 
of an association between late presentation and place of residence will be examined 
in Chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: ASIR for breast cancer by region in Saudi Arabia
7
 
Source of ASIR : (Alghamdi et al., 2013) 
As has been noted, there is no national programme for breast cancer screening in 
Saudi Arabia, although there have been and continue to be a number of local 
                                                 
7
 Source: Shape files downloaded from Otlet.sims.berkeley.edu/imls and  modified by Robert West 
using R software with a map tools and maps libraries, 2014 
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screening initiatives in place that have been designed to provide screening (Ibrahim 
and Ezzat, 2010). For example, Abdul Lateef Charitable Screening Centre provides 
mammography screening and forty years is officially recommended that women 
begin mammography screening in Saudi Arabia (Abulkhair et al., 2010b). 
Implementing a national screening programme in Saudi Arabia might not be a cost-
effective strategy for controlling the breast cancer burden because of the lower 
incidence of breast cancer there compared to that seen in developed countries, 
together with a low awareness of the importance of screening—as women’s 
compliance with timely screening is regarded as a parameter of the success of breast 
cancer screening programmes (Al-Foheidi et al., 2013, Nyström, 2000).   
An increase of 350% in breast cancer rates is predicted to occur by 2025—an 
alarming rise in breast cancer cases (Ibrahim et al., 2008). These changes can be 
attributed to a number of factors, including population growth, aging, declines in 
fertility, increases in age at first pregnancy, increases in obesity and physical 
inactivity, and changes in dietary habits (Al-Foheidi et al., 2013).  
The government of Saudi Arabia, like those of other Gulf States, has responded to 
the needs that will arise from this cancer burden by establishing a National Cancer 
Care Programme. This initiative is still in its early stages, but is expected to provide 
greater support for cancer care (Ibrahim and Ezzat, 2010). Meanwhile, the National 
Cancer Control Programme launched by the Ministry of Health has focused on breast 
cancer as part of their agenda for cancer prevention and control (Ministry of Health, 
2013). In 2012, the Ministry of Health launched a national campaign for breast 
cancer awareness and early detection in Riyadh. This campaign includes a breast 
cancer awareness programme, a telephone consultation service, and breast cancer 
screening clinics and referrals for breast cancer care for women diagnosed with 
breast cancer (Ministry of Health, 2012c). A non-governmental organisation called 
the Saudi Cancer Society offers support to cancer patients and public education 
initiatives regarding cancer and screening services for breast cancer. It also works in 
partnership with the Ministry of Health and other sectors to support cancer research 
and care (Saudi Cancer Society, 2012).  
Even though advances in cancer care are being made, more focus needs to be given 
to patient behaviour concerning cancer and other health problems (Ibrahim and 
Ezzat, 2010). Women’s reasons for early and late presentation for breast cancer 
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diagnosis and treatment following symptoms discovery will be addressed. This thesis 
intends to help to address this problem through gaining insights about why late 
presentation occurs in female patients with breast cancer. 
2.4 Summary  
This chapter has provided information about the study setting—Saudi Arabia. It has 
described the country, its population, and the most important aspects of its culture in 
relation to breast cancer diagnosis and treatment—Islam and the family. In addition, 
it has described how healthcare in Saudi Arabia is organised; looking at the strengths 
of the system and the challenges it faces for providing and disseminating information 
about breast cancer care. This chapter has thus contributed to understanding the 
study site. The next chapter will now explain the methods used to acquire and 
analyse the relevant data for the thesis.  
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Chapter 3: Methodology 
3.1 Introduction  
This PhD thesis contributes to the understanding of the reasons behind late 
presentation for breast cancer diagnosis in women, focusing on patient-related 
factors. The current chapter describes the methodologies used to address the aim and 
the objectives of the thesis together with the rationale for their use. The methods 
were carefully selected to comprehensively address the problem of late presentation, 
with each phase in this PhD being designed to inform the next one, although some 
flexibility was necessary for examining the problem of late presentation and for 
enabling the development of research skills.  
Exploring the factors that are cited in association with delayed breast cancer 
diagnoses in the current literature (see Chapter 4) showed that the research problem 
is multifactorial and complex, and that a single research approach would be 
insufficient for achieving the thesis objectives. Thus, a study design was designed 
during the first year of the PhD to meet the thesis objectives, and is described in 
section 3.4.1. After the data collection and the analysis of the quantitative and 
qualitative studies had been carried out, the study design required modification to 
provide a better understanding of the interactions between the relevant factors (see 
section 3.4.5). These two versions of the study design show the value of employing a 
mixed methods approach for understanding late presentation and diagnosis of breast 
cancer in Saudi women.      
The current chapter describes the mixed methods and the design utilised in the thesis 
(section 3.2) together with the rationales for using this design (section 3.3), as well 
as outlining the study design used to address the PhD objectives (section 3.4). 
3.2 Thesis design  
This PhD thesis uses a ‘‘mixed methods’’ (Teddlie and Tashakkori, 2009 p.4) 
research design that combines quantitative and qualitative approaches in order to 
provide a comprehensive investigation into late presentation of female breast cancer 
diagnosis in the Middle East and Saudi Arabia in particular. Creswell and Plano 
Clark (2007) define mixed methods research as: 
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A research design with philosophical assumptions as well as 
methods of inquiry. As a methodology, it involves philosophical 
assumptions that guide the direction of the collection and analysis 
and mixture of qualitative and quantitative approaches in many 
phases of the research process. As a method, it focuses on 
collecting, analysing and mixing both quantitative and qualitative 
data in a single study or series of studies. Its central premise is that 
the use of quantitative and qualitative approaches, in combination, 
provides a better understanding of research problem than either 
approach alone (Creswell and Plano Clark, 2007 p.5). 
There are two main research paradigms: the quantitative and the qualitative. Mixed 
methods research is increasingly recognised as a third research paradigm involving 
multiple perspectives, viewpoints and positions (Johnson et al., 2007) which, as 
Campbell and Fiske (1959) have argued, can be used for validation (Creswell and 
Plano Clark, 2011, Dellinger and Leech, 2007). There are several terms used for 
denoting the use of multiple methods, including ‘multi-methods research’ and 
‘multiple research’. However, the term ‘mixed methods research’ has recently 
become the norm for denoting the use of quantitative and qualitative research 
methods that mix or integrate evidence from both methods with the aim of providing 
a superior level of results to answer the relevant study questions (Creswell and Plano 
Clark, 2011, Johnson et al., 2007, Teddlie and Tashakkori, 2009). Quantitative 
research is deductive and hypothetically driven, while qualitative research is 
inductive and grounded in narrative data that is systematically collected and 
analysed. However, the process of evidence-generation in mixed methods research is 
abductive (inductive-deductive), thus ‘making inference to the best available 
explanation’ (Rychetnik et al., 2004) by  moving beyond the statistical prediction of 
the inductive model to a generalised mixed methods inference in which both 
numerical and narrative data are gathered to address research questions (Teddlie and 
Tashakkori, 2009).  
The mixed methods approach thus represents a third research movement that enables 
dialogue between researchers from the quantitative and qualitative research groups. 
The proponents of the first research group pursue scientifically-grounded research 
that emphasises the study of causation or association and then draws conclusions 
based on generalisability. It uses statistical analysis to confirm hypotheses, using 
numbers as an output. Findings from this group (quantitative) are limited in 
explaining issues relating to causation or association, which is the strength of the 
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second group—the qualitative researchers. Qualitative research is often exploratory, 
seeking to uncover unknown aspects of the research problem. Narrative data is 
analysed in the form of text and words (Teddlie and Tashakkori, 2009). 
In the continuum of research approaches (see Figure 5), the mixed methods approach 
does not favour quantitative or qualitative approaches, instead giving priority to 
both, especially in applied research projects (Teddlie and Tashakkori, 2009) such as 
this thesis. However, the priority or weight given to qualitative approaches in 
comparison to quantitative approaches within mixed methods research varies 
depending on the research questions, so they may or may not have an equal weight 
within a study (Creswell and Plano Clark, 2011). 
 
 
 
 
 
 
Figure 5: Research approaches 
3.3 Rationale 
The mixed methods philosophy is often one of pragmatism, focusing on “what 
works” in answering research questions (Teddlie and Tashakkori, 2009). The aim in 
this PhD thesis is to provide a clear picture of the reasons for late presentation in the 
study context, and the use of a single research approach (qualitative or quantitative) 
was judged to be insufficient for achieving this end.  
The aim of this thesis is to discover what factors are associated with late presentation 
among women with breast cancer and why these factors may affect women’s 
presentation time in seeking medical care and diagnosis. Mixed methods optimally 
address the research question. This thesis has multiple objectives, and each objective 
required a certain method, population, and type of data collection (see Table 3). All 
of the objectives, however, are linked with each other by time and task, so a mixed 
methods approach was used to provide a comprehensive explanation of women’s 
late-presentation for breast cancer diagnosis. This involved triangulating qualitative 
data with quantitative results in order to provide a contextual understanding of why 
Mixed methods 
Research approach  
Quantitative  Qualitative 
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and how the quantitative figures might occur, thus enhancing the analysis of the 
research problem (Bryman, 2006).   
From an academic point of view, the mixed methods approach suits the need to 
understand complex health problems and fulfil the researcher’s curiosity about the 
reasons behind the research problem (see section 6.6 on the researcher role in the 
qualitative study). From a personal development point of view, the mixed methods 
approach enabled the researcher to learn and apply different research methods and 
skills that are important for academic development (Teddlie and Tashakkori, 2009). 
In addition, using the mixed methods approach allows the thesis findings to be 
communicated and disseminated to a wider range of people—those with quantitative, 
qualitative and mixed methods backgrounds. 
Table 3: Thesis objectives and questions, required data and methods 
Research objective Research question Data needed to 
identify 
Research 
method 
To review evidence on 
the factors influencing 
late-presentation breast 
cancer in the Middle 
East. 
What factors are 
involved in late 
presentation in the 
Middle East? 
Factors that 
influence late 
presentation. 
Literature 
review. 
To conduct a 
quantitative study in 
order to examine factors 
associated with late-
stage diagnosis of female 
breast cancer in Saudi 
Arabia. 
What factors are 
associated with late-
stage diagnosis of 
female breast 
cancer? 
 
Factors 
associated with 
late-stage 
diagnosis of 
breast cancer. 
Quantitative 
(using data 
from SNCR). 
 
To conduct an in-depth 
qualitative study in order 
to explore factors 
influencing late-
presentation for female 
breast cancer in Saudi 
Why are the 
relevant factors 
associated with 
women’s late 
presentation for the 
diagnosis of breast 
Barriers to and 
facilitators for 
seeking medical 
care after the 
recognition of 
breast cancer 
Qualitative 
(interviews 
with 
patients). 
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Research objective Research question Data needed to 
identify 
Research 
method 
Arabia.  cancer? symptoms. 
To integrate findings 
from the systematic 
review, using 
quantitative and 
qualitative results to 
build an overview of 
what factors influence 
late-presentation female 
breast cancer and how. 
What is the 
evidence regarding 
factors associated 
with late 
presentation from 
the thesis data? 
A review using 
the quantitative 
and qualitative 
results.  
Integrating 
the evidence 
from the 
thesis 
findings. 
 
3.4 The implementation of the mixed methods approach 
Data quality has special importance in public health research. Health research is 
frequently instigated by problems that need solutions, with the results being used to 
articulate healthcare policy, and thus the power of findings is therefore far-reaching. 
It is therefore, critical that the evidence reflects the actual situation (Rychetnik et al., 
2004). This led me to think about innovative methods for investigating research 
problems that affect health, in particular, for the late-presentation female breast 
cancer.   
This PhD thesis used an “explanatory sequential mixed method design” (Creswell 
and Plano Clark, 2011). This involved two distinct sequential phases: data collection 
and analysis in a quantitative study, followed by data collection and analysis in a 
qualitative study. The mixed methods design adopted here is helpful for sorting 
quantitative variables according to their importance, and the subsequent qualitative 
results help explain and expand on the quantitative results. This design also suits 
researchers with quantitative backgrounds (Creswell and Plano Clark, 2011). The 
following sections describe the process of the thoughts behind the research plan and 
its implementation. 
- 42 - 
 
3.4.1 Development of the study design for the thesis 
A study design (version I) (see Figure 6) was designed for answering the research 
inquires, and provided a strategy for addressing late-presentation breast cancer 
diagnoses in women without being restricted to the existing literature, and for 
moving beyond the mere description of the problem. Although the existing literature 
provides the source of key information about the problem, results, models and 
theories from the literature may be misleading because their description might be 
incomplete or inappropriate (Maxwell, 2013).  
Several theoretical models are used to explain the reasons for the late presentation of 
breast cancer patients in the existing literature. Lim (2011) has reviewed and 
compared the models used to explain breast cancer delay, including: the Total 
Patient Delay model (Andersen et al., 1995), the Judgement to Delay model (Facione 
et al., 2002), the Passive Detection and Help-Seeking model (de Nooijer et al., 
2003), the Understanding Patient Delay model (Bish et al., 2005), the Care-Seeking 
Behaviour model (Reifenstein, 2007), the Prolonged Patient Delay model (Rauscher 
et al., 2010), and the Help-Seeking Behaviour and Influencing Factors framework 
(O’Mahony et al., 2011). These models often utilise behavioural theories and 
constructs, and investigate individual and sociocultural interactions (Lim, 2011). 
However, there are (again) a variety of different features used to assess delays, and 
thus a number of questions arise regarding the contexts to which these models are 
applicable and the extent to which they are generalisable to other populations or 
cultures (Lim, 2011). Most of these models and theories are designed within Western 
cultural contexts, and are thus might not globally applicable.  
Walter et al. (2012) reviewed the literature for studies which used Andersen’s Model 
of Total Patient Delay in cancer diagnosis delay. They found that there was variation 
in how the model was understood and applied in these studies with differences in the 
‘time interval’ or ‘delay’ and this did not facilitate international comparison between 
them.  
As a result of their review, they proposed a Model of Pathway to Treatment. This 
model provides a theoretical perspective for studies which examine delay in 
diagnosis. It acknowledges the distinction between stages or ‘intervals’ from 
symptom detection, to first medical consultation, to diagnosis and to treatment. 
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These intervals can be determined by specific events, for example, the detection of 
bodily changes to perceived reasons to discuss symptoms with healthcare 
professionals determined the ‘appraisal interval’. It differentiates between patients’ 
pathways to treatment, and recognises that pathways might not be linear or similar in 
their starting points. The complexity of factors that could influence pathways to 
treatment is acknowledged. Factors can be related to the patient, healthcare 
professional and system or disease specific characteristics (Walter et al., 2012). 
Models based on behavioural theories, such as the Health Belief Model (Becker, 
1974), are commonly used for understanding behaviour and for informing 
behavioural change. However, one of the most striking limitations of such 
behaviourally-based models is their focus on individual cognition, which takes the 
behaviour away from its societal context (Pasick and Burke, 2008). There is 
currently a growing interest in understanding the socio-cultural components that 
affect health and behaviour, and such an understanding may be best achieved by 
employing a qualitative approach (Pasick and Burke, 2008).  
This thesis adopts an applied approach to research, with an emphasis on context-
specific evidence that is based on the fact that countries might show variations in the 
barriers that they have regarding early presentation and survival (Forbes et al., 2013). 
Using a mixed methods approach without the predetermination of behavioural 
theories enables new insights to be brought to bear through contextual constructs as a 
result of the ‘‘lack of the road map’’ (Pasick et al., 2009), because this provides the 
opportunity to learn about the problem through applying a variation of research 
methods (Pasick et al., 2009). Therefore, a study design was designed to answer the 
study questions, using empirical evidence and researcher experience in the study 
context to enhance the consciousness of late-presentation breast cancer (Maxwell, 
2013). This study design utilises the benefits of a mixed methods approach, and was 
planned and implemented to achieve the central aim of the thesis. 
Figure 6 illustrates the first version of the study design used in this thesis. This 
design started by reviewing evidence about the factors associated with late 
presentation (Phase I), which guided the selection of the quantitative approach to 
answer the question of what factors are associated with late presentation of female 
breast cancer in Saudi Arabia (Phase II), which in turn informed the selection of 
representative women to participate in the qualitative study (Phase III), which sought 
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to answer the questions of why and how these factors affect late presentation. It was 
planned that the evidence from phases I, II and III would be integrated to synthesise 
evidence (Phase IV).  
The methods implemented in each phase were different in terms of their approach, 
their participants, the time at which they were undertaken, their results (as shown in 
Table 4), and their strengths and limitations. The combination of these methods and 
the sequence of their implementation helped to build better insights into the problem, 
to acquire stronger evidence to answer the what and why questions, to overcome 
biases and limitations in each phase, thus providing more generalisable findings 
(Phase IV) and to develop the researcher’s research skills.  
Table 4: Comparison between the three phases of research in the thesis 
 
 
 
Sequence Phase I Phase II Phase III 
Method Systematic review Quantitative  Qualitative  
Target population Women with breast 
cancer in the 
Middle East. 
Women with breast 
cancer in Saudi 
Arabia. 
Saudi female 
breast cancer 
patients. 
Results General overview 
of factors 
associated with late 
presentation. 
Main effects of 
factors on late 
stage at diagnosis.  
Factors affect late 
presentation and 
diagnosis.  
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Figure 6: The PhD study design (version I) 
Electronic search of 
quantitative and qualitative 
studies in the Middle East 
region 
Systematic literature review 
Quantitative study 
(Data collection and analysis) 
Qualitative study 
(Data collection and analysis) 
 
Integration of thesis studies  
Phase I 
Designing the study 
methodology 
Sampling design of the 
qualitative study  
Data on breast 
cancer from the 
Saudi National 
Cancer Registry 
cases (1994–
2006) 
Interviews with 19 
breast cancer 
patients diagnosed 
at early and 
advanced stages 
Inform Inform 
Phase II Phase III 
Phase IV 
Conclusion & recommendations 
- 46 - 
 
3.4.2 Phase I 
The first phase comprised a literature survey of the evidence that could be found for 
answering the research questions. This phase addressed the first objective of the 
thesis—to seek possible causes of late presentation in contexts similar to those 
experienced by Saudi Arabian women, and to base evidence on the existing 
literature. Thus, a systematic review of the possible determinates of late presentation 
in Middle Eastern countries was conducted. Chapter 4 describes phase I in detail.  
This review in phase I had two purposes: the first to systematically search the 
literature in order to identify whether the evidence provided by these studies was 
similar or different to the study context and to findings in the wider literature; the 
second to confirm the originality of the thesis. 
The review established that no previous studies have been conducted in Saudi 
Arabia, and that qualitative research is not commonly employed in this area. The 
review is part of the thesis, so the results of the review were used to inform the 
selection of the methods for phases II and III.  
3.4.3 Phase II 
Given that little was discovered about the research problem in Saudi Arabia from the 
literature review, it was considered to be important to develop a general idea of what 
factors might be associated with late presentation. So it was decided that a 
quantitative study should be conducted before the qualitative inquiry was 
undertaken. It was decided that cancer census data would be retrieved from the 
SNCR in Saudi Arabia, as such data was the most expansive data set that could be 
accessed on breast cancer in Saudi Arabia, and its use would enable an examination 
of the association between covariate and late-stage diagnoses together with the 
trends seen over time.  
The quantitative approach that was employed in this phase provided evidence of the 
effects of specific factors on the stage of breast cancer at diagnosis from a large 
number of participants, thus providing powerful generalisable estimations. Using the 
SNCR enabled a quick collection of data with little cost, but the data set was subject 
to availability. This phase focused on answering the question: ‘what are the main 
effects of age, place of residence, nationality, year of diagnosis and marital status on 
the late-stage diagnosis of female breast cancer?’ 
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This phase informed the next phase. Generalisable findings from the phase-II 
quantitative study were used to select a small representative sample for phase-III—
the in-depth qualitative study that was used to further investigate the reasons for late-
presentation. Chapter 5 describes phase II of the study in detail. 
3.4.4 Phase III 
Several factors that were considered to have an effect on the stage of breast cancer at 
the time of diagnosis emerged in phase II. After examining the associations between 
these factors, an idea of the problem at the macro level began to form, and it became 
clear that contextual understanding would be important. Thus, the results of the 
quantitative study were used to inform the sampling strategy of phase III of the 
study—the qualitative study. The main objective of the qualitative study was to 
provide in-depth understanding from a patient’s perspective on the reasons that 
might lead to late presentation by answering the why questions. Therefore, in this 
phase, women diagnosed with breast cancer were interviewed, and their narratives 
used to expand the findings of the quantitative results and put the problem of late 
presentation into context. Chapters 6 and 7 describe phase III in detail. This phase of 
the study located patterns of late-presentation among participants by age at 
diagnosis, which lead to a further research question about the quantitative data: ‘how 
do age, place of residence, nationality, year of diagnosis interact and affect the stage 
of female breast cancer at the time of diagnosis?’   
After analysing and reporting the qualitative data, there were two options: either to 
follow the study design (version 1) and draw evidence-based findings and 
interpretations from phases I, II and III, or to re-examine the quantitative data and 
look at how the covariates interact with the stage of cancer at diagnosis. The first 
option would have been more straightforward, but the second option reflects the 
flexibility of the mixed methods approach, and also had the potential to enhance the 
validity of the thesis’s inferences using the qualitative data. Although there was a 
risk of this latter approach being too time-consuming, it was chosen and, as a result, 
phase IV of the study design (version I) was modified.  
3.4.5 Phase IV  
According to version I of the study design for the thesis (see Figure 6), the results 
from the phase-II and phase-III studies were supposed to integrate and thus help to 
clarify the examination and interpretation of the problem of late presentation. 
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However, a modification of the study design (see Figure 7) was made following the 
results of phase III—the qualitative study. Phase IV consist of two parts: 
Part I: several themes that emerged from the qualitative data suggested that there was 
an interaction between factors, especially with respect to age. Both qualitative and 
quantitative research were given the same priority in this thesis, and to produce a 
holistic understanding of the problem, the quantitative data was re-analysed to 
examine the interactions between the covariates and the stage of breast cancer at the 
time of diagnosis. This led to a clearer understanding of the characteristics of women 
who are at higher and lower risks of late-stage diagnosis. 
Part II: to produce the best available understanding of the problem, the re-analysed 
results from the quantitative data, the qualitative results (phase III) and the 
systematic review (phase I) were integrated. The integration of the results brought 
different data together, as described in Table 4, with the aim of answering the thesis 
question illustrated in Table 3. The diversity of forms of data, methods and sources 
from which it was collected enabled the research problem to be viewed from 
different perspectives, although the variety of research questions, participants, 
methods and data used made it challenging to develop conclusions to the thesis (i.e. 
to integrate and interpret the findings). Inferences from the mixed methods employed 
in the thesis enhanced the understanding of the factors associated with late-
presentation by women with breast cancer, and increased the transferability of the 
findings for the future, as well as in relation to other settings with similar 
characteristics to those of the context of the current study (Teddlie and Tashakkori, 
2009). This is because the quantitative data was large enough to be representative, 
and was analysed using different methods to provide greater confidence about the 
generalisability of the findings. The qualitative findings provided details that 
enhanced the inferences and made them more likely to be transferable (Teddlie and 
Tashakkori, 2009). Chapter 8 describes Phase IV in detail.  
Although the methods used in this thesis started with the explanatory sequential 
mixed method design, as a result of the reanalysis of the quantitative data the study is 
no longer best categorised as being simply sequential. In fact, the term ‘spiral’ would 
be better suited to describing the methodology of this thesis. The research moves in 
circles of quantitative-qualitative-quantitative, but each time on a higher level. As 
shown in Figure 7, the PhD study design (version II), the analysis of the thesis was 
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an ongoing process, although it was conducted in a sequence of phases in order to 
build better inferences. Starting from a first base, the analysis of the evidence then 
went through a circular series of steps using different data and methods. 
The literature review for the study was conducted in 2010 and then rerun in 2014 to 
ensure that the evidence was consistent and up to date. The quantitative data was 
analysed using two statistical regression methods during phase II to enhance its 
validity. The qualitative data was collected and incorporated into the quantitative 
findings, then systematically thematically analysed (phase III). As a result of this, the 
quantitative data was then re-analysed (phase IV) using statistical methods 
(classification trees) different to those used in phase II to integrate quantitative and 
qualitative findings. The analysis process was abductive, placing the deductive and 
inductive processes together (see Table 5). All the data collected in this study was 
used to inform the thesis’s conclusion, enabling the thesis objectives to be addressed 
(see Chapter 8). 
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Figure 7: The PhD study design (version II)
Systematic literature review 
Quantitative study 
(Data collection and analysis) 
Qualitative study 
(Data collection and analysis) 
 
Integration of thesis studies  
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Phase I 
Designing the study 
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Electronic search of 
quantitative and qualitative 
studies in the Middle East 
region 
Data on breast 
cancer from the 
Saudi National 
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Interviews with 19 
breast cancer cases 
diagnosed at early 
and advanced 
stages 
Inform Inform 
Re-visit quantitative data  
Phase II Phase III 
Phase IV 
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Table 5: Description of the PhD study stages and methods 
Study Stage Method Output 
1 - Systematic review Electronic search of the 
literature. 
Overview of the problem 
of late presentation in the 
Middle East. 
Input into study 
methodology. 
2 - Quantitative study Data collection Data on breast cancer 
patients 1994-2006. 
3 - Study analysis Univariate and 
multivariate analyses to 
ascertain the relationship 
between a variety of 
different factors and the 
stage of breast cancer at 
the time of diagnosis. 
Descriptive data on breast 
cancer patients. 
Models for factors that 
influence late-stage 
diagnosis. 
 
4 - Development of a 
sampling strategy for the 
qualitative study. 
Purposive sampling based 
on the findings of the 
quantitative study. 
Development of an 
interview guide. 
 
5 - Qualitative study Face-to-face interviews 
with selected cases. 
Nineteen interviews 
6 - Study analysis Thematic analysis A model for explaining late 
presentation. 
7 - Re-think the 
quantitative data 
Re-visit quantitative data 
and re-analyse.  
Characteristics of women 
at higher and lower risk of 
an advanced-stage 
diagnosis. 
8 - Integration of Interpretation of the Discussion of the results. 
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Study Stage Method Output 
quantitative and 
qualitative studies. 
findings from phases I, II, 
and III. 
Recommendations for 
health education 
interventions. 
 
3.5 Summary  
This chapter described the sequential mixed methods design used in this thesis. The 
rational for the use of mixed methods is given along with the philosophy of this 
approach. The four phases of the research are explained and in particular how they 
will provide a comprehensive understanding of late presentation of breast cancer 
from both clinical and patient perspectives to yield guidance for implementation of 
breast cancer care in Saudi Arabia. The following chapters present these outlines, 
results and analysis of the different phases of the research in detail. 
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Chapter 4 Phase I: Late presentation female breast cancer 
in the Middle East—a systematic review 
4.1 Introduction  
This chapter undertakes the first phase of this mixed methods PhD—the systematic 
review. During the development of the study design, two questions were raised: (1) 
to what extent has the problem of late presentation been examined in contexts similar 
to the study setting? And, (2) are the factors associated with late presentation similar 
to those in other cultures, such as those in the Western World? These questions led to 
the need to review the relevant literature in order to locate evidence of factors 
associated with the late presentation and diagnosis for breast cancer in the Middle 
East (see Figure 8).  
The systematic review was used as a method for summarising and analysing 
evidence from studies on late presentation that look at places similar to the study 
setting, and to thus also identify the extent to which the problem has been 
investigated. A systematic review of the literature represents a quick and cost-
effective way of gathering a large amount of data (Mulrow, 1994). This review 
focuses on factors associated with late-presentation breast cancer among females and 
the methods used to investigate this problem.  
The review was conducted to inform the other phases (II, III and IV) of this thesis 
(see Chapter 3), and thus it was conducted and published (Alhurishi et al., 2011) 
prior to the quantitative and qualitative studies. In addition, it has been cited in 
articles relevant to cancer in the Middle East (Brown et al., 2012, González Jiménez 
et al., 2012, Taha, 2013, Taha et al., 2012). 
The results of the first systematic review (Alhurishi et al., 2011) underlined the need 
for this research due to the lack of published studies on the study setting. In addition, 
the results indicated that quantitative methods were the dominant type of research 
enquiry in this area. In the quantitative studies reviewed, increasing age and lower 
educational levels were identified to be strongly associated with late presentation, 
whilst employment status was found to have no association with late presentation 
(Alhurishi et al., 2011).  
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In order to improve the integration of the data produced in this thesis and the 
conclusions reached through integrating it (see Chapter 8), the original review that 
was undertaken needed to be updated to account for the possibility that new evidence 
had emerged between the time of publishing the review (2011) and integrating the 
evidence (2014). This chapter presents the updated systematic review. 
4.2 The aim of the review  
This systematic review summarises the literature concerning factors associated with 
the late presentation and diagnosis of female breast cancer in the Middle East and 
records the methods used to examine this issue. The review seeks to discover what 
evidence exists for a variety of factors associated with the late presentation and 
diagnosis of breast cancer among women in the Middle East. 
4.3 Methods 
4.3.1 Studies selection 
Studies (using quantitative or qualitative methods) were eligible for inclusion in the 
review if they met the inclusion and exclusion criteria presented below. 
4.3.1.1 Inclusion criteria 
1- The population of the study is female breast cancer patients who lived in 
one of the countries listed in Table 6.  
2- The study provides a clear definition of late/delayed presentation.  
3- The study focused on causes or factors associated with delay or late 
presentation for breast cancer.  
4- The study was conducted after 1970, but follow-up of cases was not 
required. 
5- The study used either quantitative or qualitative methods. 
4.3.1.2 Exclusion criteria  
1- The study included male breast cancer cases, benign diseases, or breast 
cancer cases for those living in countries other than those listed in Table 6. 
2- The study was conducted before 1970. 
3- The study did not have a clear definition of delayed presentation. 
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4- The study was a quantitative one that made no attempt to correlate late 
presentation for breast cancer with its possible causes. 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Map of the Middle East
8
 
4.3.2 The search strategy  
Published studies were identified using the search strategy presented in Table 6. This 
strategy was developed through identifying keywords used in similar studies, 
discussion with supervisors, examining published systematic reviews, attending a 
systematic review course, and discussion with a librarian. 
The search strategy contains four main terms: breast cancer, late presentation, 
Middle East and seeking behaviour. Table 6 describes the synonyms used for 
searching. The Middle East countries chosen were those that are either near to Saudi 
Arabia or share similar culture, religion and level of economic development (or 
both).  
The first search was conducted numerous times between January and March 2011 
using multiple sources (Alhurishi et al., 2011). In May 2014, the search was rerun to 
update the previous review.  
                                                 
8
 Source: GIS base maps, modified by Suad Al Manji in GIS software, 2014. 
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The searches focused on published literature and used electronic databases 
comprising PubMed; Online OVID databases (BIOSIS, EMBASE, Global Health, 
MEDLINE and PsycIFNO); ISI Web of Knowledge (see Appendix A); and the 
Cochrane Library. The search terms presented in Table 6, using abbreviation of 
terms, for example  Saudi* and present*, were combined using Boolean operators 
(and/or).  
Table 6: Searching strategies 
Breast cancer Middle East Late presentation Seeking medical 
attention 
Breast tumour  
Breast neoplasm 
Breast carcinoma 
 
Eastern 
Mediterranean 
Saudi 
 Kuwait 
 Qatar 
 Bahrain 
 Oman 
 Emirate 
 Egypt 
 Sudan 
 Algeria 
 Morocco 
 Tunis 
Libya 
 Palestine 
 Lebanon 
 Iraq 
 Syria 
 Yemen 
 Iran 
Jordan 
Delay 
Late present 
Early present 
Postpone 
Wait 
Hesitate 
Defer 
Early stage 
Late stage 
Advanced stage 
Late action 
Early action 
 
 
Help seeking 
behaviour 
Waiting times 
Motivation 
Priorities 
Consultation 
Use of health 
services 
Access to care 
Symptoms duration 
Symptoms 
attribution 
Sick role 
Lag-time 
Seeking advice 
Barrier 
Time-factor 
Seek or ask or 
Look Near care or 
attention or Assist 
or help  
 
Since the public health literature on observational studies is widespread (Jackson and 
Waters, 2005) and the possibility of finding publications in languages other than 
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English is high—particularly in the Middle East (Habibzadeh, 2006)—other search 
methods were also used. Medical Journals in the Middle East were identified using 
the World Health Organization website
9
, as most of these journals are indexed and 
could be accessed through searches in the above databases. Thus, it was anticipated 
that recent publications could be identified from searching the medical databases 
above.  
Online thesis libraries (ProQuest and EThOS) and popular search engines (Google 
and Google Scholar) were also used. In addition, manual searches were also used, 
which involved looking at the reference lists of key sources. The searches were 
conducted using the English language. 
4.3.3 The output of the search strategy 
An updated search was run, and 2,491 studies were located (PubMed (n=1121); 
Online OVID databases (BIOSIS (n=107), EMBASE (n=710), Global Health 
(n=81), MEDLINE (n=203) and PsycIFNO (n=23)); ISI web of knowledge (n=239); 
Google website (n= 1) and manual searching (n=6)). Figure 9 shows the flow for the 
studies selection process undertaken in this review. After duplicate removal, a total 
of 1,815 studies remained. From their titles, 37 studies were identified as being 
relevant for inclusion in the review. After the abstracts had been screened, a further 
19 of these 37 were excluded.  
The final eligibility of these remaining 18 studies to be included in this review was 
then assessed, with a further six being excluded in total, either because they did not 
meet the inclusion criteria as no attempt to correlate late presentation for breast 
cancer with its possible cause was made (Abdelhadi, 2008, Aboserea et al., 2011, 
Ahmad, 2004, Landolsi et al., 2010) (see Appendix A), or because they had been 
located through manual searches and were non-retrievable (Corbex and McEwan, 
2010, Elzawawy, 1987).  
Thus, 12 studies were included in this review, of which ten used quantitative 
methods (Abdel-Fattah et al., 1999, Al Saad and Alsayed, 2012, Corbex, 2009, El-
Zawawy, 1991, Elzawawy, 1999, Ermiah et al., 2012, Harirchi et al., 2005, 
Montazeri et al., 2003, Mousa et al., 2011, Stapleton et al., 2011) and two used 
qualitative methods (McEwan et al., 2014, Rastad et al., 2012). 
                                                 
9
 http://applications.emro.who.int/library/imjournals/Default.aspx?id=2 Accessed 29 May 2014. 
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Figure 9: Flow chart of the studies searching and selection 
4.3.4 Quality assessment  
4.3.4.1 Quantitative studies  
Different methods exist for assessing the quality of observational studies in 
systematic reviews (Shamliyan et al., 2010). Unlike randomised controlled trials, 
there is no consensus on how to assess the quality of studies included in reviews of 
observational studies, and there is no transparent measure for differentiating between 
poor methods and poor reporting (Shamliyan et al., 2010).  
Records identified through 
database searching  
(n = 2,484) 
Additional records identified 
through other sources  
(n = 7) 
Records after duplicates removed  
(n = 1,815) 
Records screened  
(n = 37) 
Records excluded  
(n = 19) 
Full-text articles 
assessed for eligibility  
(n = 18) 
Full-text articles 
excluded, with reasons  
(n = 6) 
Studies included in 
qualitative synthesis  
(n = 2) 
Studies included in 
quantitative synthesis  
(n = 10) 
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To overcome the potential bias produced through poor quality studies, each 
quantitative study was assessed using a modified version of the elements from the 
Agency for Healthcare Research and Quality to rate the quality of individual 
observational studies. This comprised of a clear study question, a defined study 
population, an examination of the comparability of participants, an assessment to 
exposure to interventions, an outcome measurement, statistical analysis, the results, 
discussion and information about funding and sponsorship (West et al., 2002). 
Additional items were added (see Table 7) based on Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) recommendations (Von Elm et 
al., 2007b).  
Each study was given a weighed score out of 30, as shown in Table 7. A score of 24 
or above was considered to be indicative of high quality, while a score between 15 
and 23 was considered to be representative of moderate quality and a score of less 
than 15 was deemed to indicate low quality. 
None of the studies were excluded as a result of the quality assessments, and Table 7 
shows the quality assessment scores for the quantitative studies included in this 
review. Two studies were scored in the high quality range and the rest were 
considered to have moderate quality. All of these studies are included in the evidence 
synthesis. 
Generally, the studies included are of good quality, and use female patients that have 
been diagnosed with breast cancer patients in their studies. A common issue noticed 
among these studies is that they did not utilise the expected sample size that would 
be sufficient for generalising that factors are associated with late presentation in 
breast cancer. Montazeri et al. (2003) reflected on the generalisability of the findings 
and the possibility that they may have less power due to their small sample sizes. 
The power of the study findings was not commonly mentioned in the rest of the 
included studies, perhaps because of the limited number of available breast cancer 
patients, and it is possible that researchers recruited as many as they could for their 
studies. For example, Harirchi et al. (2005), in their cross-sectional study, reported 
that two hundred breast cancer patients from a health facility that had been 
diagnosed at stages IIb, III or IV had agreed to participate in their study over the 
course of a year (April 2000 to April 2001). 
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Table 7: Quality assessment of quantitative studies 
 
Item 
W
ei
g
h
ed
 
sc
o
re
 
(A
b
d
el
-F
a
tt
a
h
 
et
 a
l.
, 
1
9
9
9
) 
(A
l 
S
a
a
d
 a
n
d
 
A
ls
a
y
ed
, 
2
0
1
2
) 
(C
o
rb
ex
, 
2
0
0
9
) 
(E
l-
Z
a
w
a
w
y
, 
1
9
9
1
) 
(E
lz
a
w
a
w
y
, 
1
9
9
9
) 
(E
rm
ia
h
 e
t 
a
l.
, 
2
0
1
2
) 
(H
a
ri
rc
h
i 
et
 
a
l.
, 
2
0
0
5
) 
(M
o
n
ta
ze
ri
 e
t 
a
l.
, 
2
0
0
3
) 
(M
o
u
sa
 e
t 
a
l.
, 
2
0
1
1
) 
(S
ta
p
le
to
n
 e
t 
a
l.
, 
2
0
1
1
) 
1. Title and abstract are clear and appropriate. 
1 1 1 1 1 1 1 1 1 1 1 
2. Study question and aim are clear and focused. 
1 1 1 1 1 1 1 1 1 1 1 
3. Study population is female breast cancer patients. 
1 1 1 1 1 1 1 1 1 1 1 
4. Sample size is justified. 
1 1 0 0 0 0 1 0 1 0 0 
5. Subjects are comparable. 
1 1 1 1 1 1 1 1 1 1 1 
6. Inclusion & exclusion criteria are appropriate.  
1 1 0 0 1 1 0 1 1 0 1 
7. Criteria are applied equally to all groups. 
1 1 0 0 1 1 0 1 1 0 1 
8. Exposure exists. 
1 1 1 1 1 1 1 1 1 1 1 
9. Methods are standards and valid. 
1 1 1 1 1 1 1 1 1 1 1 
10. Outcome measure: outcome variables, predictors 
and confounders are clear. 3 3 2 2 2 2 1 2 2 2 3 
11. Efforts to address bias are described. 
 1 0 0 0 0 0 1 1 0 1 1 
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12. An explanation for how the sample size was 
arrived at is provided. 1 1 0 0 1 1 1 0 1 0 1 
13. Statistical analysis: test is appropriate. 
1 1 1 1 1 1 1 1 1 1 1 
            
14. Statistical analysis: univariate analysis or 
multivariate analysis (or both) are provided.  3 3 1 1 1 1 2 1 3 3 1 
15. Studies have statistical power. 
1 0 0 0 0 0 0 0 0 0 0 
16. Results: the number of participants at each stage is 
provided, together with non-participation rates and 
the reasons for these. 
2 2 1 1 2 2 2 2 2 2 2 
17. Descriptive data is provided 
1 1 1 1 1 1 1 1 1 1 1 
18. Main results are provided 
1 1 1 1 1 1 1 0 1 1 1 
19. Other results are provided. 
1 1 1 1 0 0 1 0 0 1 1 
20. Discussion: summary of the key results is given. 
1 1 1 0 1 1 1 1 1 1 1 
21. Bias and limitations are addressed. 
1 0 0 0 0 0 0 1 1 1 0 
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22. Interpretation of the findings is provided. 
1 1 1 1 1 1 1 1 1 1 1 
23. The study has generalisability.  
1 1 0 0 0 0 0 1 1 0 1 
24. Funding or sponsorship has been provided. 
1 1 0 1 0 0 1 0 0 1 0 
25. Ethical issues, including approval, have been 
addressed and secured. 1 0 1 0 0 0 1 0 0 0 1 
Total Weighed score 30 26 17 16 19 19 22 20 23 22 24 
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4.3.4.2 Qualitative studies  
The trustworthiness of the results in the included studies was evaluated to explore 
the extent to which these studies could contribute to this review. The Critical 
Appraisal Skills Programme’s (CASP) qualitative research checklist (Critical 
Appraisal Skills Programme (CASP), 2014) was used to assess the reporting in the 
qualitative studies. Each study was given a weighed score out of 34, as shown in 
Table 8. A score of 26 or above is considered to indicate high quality, a score of 17 
to 25 to indicate moderate quality, and a score of less than 17 to indicate low quality. 
Table 8 presents the total scores for the quality assessments of the qualitative studies, 
which were all scored to be of acceptable quality, even though there was significant 
variation in the scores.  
Table 8: Quality assessment of qualitative studies 
Item 
Weighed 
score 
(Rastad 
et al., 
2012) 
(McEwan 
et al., 2014) 
Was there a clear statement of the aims of 
the research? 
3 3 3 
Is a qualitative methodology appropriate? 2 2 2 
Was the research design appropriate to 
address the aims of the research? 
1 0 1 
Was the recruitment strategy appropriate to 
the aims of the research? 
3  1 3 
Was the data collected in a way that 
addressed the research issue? 
7 3 3 
Has the relationship between researcher and 
participants been adequately considered? 
2 2 1 
Have ethical considerations been taken into 
account? 
3 1 3 
Was the data analysis sufficiently rigorous? 6 1 4 
Is there a clear statement of the findings? 4 2 4 
How valuable is the research? 3 2 1 
Total Weighed score 34 17 23 
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4.4 Data analysis  
4.4.1 Quantitative studies  
It was difficult to draw evidence of factors that influenced late presentation from the 
selected studies using meta-analysis because of differences in how late presentation 
was defined (as described in section 4.5.1), together with differences in the factors 
that were included in the studies (Ramirez et al., 1999). Conclusions about the 
direction of effect of factors on late presentation were drawn using Ramirez et al. 
(1999) classification of ‘evidence strength’. This classification weighs the number of 
studies and the sample sizes of those studies in relation to their effects on late 
presentation. The direction of evidence (strength) was assessed in terms of one of 
three categories: strong, moderate or insufficient.   
A ‘strong’ association between a factor and late presentation can be said to exist if a 
high proportion of studies supports the association, there are a large number of 
patients to support the effect, and there is a low chance that a new and large study 
will have contradictory results.  
A ‘moderate’ association between the factor and late presentation exists if at least 
two studies support the association, but it is possible that a new large study could 
affect the conclusion.  
An ‘insufficient’ evidence to support the association of a factor and late presentation 
if only one study supports the effect of the factor, or when the numbers of studies for 
and against the effect of the factor are equal.  
4.4.2 Qualitative studies  
Meta-ethnography (Noblit and Hare, 1988) was used to synthesise evidence from 
qualitative studies by identifying common themes and concepts from each study 
included in the review. The themes or concepts in each study are then examined to 
see if there are contradictions and to explain objections in results , before a general 
interpretation from the results of the studies can be drawn (Dixon-Woods et al., 
2005). Meta-ethnography is a commonly used method (Britten et al., 2002, Campbell 
et al., 2003, Elmir et al., 2010, Malpass et al., 2009), and has previously been utilised 
in systematic reviews to understand cancer patient’s health-seeking behaviours and 
delays (Smith et al., 2005).  
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4.5 Results  
This section presents the results of the review. In total, 12 studies (quantitative, n=10 
and qualitative, n=2) were found to be relevant and thus included in the review (see 
Table 9). None of the included studies was conducted in Saudi Arabia, but included 
studies from Egypt (n=7), Iran (n=3), Bahrain (n=1) and Libya (n=1). The evidence 
explored in this review comes from studies that investigated factors associated with 
late-presentation breast cancer among women, and were published between 1991 and 
2014. 
These studies examined the effect of certain factors on late-presentation breast 
cancer among female patients at various points, from recognition of breast cancer 
symptoms to seeking medical care (point I); to diagnosis (point II); to treatment 
(point III), as illustrated in Figure 10.  
There was no common definition used for late presentation or diagnosis with breast 
cancer (see Table 9). However, the majority of the included studies focused on point 
I of late presentation, which commonly invoked more than three months between 
systems recognition and contact with medical practitioners as the marker for late 
presentation. The disparity that is seen in the length of time that is classified as late 
presentation for point I in Middle Eastern studies perhaps reflects the tension 
between global scientific findings on the significance that delaying more three 
months has for breast cancer survival rates (Richards et al., 1999a) and the need to 
reduce the time for presentation in the Middle East, where seeking medical care in 
less than one month from the self-recognition of symptoms has been viewed as being 
critical (Harirchi et al., 2005).   
The lack of a standardised cut-off point was also common for Point II of the medical 
care process, which was assessed using four weeks (Abdel-Fattah et al., 1999), three 
weeks (Ermiah et al., 2012) and two weeks (Mousa et al., 2011) as cut-off points. 
Another way to examine factors associated with point II of late presentation was to 
use the stage at breast cancer diagnosis, which might reflect on the time from 
seeking medical care (point I) to the point at which a definite diagnosis is made 
(point II). Point III of late presentation was given little attention in the literature 
(Corbex, 2009, McEwan et al., 2014).  
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Figure 10: Points of late-presentation breast cancer among females journey 
from seeking healthcare to treatment 
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of symptoms  
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before seeking 
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health facility 
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diagnosis 
Treatment 
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Treatment 
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Table 9: Description of the review studies 
No. Study Sample size  Methods Country Late-presentation point Criteria 
1 (El-Zawawy, 1991) N=80 Quantitative Egypt Patient delay Three months 
2 (Elzawawy, 1999) N=182 Quantitative Egypt Patient delay  Three months 
3 (Montazeri et al., 2003) N=190 Quantitative Iran Patient delay Three months 
4 (Harirchi et al., 2005) N=200 Quantitative Iran Patient delay One month 
5 (Corbex, 2009) N=204 Quantitative  Egypt Patient, diagnosis and 
treatment delay 
Patient delay: one month 
Treatment delay: 
fourteen days 
6 (Abdel-Fattah et al., 1999) N=565 Quantitative Egypt Patient and diagnosis 
delay 
Patient delay: three 
months 
Diagnosis delay: four 
weeks 
7 (Mousa et al., 2011) N=163 Quantitative  Egypt Patient and diagnosis 
delay  
Patient delay: three 
months 
Diagnosis delay: two 
weeks 
8 (Ermiah et al., 2012) N=200 Quantitative Libya Patient and diagnosis 
delay 
Patient delay: three 
months 
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Diagnosis delay: three 
months 
9 (Stapleton et al., 2011) N=345 Quantitative  Egypt Diagnosis delay Early stage breast cancer: 
stages I and II.  
Late stages: stage III and 
IV. 
10 (Al Saad and Alsayed, 2012) 
 
N=161 Quantitative  Bahrain Diagnosis delay  Early breast cancer (T1, 
T2, N0-N1, M0), locally 
advanced (T3, T4, N0-
N2, M0), advanced or 
systematic (T1-T4, N0-
N3, M1)  
11 (Rastad et al., 2012) N=10 Qualitative  Iran  Patient delay  Three months 
12 (McEwan et al., 2014) N=15 Qualitative Egypt  Patient, diagnosis and 
treatment delay 
Three months.  
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4.5.1 Results from the review of the evidence from the quantitative studies 
Table 10  lists the factors that are associated with late-presentation, point I. Strong 
evidence from four studies (n=1,168) supported the hypothesis that there is an 
association between education and late-presentation breast cancer (Abdel-Fattah et 
al., 1999, Ermiah et al., 2012, Harirchi et al., 2005, Montazeri et al., 2003), although 
one study (n=163) did not find a significant association (Mousa et al., 2011). The 
latter study understood education in terms of either having or not having a bachelor’s 
degree, however, whereas the other studies understood it with reference to a wider 
range of features, such as being literate or not (Abdel-Fattah et al., 1999, Ermiah et 
al., 2012, Harirchi et al., 2005, Montazeri et al., 2003). Illiteracy still exists in the 
Middle East
10
 (UNESCO, 2003), and so the association between late presentation for 
diagnosis with breast cancer and education may not concern women’s levels of 
formal higher education, but rather whether they are literate or illiterate. 
Moderate evidence suggests that age is associated with late presentation for female 
breast cancer (n= 1,027) (Abdel-Fattah et al., 1999, El-Zawawy, 1991, Elzawawy, 
1999, Ermiah et al., 2012). In contrast, two studies did not support the likelihood of 
this association (Montazeri et al., 2003, Mousa et al., 2011). However the net sample 
(n= 366) was smaller compared to the supportive studies (as shown in Table 10).  
There was moderate evidence for an association between knowledge about breast 
cancer (n=404) and late presentation (Corbex, 2009, Harirchi et al., 2005), and 
similarly with breast self-examination (n=765) (Abdel-Fattah et al., 1999, Ermiah et 
al., 2012). This relationship was examined in two studies, and both provided 
evidence supporting the association.  
There was moderate evidence from four studies (n=1,027) of no association between 
marital status and late presentation (Abdel-Fattah et al., 1999, El-Zawawy, 1991, 
Elzawawy, 1999, Ermiah et al., 2012). Two Iranian studies suggested that marital 
status is associated with late presentation, but marital status was categorised 
differently in these studies. In one of them, being divorced or widowed was 
significantly associated with late presentation compared to being married or single 
(Montazeri et al., 2003). A later study classified women as being married or single, 
and found that  single women less likely to delay compared to married ones (Harirchi 
                                                 
10
 70 million illiterates people 
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et al., 2005). This finding indicates the likelihood that socio-cultural elements 
influence whether marital status has an impact on late presentation.  
Similarly, there was moderate evidence to suggest that employment status is not 
associated with late presentation, with three studies (n=825) (Abdel-Fattah et al., 
1999, El-Zawawy, 1991, Elzawawy, 1999) reporting no link, whilst one study found 
it to be significantly associated with late presentation (Ermiah et al., 2012).  
Breast cancer symptoms were found not to be associated with late-presentation for 
diagnosis with breast cancer in studies on a total of 931 women (Abdel-Fattah et al., 
1999, Montazeri et al., 2003, Mousa et al., 2011), whilst a study on 200 women 
found a link  between having breast lump  or having other breast cancer symptoms 
(Ermiah et al., 2012). There was also insufficient evidence to draw conclusion about 
the effects of many other factors (see Table 10).   
Table 11 presents evidence gathered from the included studies about factors 
associated with late-stage diagnosis (point II of late presentation for breast cancer 
diagnosis). The evidence strongly suggested that the type of healthcare that is sought 
is significantly associated with late presentation (n=1,275) (Abdel-Fattah et al., 
1999, Corbex, 2009, Mousa et al., 2011, Stapleton et al., 2011), and that age is not 
associated with late-stage diagnosis (n=1,232) (Abdel-Fattah et al., 1999, Al Saad 
and Alsayed, 2012, Mousa et al., 2011, Stapleton et al., 2011).  
There is a moderate level of evidence to suggest that types of breast cancer 
symptoms, having lump vs other symptoms and no pain, are associated with late-
stage diagnosis (n=1,108) (Abdel-Fattah et al., 1999, Ermiah et al., 2012, Stapleton 
et al., 2011). However, Mousa et al. (2011) did not find this association based on 
their study of 163 women.  
Education was not associated with late-stage diagnosis based on the moderate level 
of evidence provided by 543 women (Mousa et al., 2011, Stapleton et al., 2011). 
However, Ermiah et al. (2012) found the opposite relationship to hold in a study of 
200 women. In addition, there is a moderate level of evidence to suggest that a 
family history of breast cancer is not associated with late-stage diagnosis (n=324) 
(Al Saad and Alsayed, 2012, Mousa et al., 2011).  
The evidence from these studies was not sufficient for drawing conclusions 
concerning the association between late-stage presentation and numerous factors (as 
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presented in Table 11). Similarly, there was insufficient evidence to draw any 
conclusion about factors associated with point III of late presentation, as it was 
investigated in only one study (Corbex, 2009).  
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Table 10: Factors associated with the first point of late presentation: from discovery of symptoms to seeking medical attention 
Factors 
Association with late presentation Direction and strength of 
association established Significantly associated   Not associated  
Education  N=1,168 (Abdel-Fattah et al., 1999, Ermiah et 
al., 2012, Harirchi et al., 2005, Montazeri et al., 
2003) 
N=163 (Mousa et al., 2011) Strong association  
Age    N= 1,027 (Abdel-Fattah et al., 1999, El-
Zawawy, 1991, Elzawawy, 1999, Ermiah et al., 
2012) 
N= 366 (Montazeri et al., 
2003, Mousa et al., 2011) 
Moderate association  
Breast self-examination N=765 (Abdel-Fattah et al., 1999, Ermiah et al., 
2012) 
 Moderate association  
Knowledge about 
symptoms 
N=404 (Harirchi et al., 2005) (Corbex, 2009)  Moderate association 
Marital status N= 403 (Harirchi et al., 2005, Montazeri et al., 
2003) 
N= 1,027 (Abdel-Fattah et al., 
1999, El-Zawawy, 1991, 
Elzawawy, 1999, Ermiah et 
al., 2012) 
Moderate evidence of no 
association  
Employment status N=200 (Ermiah et al., 2012) N= 827 (Abdel-Fattah et al., 
1999, El-Zawawy, 1991, 
Moderate evidence of no 
association 
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Elzawawy, 1999) 
Breast cancer symptoms  N=200 (Ermiah et al., 2012) N= 931 (Abdel-Fattah et al., 
1999, Montazeri et al., 2003, 
Mousa et al., 2011) 
Moderate evidence of no 
association 
Place of residence  
 
N= 200 (Harirchi et al., 2005) N= 163 (Mousa et al., 2011) Insufficient evidence 
Access to physician in 
place of residence  
N=200 (Harirchi et al., 2005) None Insufficient evidence 
Low economic status N=200 (Harirchi et al., 2005) None  Insufficient evidence 
Menopause status  None  N=200 (Ermiah et al., 2012) Insufficient evidence 
Breastfeeding N=200 (Ermiah et al., 2012) None  Insufficient evidence 
Oral contraceptives  N=200 (Ermiah et al., 2012) None  Insufficient evidence 
Number of children None  N= 203 (Montazeri et al., 
2003) 
Insufficient evidence 
Family history of breast 
cancer 
N=204 (Harirchi et al., 2005, Montazeri et al., 
2003) (contradictory) 
N=200 (Ermiah et al., 2012) Insufficient evidence   
History of benign breast 
disease 
N=200 (Ermiah et al., 2012) N= 203 (Montazeri et al., 
2003) 
Insufficient evidence 
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History of chronic illness  None  N= 200 (Harirchi et al., 2005) Insufficient evidence 
Not disclosing symptoms  N=204 (Corbex, 2009) None  Insufficient evidence 
Knowledge about 
prevalence 
None  N=200 (Harirchi et al., 2005) Insufficient evidence 
Knowledge about the 
main way of diagnosis  
N=200 (Harirchi et al., 2005) None  Insufficient evidence 
Attitudes about 
prevention and treatment  
None  N=200 (Harirchi et al., 2005) Insufficient evidence 
Attitude toward breast 
self-examination  
N=200 (Harirchi et al., 2005) None  Insufficient evidence 
Familiarity with breast 
self-examination  
None  N=200 (Harirchi et al., 2005) Insufficient evidence 
Not Receiving education 
about breast cancer after 
discovering a lump 
N=204 (Corbex, 2009) None  Insufficient evidence 
 
 
- 75 - 
 
Table 11: Factors associated with the second point of late presentation, breast cancer diagnosis 
Factors 
Association with late presentation 
Direction and strength of 
association established Significantly associated  Not associated  
Type of health care  N= 1275 (Abdel-Fattah et al., 1999, 
Corbex, 2009, Mousa et al., 2011, 
Stapleton et al., 2011) 
None  Strong association  
Age    None  N= 1232 (Abdel-Fattah et al., 1999, Al 
Saad and Alsayed, 2012, Mousa et al., 
2011, Stapleton et al., 2011) 
Strong evidence of no 
association 
Type of symptoms N= 1108 (Abdel-Fattah et al., 1999, 
Ermiah et al., 2012, Stapleton et al., 
2011) 
N= 163 (Mousa et al., 2011) Moderate association  
Education  N= 200 (Ermiah et al., 2012) N= 543 (Mousa et al., 2011, Stapleton 
et al., 2011) 
Moderate evidence of no 
association 
Family history of breast 
cancer  
None  N= 324 (Al Saad and Alsayed, 2012, 
Mousa et al., 2011) 
Moderate evidence of no 
association 
Health insurance  N=565 (Abdel-Fattah et al., 1999) None  Insufficient evidence 
Place of residence  None  N= 163 (Mousa et al., 2011) Insufficient evidence 
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Breast self-examination N= 200 (Ermiah et al., 2012) None  Insufficient evidence 
History of benign 
disease  
N=200 (Ermiah et al., 2012) None  Insufficient evidence 
Oral contraceptives  N=200 (Ermiah et al., 2012) None  Insufficient evidence 
Marital status  None  N= 161 (Al Saad and Alsayed, 2012) Insufficient evidence 
Having children  None  N= 161 (Al Saad and Alsayed, 2012) Insufficient evidence 
Employment None  N= 343 (Stapleton et al., 2011) Insufficient evidence 
Treatment status  N= 343 (Stapleton et al., 2011) None  Insufficient evidence 
History of mammogram None  N=343 (Stapleton et al., 2011) Insufficient evidence 
History of clinical breast 
examination  
None  N=343 (Stapleton et al., 2011) Insufficient evidence 
Knowledge of breast 
self-examination 
N=343 (Stapleton et al., 2011) None  Insufficient evidence 
Social, financial and 
time 
None  N=343 (Stapleton et al., 2011) Insufficient evidence 
Physician misdiagnosis  N=204 (Corbex, 2009) None  Insufficient evidence 
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4.5.2 Results from evidence review of qualitative studies 
There have been two original studies in the Middle Easton late presentation using 
qualitative methods (McEwan et al., 2014, Rastad et al., 2012), and these are 
published in oncology-related journals. They collected qualitative data in total was 
from 25 participants through interviews, and both looked at how women recognise 
their symptoms and seek medical care. There are several reasons for late 
presentation, and these can be grouped into two categories: patient-related and 
healthcare-related.  
4.5.2.1 Patient-related factors  
An important element relating to late presentation is whether breast cancer patients 
successfully recognise breast changes, interpret them as being serious, and relate 
them to breast cancer.  
The false interpretation of symptoms is common and leads women to postpone 
seeking medical advice (McEwan et al., 2014, Rastad et al., 2012). Incorrect 
interpretation of symptoms might result from poor knowledge or misconceptions 
about breast cancer (McEwan et al., 2014, Rastad et al., 2012), and the prevalence of 
late presentation might increase when women underestimate the risk of having breast 
cancer.  
As Rastad et al. observed, this happens when patients think:  
I thought that it [cancer] could occur to others but I didn’t think that 
it would occur to me (Rastad et al., 2012 p.4513). 
The possibility of late presentation might also increase due to the fear of ‘saratan’ 
(McEwan et al., 2014) (as illustrated in Chapter 2). This fear may result from women 
hearing the experiences of other people diagnosed with cancer (McEwan et al., 2014, 
Rastad et al., 2012). Some women might feel happier or less afraid by postponing 
seeking medical care and thus not knowing whether they have breast cancer than 
they would be were they to have a diagnosis of breast cancer confirmed (Rastad et 
al., 2012). 
In addition, family or work commitments can be barriers to the prompt seeking of 
healthcare. A woman might have several roles—as a mother, wife, daughter, and 
sister (Rastad et al., 2012)—and these competing roles and the priorities they are 
perceived as generating may provide some explanation for late presentation.  
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Close family contact and support might encourage women to present early if they 
notice symptoms. McEwan et al. (2014) relay their finding that none of the 
participants in their study reported being discouraged by close family or friends. This 
may be explained by the fact that Muslims are encouraged to look after their health 
and to seek medical care if needed (as discussed in Chapter 2). In addition, social 
networks might play a fundamental role in receiving breast cancer-related advice and 
information. Depending on the advice received, social networks may even facilitate 
early presentation (McEwan et al., 2014).  
4.5.2.2 Healthcare-related factors 
Two issues relating to healthcare may play role in the late presentation for and/or late 
diagnosis of breast cancer in the Middle East. The first one is related to the health 
systems found in the different countries in this region. In Egypt, for example, 
financial considerations have been linked to late presentation, in particular the cost 
of healthcare and transportation to health facilities (McEwan et al., 2014). However, 
financial matters are unlikely to have a significant bearing in all Middle Eastern 
countries, such as in the Gulf States, for example, where healthcare is free for all 
nationals.  
Moreover, the process of navigating through the healthcare system to receive the 
proper diagnosis could be an issue for some women, who may not be sure where to 
go to check their breast cancer symptoms, which may be located a long distance 
away from them (McEwan et al., 2014).  
The second healthcare issue relating to late presentation and diagnosis is health 
professional-related. Misdiagnosis has been reported to be an issue that has led to a 
number of advanced stage diagnoses and treatment delays (McEwan et al., 2014, 
Rastad et al., 2012). Moreover, patient-doctor communication can also contribute to 
a delay in diagnosis or treatment. Women sometimes fear having a lack of 
knowledge and certainty about what could happen after they seek healthcare, and 
health professional might worsen the situation if they do not communicate with 
patients well, as the following quote from McEwan et al. highlights: 
He spoke in dry manner. I was frightened … He said that we will do 
this and that and maybe the breast will be removed. Maybe we cut a 
bit away. It was a shock (McEwan et al., 2014 p.5). 
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The variation in healthcare systems could help to explain the difference in issues 
such as financial burdens. The ability to afford health costs was mentioned in one 
study (McEwan et al., 2014), but not in the other one (Rastad et al., 2012). The cost 
of healthcare might be unique to certain countries, particularly where it is not 
provided free of charge. 
4.6 Discussion 
Research into late-presentation and diagnosis for breast cancer among women in the 
Middle East is in its infancy, going back only as far as the 1980s, although the 
international literature on late presentation for breast cancer goes back as far as 1932 
(Ramirez et al., 1999). Perhaps the growing interest in research in this area can be 
attributed to the combination of the alarming rises in the incidence of breast cancer 
and the fact that it is often diagnosed at advanced stages (World Health Orgnization, 
2009).  
This review included an additional six quantitative and two qualitative studies 
compared to the previously published one (Alhurishi et al., 2011). No standard 
definition of late presentation was seen in the literature, although there were 
distinctions between the seeking of healthcare, and diagnosis and treatment for 
cancer (as shown in Table 9 and Figure 10).  
The present review indicated the complexity of breast cancer and the possibility that 
multiple factors might be associated with the late presentation, diagnosis and 
treatment of it in the Middle East. There was no unified approach for examining 
factors associated with breast cancer in these studies, and therefore drawing 
conclusions from all the different factors addressed in them was challenging. 
However, all the studies shared the idea of examining late-presentation breast cancer 
in women with confirmed diagnoses.  
The heterogeneity in definitions of late presentation, as well as in the variables (or 
factors) examined in relation to late presentation and the categories within each 
variable prevented a meta-analysis from being conducted. Instead, each variable’s 
direction of effect was assessed, and this approach thus diverged from previous 
reviews in this area (Facione, 1993, Ramirez et al., 1999). In addition, these studies 
recruited a small number of diagnosed women, which made it difficult to draw firm 
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and reliable conclusions—a problem that is common in studies of breast cancer delay 
(Ramirez et al., 1999).    
4.6.1 Late-presentation breast cancer  
There is moderate evidence that types of symptoms are not associated with late 
presentation by breast cancer patients. This may be because seeking medical 
treatment revolves less around women’s recognition of symptoms than their 
mistaken interpretations of these symptoms as being unrelated to breast cancer, as 
described in the qualitative synthesis. Many women may have a low awareness about 
breast cancer and its symptoms, and this might interfere with the timely seeking of 
medical care due to faulty interpretations that the symptoms are not an indication 
breast cancer. This factor is well-documented across cancer help-seeking studies 
(Smith et al., 2005). Perceptions of illness can also be influenced by the type of 
symptoms, their severity, pain, previous experiences of benign diagnoses, and beliefs 
about symptoms.   
The role that misconceptions play in preventing the timely seeking of medical care is 
supported by moderate evidence from the quantitative syntheses, which suggest that 
not practicing breast self-examination and being less aware of cancer symptoms, is 
moderately associated with late presentation.  
Women’s lack of awareness in Middle eastern countries could be explained by the 
strong association between lower education levels and late presentation––in terms of 
being literate vs. illiterate, as this relationship does not hold when illiteracy is not a 
factor in educational levels (Mousa et al., 2011). Illiteracy is assumed to be higher 
among older women than younger women in Middle Eastern countries, and this 
might explain the moderate association between older age and late presentation, as 
noted in the quantitative evidence. The association between older age and late 
presentation in the Middle East fits with the published literature in this area (Ramirez 
et al., 1999).  
It is also a possibility that lower education levels might prevent individuals from 
accessing correct health messages, resulting in misconceptions and fears about breast 
cancer, as reported in the qualitative synthesis. This could also interfere with the 
timely seeking of medical care. The literature supported the association between 
fewer years of education and breast cancer treatment-seeking delays (Ramirez et al., 
1999). 
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A synthesis from the qualitative studies will provide further explanations concerning 
the effects that patient-related and healthcare-related factors have on late 
presentation. One important factor that may explain why some patients take a long 
time to seek medical attention is the issue of how breast cancer patients interpret 
symptoms and what makes them consider symptoms serious enough to seek 
healthcare. Fears about cancer or embarrassment are commonly cited as causal 
barriers to seeking treatment in qualitative studies of cancer (Smith et al., 2005). 
Dubayova et al. (2010) examined the role of fear in cancer and acute myocardial 
infarction, with 6 out of the 15 studies they reviewed focussing on breast cancer, and 
their review provides some candidate explanations about how fear might affect 
delays in seeking healthcare. Fear can either encourage or act as a barrier to help-
seeking behaviour, depending on the reasons for the fear and how the patient copes 
with it (Dubayova et al., 2010). The relationship between fear and help-seeking is 
linked with differences in the perceptions of symptoms. Thus, women might have 
different symptoms and experience different sensations from the same symptoms, 
and this may be a factor in their “fight or flight” in coping with fear (Dubayova et 
al., 2010). 
The quantitative synthesis in this study did not support the association between 
marital status and late stage diagnosis as in those in other parts of the world 
(Ramirez et al., 1999).  
One of the challenges for understating the effect of marital status is that there are 
differences in how studies categorise marital status, with some using the simple 
alternatives married vs. unmarried, and others using the more detailed list of married, 
single, widowed and divorced. However, the qualitative synthesis illustrates the 
positive role that family members and other close people have on health-seeking 
behaviours, and perhaps it is thus no longer important to know if a female patient is 
married or not if she receives proper support and encouragement from her family to 
seek medical care. 
4.6.2 Late diagnoses of breast cancer  
In this review, some studies move beyond point I of late presentation in exploring 
the factors associated with late diagnoses of breast cancer. While patients might play 
role in late diagnosis, the quantitative synthesis did not show support for a 
relationship between age, education, family history and late diagnosis, although it 
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did show that type of healthcare provision is associated with late diagnosis, possibly 
as a result of the variations in availability  and  quality of healthcare services and in 
Middle Eastern countries. The qualitative synthesis explains the role that healthcare 
plays in late diagnosis in terms of the cost of healthcare and the fact that referrals to 
health specialists might present an obstacle to early diagnosis.  
While types of breast cancer symptoms are not associated with late presentation 
(point I), they are however moderately associated with late diagnosis 
(quantitatively). This might (qualitatively) explain the reasons for misdiagnosis by 
healthcare professionals, who might have a low awareness about breast cancer and 
its epidemiology in the Middle East. 
There was no consistency in the sets of factors that different studies examined, 
leading to insufficient strengths in the associations made between many of them. As 
a result, this review cannot confirm the magnitude of the effect of these factors on 
late presentation, and cannot thus inform future policy and interventions using such 
data. However, it can make suggestions about factors that should be prioritised for 
future research and interventions. Older women and women with lower educational 
levels are more likely to present later compared to others, and these facts might be 
important for generating hypotheses for new research in this area. 
As noted, none of the included studies described the power of their studies during the 
quality assessment, and future studies need to be clear in reporting their sample size 
and powers in order to strengthen evidence for future policies.  
A majority of the studies that were included focused on the patients’ opinions in 
order to understand the reasons for late presentation, with a few studies focussing on 
further points in the diagnosis and treatment of the patients. Future research would 
benefit from exploring the points further on in the treatment process of late 
presentation patients, and focusing on key players that might influence late 
presentation other than the patients. 
While the qualitative synthesis provided here provides some understanding of the 
reasons for late presentation, it was only based on two studies. Although the main 
reasons for late presentation did not differ from those found in other studies (Smith 
et al., 2005), more qualitative studies could provide a better understanding of the 
contextual factors relating to late presentation in the Middle East. 
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4.7 Strengths and limitations of the research review  
One of the strengths of this review compared to the one that was previously 
undertaken by the author is its interpretive synthesis, which brings qualitative and 
quantitative evidence together (Dixon-Woods et al., 2005). The process of data 
analysis was carried out without previously determining the empirical evidence, and 
the definition of late-presentation breast cancer was not fixed in advance either, with 
the synthesis bringing evidence and summarising data in relation to the definitions 
that were adopted.  
The systematic review provided an efficient research method for locating and 
understanding recent studies on late-presentation breast cancer among women in 
countries similar to the context of the study, and assisted in weighing the consistency 
and generalisability of the evidence. The review utilised comprehensive searches to 
reduce bias through locating studies using specific inclusion and exclusion criteria, 
and by allowing evidence to be gathered from a wide range of methods. 
A number of limitations of the review need to be highlighted, however, in order to 
make its scope clear. First, the searches were mainly conducted electronically and in 
the English language. There are several languages used across Middle Eastern 
countries, and it was difficult to search for evidence in all of them (Habibzadeh, 
2006). It is possible that evidence published in languages other than English was not 
located, and therefore not included. A challenge for conducting systematic reviews 
in Middle Eastern countries is the difficulty of locating studies, as some journals are 
not published electronically (Habibzadeh, 2006).  
Second, the analysis of the results from the quantitative studies produced likelihoods 
of strength of the effects of the various factors explored on late presentation. 
However, it did not provide estimates of the magnitude and likelihood of risk for any 
of the factors explored in relation to late presentation, because a meta-analysis was 
not undertaken. Therefore, the evidence that was generated from this review was 
insufficient to inform policies for addressing the problem of late-presentation breast 
cancer. 
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4.8 Output of phase I 
The updated systematic review indicates the shortage of studies that exist in this 
research area in Middle Eastern countries. The lack of evidence from quantitative or 
qualitative studies in Saudi Arabia about factors associated with late presentation by 
women with breast cancer therefore emphasised the value of conducting further 
research in this area, as well as the originality of this thesis.  
In addition, the benefits of using qualitative methods to provide an in-depth 
understanding of the reasons for late presentation by breast cancer patients provided 
through the quantitative evidence were clearly shown. In Egypt, a qualitative study 
on late presentation was conducted to provide greater understating of quantitative 
studies (McEwan et al., 2014), indicating the value of employing mixed methods in 
this thesis.  
4.9 Summary  
The purpose of this chapter was to review evidence about factors associated with late 
presentation by female breast cancer patients. Ten quantitative studies and two 
qualitative studies were located. Following the analysis of the evidence from those 
studies, it was seen that older age and a lower education level were associated with 
an increased probability of late presentation. The variation in defining the outcome—
late presentation—and the independent variables did not facilitate the calculation of 
the estimated effects of these factors. However, some factors were addressed in the 
qualitative studies, and were overlapped with the findings of the broader literature.  
As the effects of factors such as age were not determined in this review, it is 
important to discover what effects age and other factors had in Saudi Arabia to help 
healthcare professionals identify women who are at higher at risk of presenting late 
for the diagnosis and treatment of breast cancer. In addition, the contexts that 
influence late presentation need to be understood in order to guide future 
interventions to tackle this problem. Hence, qualitative methods should also be 
utilised in such research. 
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Chapter 5: Phase II—Late-stage diagnosis of female breast 
cancer in Saudi Arabia, a quantitative study  
5.1 Introduction  
This chapter describes the second phase of in this mixed methods PhD—the 
quantitative study. This study addresses the second objective of the thesis: To 
analyse registry data from Saudi Arabia to find factors associated with late-stage 
diagnosis of breast cancer. To examine this issue, data from the SNCR in Saudi 
Arabia (1994–2006) was analysed in order to identify significant factors associated 
with late-stage tumours at the point of breast cancer diagnosis. Previous studies have 
used data from the SNCR to investigate the prevalence of breast cancer, to calculate 
breast cancer survival rates and to predict the future incidence of breast cancer 
(Alghamdi et al., 2013, Hamdan et al., 2011, Ibrahim et al., 2008). This study is 
original in that no previous published study has used this valuable data source to 
examine the problem of late presentation and diagnosis. 
This chapter starts with a recap on the study’s importance, aims and objectives, 
together with the methods used, including the key variables and strategies for 
analysing the data. It then outlines the study’s findings, beginning with the 
descriptive data, before providing the results, detailing the factors that were found to 
be associated with late-stage diagnoses of breast cancer using ordinal and binary 
logistic regressions, and assessing their impact on the following phase of the thesis 
(as previously described in section 3.4, Chapter 3). A summary of the key findings is 
provided at the end of the chapter. 
5.2 Rationale  
The systematic review of the literature on late presentation for breast cancer in the 
Middle East (see Chapter 4) highlighted deficiencies in the research in this area in 
the Gulf States, and in Saudi Arabia in particular. This chapter addresses the second 
objective of the thesis—to provide useful information about the main effect of the 
factors that have been found to influence breast cancer at diagnosis. This information 
about the stage of breast cancer diagnosis is macro-level data as it uses data from the 
SNCR in Saudi Arabia. 
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5.2.1 The aim of the study  
The aim of this phase of the PhD work is to identify risk factors associated with late-
stage breast cancer diagnosis using SNCR data for the period 1994–2006.  
5.2.2 Objectives  
1- To capture patterns of breast cancer diagnosis and to profile female patients 
presenting with breast cancer. 
2- To investigate potential risk factors and protective factors (age, marital status, 
nationality, year of  diagnosis and place of residence) associated with the stage of 
cancer at diagnosis, and to identify potential risk factors for late presentation 
using ordinal and logistic regression analyses.  
3- To establish the strengths and limitations of the data and the analysis. 
5.3 Study questions 
This study seeks to address the following questions: 
1- Is there a relationship between the stage of breast cancer and the time of 
diagnosis? 
2- What factors are associated with late stage diagnosis? 
3- Are older women more likely to be diagnosed with more late stages of breast 
cancer? 
4- Does the stage of breast cancer at diagnosis vary over time? 
5- Is a patient’s location associated with stage of cancer at diagnosis? 
6- Is there any relation between late-stage diagnosis and patients’ nationalities? 
7- Is marital status associated with late-stage diagnosis? 
5.4 Methods 
5.4.1 Study design  
This is an observational ‘routine database study’ as the data was obtained from a 
routine database system (Dos Santos Silva, 1999). This type of study design is useful 
in research because it provides information about a large population over time (Dos 
Santos Silva, 1999). It is low cost, the data collection can be performed quickly as it 
is already available, and it can be used to produce new research hypotheses (Hess, 
2004). On the other hand, the data is reliant on the precision of the data collection, 
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and not all the information that is required can necessarily be secured (Hess, 2004). 
It is important to note that this study did not examine how the factors identified 
caused late stages of breast cancer, but rather sought for associations between 
different factors and stages of breast cancer.  
In order to examine the association between age, year of diagnosis, place of 
residence, nationality, marital status and the stage of breast cancer at the time of 
diagnosis, the study required a large sample in order to produce statistically 
meaningful relationships. The best source from which to obtain a large data sample 
for this study was found to be the SNCR, which provides census data for all cancer 
patients. Registration of cancer is compulsory. So, in theory, all cancer patients will 
be documented, although reality may not reflect the ideal. The process of cancer 
registration starts by identifying cancer patients who sought medical diagnosis using 
medical records. However, it provides data for all the breast cancer patients that are 
likely to be available for analysis. Therefore, there should be very little selection 
bias.  
In 2011, anonymised data was requested from the SNCR for all patients diagnosed 
with breast cancer since 1994. Information about the patients was requested based on 
its availability in the cancer registry, which was ascertained on the basis of the 
SNCR’s data abstraction form. Data was available from 1994 to 2006 when the 
request for data was made on 29 January 2011.  
5.4.2 Cancer registration 
Cancer registries are organisations that systematically collect, analyse, report and 
interpret data on cancer patients. They can be either hospital-based registries, which 
register cancer cases in a particular hospital, or population-based registries, which 
register new cancer cases in a defined population (Dos Santos Silva, 1999).   
Population-based registries are valuable sources of data regarding statistics 
concerning cancer mortality and morbidity, which can help to guide cancer 
prevention and control. There are over 200 population-based registries across the 
world, with more of these being found in developed countries than in developing 
ones (Dos Santos Silva, 1999).  
Several variables that are collected by the registries depend on data feasibility. 
Preferably, data should be collected from multiple sources that provide cancer 
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diagnoses and treatments, such as hospitals and diagnostic departments. Death 
certificates are also important to confirm whether cancer was the cause of death. 
Personal identification numbers are usually used to link cancer-related information to 
individual cases in order to remove duplicate cases, although some registries might 
use different ways to link data, such as names (Parkin, 2006).  
5.4.3 Cancer registration in Saudi Arabia  
The second chapter of this thesis provided an outline of healthcare provision in Saudi 
Arabia. Part of cancer care is the registration of cancer-related data, and as the SNCR 
is a population-based registry under the management of the Ministry of Health—
which made reporting cancer cases mandatory in 1994 (Al-Eid and Garcia, 2012)—
the SNCR has since prepared periodic reports to disseminate cancer-related statistics.  
Data collected by the SNCR includes patient information data, such as names and 
personal identification numbers, as well as contact information, such as phone 
numbers and addresses. The demographic data they collect comprises the patient’s 
age at diagnosis, sex, marital status and nationality, whilst the cancer-related 
information they collect comprises the date of the diagnosis; topography; 
morphology; tumour stage, behaviour and grade; laterality and basis of diagnosis; 
reporting and hospital referral; and follow-up information, such as patient status and 
death. Cancer topography and morphology are identified and coded according to the 
International Classification of Diseases of Oncology 3
rd
 edition (Fritz et al., 2000). 
The SEER guidelines are used for tumour-stage coding (Young et al., 2001), and the 
sources of information are mainly clinically related (such as the names of hospitals), 
although death certificates are also included and can locate cases that are not 
clinically identified (Al-Eid and Garcia, 2012). CanReg software, developed by the 
IARC, is used for data entry and reporting (Al-Eid and Garcia, 2012). 
Cancer-related data was collected by trained SNCR registrars and abstracted from 
cancer patients’ records based on their clinical or histopathological diagnoses using 
both active and passive methods. Data was collected from Ministry of Health 
hospitals, governmental and private hospitals, clinics and laboratories from all over 
the Kingdom (Al-Eid and Garcia, 2012, Hamdan et al., 2011), covering an estimated 
population of 28,376,355(Central Departement of Statistics and Information, 2010c). 
The main SNCR office is located in Riyadh city at the KFSH&RC, and there are also 
regional branches: the Central, Eastern, Western, Southern, Madinah and Northern 
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branches. There are also institution-based registries
11
 operated in the KFSH&RC, 
Armed Forces Hospitals, National Guard Hospitals, the Security Forces’ Hospital, 
and the King Abdulaziz University Hospital (Al-Eid and Garcia, 2012).  
All of the above offices operate under the supervision of the main SNCR, which is in 
charge of quality assessment, the verification of data, accuracy and data unification, 
and comprehensive data collection (Al-Eid and Garcia, 2012). For example, it is in 
charge of removing duplicate cases through the checking of personal numbers 
entered on these records and ensuring that data is only entered for one personal 
number (Al-Eid, 2011). The quality of the data produced by the SNCR is high, with 
data inconsistencies being very low (Hamdan et al., 2011) 
5.4.3.1 Heterogeneity in breast cancer registration in the GCC 
The ASIR for Saudi women in 2004 was 15.4/100,000 (Alghamdi et al., 2013). It is 
relatively close to the overall ASIR in GCC states, which was 18.2/100,000 women 
during 1998–2005, ranging from 53.4 in Bahrain to 14.8 in Saudi Arabia (Al-Madouj 
and Al-Zahrani, 2009). This reflects the low heterogeneity in the cancer registration 
undertaken by the SNCR, as the incidence of breast cancer fits with that in GCC 
states at large, which might indicate that the rates of non-registration are similar. 
5.4.4 Participants 
This study included adult female residents in Saudi Arabia who had been diagnosed 
with breast cancer and registered by the SNCR during 1994–2006.  
5.4.4.1 Inclusion criteria  
Adult women aged 18 years or greater that were diagnosed with breast cancer during 
1994–2006 and who were resident in Saudi Arabia were eligible for inclusion in this 
study. 
5.4.4.1 Exclusion criteria   
Male breast cancer cases were excluded from the study because of its low incidence 
amongst men, the differences in prognosis (Muller et al., 2012), and the possible 
differences in factors effecting late presentation compared to female patients (Smith 
                                                 
11
 These are operated in medical institution which provides oncology care other than the Ministry of 
Health.  
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et al., 2005). Women under the age of 18 years, those living outside Saudi Arabia, 
and those diagnosed before 1994 were also excluded from the study. 
5.4.5 Variables  
5.4.5.1 The dependent variable  
The dependent variable is represented by the stage of cancer found at time of the 
breast cancer diagnosis. Ideally, the dependent variable would represent ‘appraisal 
interval’ (note that the term ‘patient delay’ in no longer recommended, another 
acceptable term is ‘help-seeking interval’), the time point when first bodily changes 
and/or symptoms are noticed and the time at which the patient first contacts a health-
care professional about their condition (Weller et al., 2012). This ideal information is 
not captured by the SNCR. The stage of breast cancer at the time of diagnosis covers 
four time points. These are: symptom recognition, presentation to healthcare, referral 
and diagnosis. Cancer stage seems to be an appropriate measure to use because of its 
impact on survival. In Europe and the US, variations in breast cancer mortality rates 
were mainly ascribed to the differences stages found at diagnosis (Sant et al., 2004), 
which have been identified as being associated with survival and delay time 
(Richards et al., 1999b). Moreover, differences in survival rates relating to the stage 
of cancer at diagnosis have also been reported in Saudi Arabia, even though this 
difference was not found to be statistically significant there (Ravichandran et al., 
2005).  
Using stage of cancer at diagnosis also overcomes the lack of accuracy that would 
feature if the interval between identification of symptoms and first contact with 
healthcare was used, due to the recall bias of participants (Partridge et al., 2012) and 
the fact that participants might not define delay in an identical way (Andersen et al., 
2009). It also takes into account the fact that breast cancer is not homogenous, in that 
some cancers might progress faster than others as a result of their different pathways 
or levels of aggressiveness (Al-Kuraya et al., 2005). Therefore, using ‘stage at 
diagnosis’ is more likely to provide an accurate estimate of late presentation. Stage at 
diagnosis was assumed to reflect on time from recognition of breast cancer 
symptoms to seek medical investigations. 
The SNCR uses the SEER summary stage system (Al-Eid and Garcia, 2012, Young 
et al., 2001). Stage at diagnosis is regarded as an ordinal outcome measure, with the 
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localised stage being more serious than in-situ, regional stage worse than localised 
and distant stage worse than regional. Stage at diagnosis is ordered based on the 
severity of disease prognosis and chances of survival (Howlader et al., 2012). The 
order of these variables helps in identifying the characteristics of women who are at 
a higher risk of being diagnosed at late stages of breast cancer.  
The SNCR record the tumour behaviour as being either in-situ or malignant (the 
latter referring to the localised, regional and distant stages). The frequent detection of 
the in-situ stage in the US is attributed to the increase in the use of mammography 
screening, which can detect abnormalities in the breast before any problem could 
otherwise be detected by women or health professionals (American Cancer Society, 
2011). Screening can also help to detect invasive or malignant breast cancers at 
earlier stages, at which point their progression can be stopped and they are less likely 
to be fatal (Esserman et al., 2013).  
The fact that all lesions at the in-situ stage may not progress to invasive breast 
cancers (Erbas et al., 2006), together with the low percentage of this stage that are 
seen in Saudi Arabia, raises questions about whether it is appropriate to include this 
stage in the analysis. However, it is possible that in-situ lesions will progress to 
invasive cancers; therefore it is worth including this stage in the first ordinal 
regression analysis. Nonetheless, the possibility that in-situ lesions may not all have 
progressed to invasive cancers was considered, and led to the development of 
regression models with and without the in-situ stage (see section 5.4.8.3). 
5.4.5.2 Dependent variables  
The SNCR provides data on age, year of diagnosis, place of residence, nationality 
and marital status, and these were thus used as independent factors in this study. 
Their independent effects were examined in relation to the stage of the cancer at 
diagnosis.  
(1) Age at diagnosis  
Age was coded as a continuous variable in the SNCR.  In order to examine the main 
impacts of patients’ ages at diagnosis on the stage at diagnosis, ages were 
categorised into three ranges; <40, 40–49, 50+, and unknown (for those who did not 
have an age entered at the time of diagnosis).  
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These categories were used to achieve a parsimonious and efficient model. They 
took into account the potentially non-linear effect of age, the likelihood that a 
significant number of diagnoses would be made at a younger age range in Saudi 
Arabia than in Western countries (Ravichandran et al., 2005), and the likelihood that 
a high percentage of breast cancer patients would fall into the age range 40–50 years 
(Abulkhair et al., 2010b). 
The mean age at diagnosis was 47.2, the median was 45 and the mode was 40, with 
the age range being set between 18–100 years. The number of patients diagnosed 
with breast cancer at an age of 81 years or over constituted 1.4% of the total cases. It 
was not possible to verify whether patient-given ages of 100 years were accurate, as 
there was no official registration of birth in Saudi Arabia 100 years ago, but these 
possible inaccuracies in age do not provide a problem for the analysis, as ages were 
categorised into ranges. 
Missing data was partially overcome as cases were not dropped from the analysis 
due to missing age. The ‘unknown’ missing data category was difficult to interpret in 
terms of its impact on other covariate estimates in the regression. 
(2) Year of diagnosis  
To achieve greater parsimony and efficiency in investigating the main effect of the 
year of diagnosis on the stage at diagnosis, this variable was categorised into four 
ranges based on three years trends: 1994–1996, 1997–1999, 2000–2002 and 2003–
2006. 
The SNCR started to collect cancer data in 1994 (Al-Eid and Garcia, 2012). The data 
from the first period—1994–1996—was consistent with the published epidemiology 
study by Ravichandran et al. (2005). During the period 1997–1999, cancer 
registration was expected to improve. Cancer diagnosis and treatment improved from 
2000 (De Angelis et al., 2014), when the new SEER staging guidelines were 
published, providing more accuracy in staging, and these changes were applied by 
the SNCR from 2001 (Al-Eid and Garcia, 2012). Therefore, it was important to 
investigate whether there were changes over the subsequent 2000–2002 and 2003–
2006 periods. This categorisation process also considered the improvement in cancer 
registration between the early years that the SNCR started collecting data and the 
most recent period provided (2003–2006).  
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(3) Place of residence  
The SNCR codes ‘place of residence’ in terms of administrative regions. To 
understand the main effect of place of residence, or region, on the stage of cancer at 
diagnosis, this variable was categorised in relation to the availability and distribution 
of advanced oncology care. From the 13 administrative regions in Saudi Arabia, 
advanced oncology care is only found in three, as already noted—in Riyadh, Makkah 
and the Eastern regions (Ibrahim and Ezzat, 2010). These regions had the highest 
breast cancer incidence (Al-Eid and Garcia, 2012), with other regions—Madinah, 
Northern, Qassim, Jazan, Ha’il, Najran, Baha, Aseer, Tabuk and Jouf—having a 
lower number of breast cancer patients (Al-Eid and Garcia, 2012). The higher 
incidence of breast cancer in regions with advanced oncology care could be 
attributed to higher population density in these regions (Central Departement of 
Statistics and Information, 2010b), but could also be attributed to the presence of 
facilities for detecting and treating breast cancer.   
Thus, to achieve parsimonious and efficient models, place of residence was 
categorised in terms of ‘regions with advanced oncology care’ (Riyadh, Makkah and 
the Eastern region), ‘regions without advanced oncology care’, and ‘unknown’. 
Errors in coding place of residence were very low. Since place of residence is coded 
according to regions, this covers wide urban and rural areas. Although nomadic 
people still exist in Saudi Arabia, there numbers are very small (Al-Yousuf et al., 
2002). 
Missing data was partially overcome by not dropping cases from the analysis due to 
missing places of residence. The ‘unknown’ missing data category was difficult to 
interpret because of its impact on other covariate estimates in the regression. 
(4) Nationality 
As this thesis focuses on Saudi Arabian nationals, nationality was categorised as 
‘Saudi Arabian’ for all Saudi nationals, ‘non-Saudi’ for all non-Saudi nationals, and 
‘unknown’ if the nationality was not reported. 
Missing data was partially overcome here by not dropping cases from the analysis 
due to missing nationality. The ‘unknown’ missing data category was difficult to 
interpret because of its impact on other covariate estimates in the regression. 
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(5) Marital status 
In this study, marital status was categorised as ‘married’, ‘unmarried’ or ‘unknown 
marital status’. The ‘married’ category represented those with valid married status, 
with ‘unmarried’ including single, divorced and widowed women, and ‘unknown’ 
representing unreported marital status. For parsimony and to create an efficient 
model, single, divorced and widowed women were collapsed together because of the 
small number of members in each category.  
This categorisation aimed at producing consistency with categories used in the 
literature that was examined in the systematic review (Alhurishi et al., 2011) and 
within the international literature (Ramirez et al., 1999) in order to investigate any 
significant effects of marital status on the stage of cancer seen at diagnosis. 
The registry data provides little evidence of any association with marital status, but 
this might be due to the large number of those in the ‘unknown’ category (28.6% of 
the total). There is thus a lack of evidence to suggest that marital status has any 
association with the diagnosis of breast cancer. These results led to the exclusion of 
this variable from the regression models, as the results were not easy to interpret. 
(This will be explained further in results section 5.6.2)   
5.4.6 Study size  
The study size was determined by the number of breast cancer cases registered by 
the SNCR. Between 1994 and 2006, there were a total of 12,863 breast cancer 
patients registered in Saudi Arabia, of whom 304 were male patients, comprising 
2.3% of the total number. Data related to male breast cancer was excluded from the 
study. There were thus 12,559 female breast cancer patients. However, for the 
analyses, only those who had a valid stage at diagnosis (n=10,663) were included, 
and thus a total of 1,896 further cases were excluded from the study (see Figure 11).  
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Figure 11: Flow chart of the study sample size 
5.4.7 The study’s power 
The power of the study is “the probability of obtaining a statistically significant 
result, i.e. a P-value below certain pre-established significance level (usually 0.05) if 
the true magnitude of the effect is as anticipated” (Dos Santos Silva, 1999 p. 334-
335). The statistical power of this study was calculated to ensure that the number of 
participants recruited for this study was appropriate for meeting its objectives—i.e. 
that the available number of female breast cancer patients was enough to determine 
the relationship between predictors and stage of cancer at diagnosis. The power of 
the study was calculated in order to detect the association between the most 
important predictors—age and outcome, and stage at diagnosis.  
Table 12 shows the number of female patients diagnosed with breast cancer at early 
and late stages for women younger than 50 years and women aged 50 years or older 
as reported by Ravichandran et al. (2005). The proportion of women under the age of 
50 that were diagnosed with breast cancer at late stages was 56.6%, compared to 
62.5% of the women diagnosed with breast cancer at the age of 50 or over. A 
difference of 5.9% is expected to be clinically relevant. The cases with breast cancer 
from the SNCR were anticipated to be 10,000, with 6,000 of them among younger 
women and 4,000 of them among older ones.  
Accessible population 
Total breast cancer patients (1994–2006) =12,863. 
Male breast cancer=304 (excluded from the analyses) 
Female breast cancer=12,559 
 
Analytic population 
Total female breast cancer patients (1994-2006) =12,559 
Valid stage at diagnosis=10,663 (number of female breast cancer patients 
available for analysis)  
Unknown stage at diagnosis=1,896 (excluded from the analysis) 
Less than 50 years=6,648 
50 years or older=3,997 
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The statistical power of this study was calculated by comparing two proportions 
using Java Applets for power and sample size (Lenth, 2006-9). The power to detect a 
5.9% difference in stage at diagnosis (early vs. late stages) between older and 
younger women was 100%, bearing in mind that normality was not assumed in the 
calculations. This power concludes that there will be good power to detect 
differences due to all risk factors included in this study. Thus, the study findings are 
informative and clinically important. 
Table 12: Cross tabulation between age and stage at diagnosis 
Variables 
Early stages 
(Localised) 
Late stages 
(Regional and distant) 
Total 
Age 50 and over 36 60 96 
Under the age of 50 72 94 166 
Total 108 154 262 
Source: (Ravichandran et al., 2005) 
5.4.8 Statistical methods  
The analysis and model-fitting was performed using the Statistical Package for 
Social Science (SPSS) version 20 (IBM Corp., Released 2011). The first step in this 
process was to check data completeness, and then to perform a descriptive analysis 
and a regression analysis. 
5.4.8.1 Step 1: Data completeness  
‘Missingness’ is a common problem that arises for data analysis, and thus observing 
any patterns in missing data is crucial (Tabachnick and Fidell, 2013). Missing data 
can be a challenge for studies that utilise registry data, like this one (Gliklich and 
Dreyer, September 2010). An examination of the missing data was conducted before 
the data analyses in order to examine the magnitude of missing data and assess its 
impact on the study findings, as missing data can lead to biased results. Thus, 
deciding how to reduce the inconsistency in the data and the results also needed 
addressing.  
For all variables, an unknown value was categorised as a missing value, and placed 
in the ‘unknown’ category, and was treated for all variables except stage at 
diagnosis, the outcome variable. Table 13 shows the percentage of missing data in 
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each variable. Marital status has the highest percentage of missing values (28.6%), 
followed by stage at diagnosis (15.1%).  
Table 13: Frequency of missing data for female breast cancer (n=12,559) 
Variables 
Missing 
Percentage 
Yes No 
Stage at diagnosis 1896 10663 15.1 
Year of diagnosis 0 12559 0 
Place of residence 939 11620 7.5 
Age at diagnosis 39 12520 0.3 
Nationality 244 12315 1.9 
Marital status 3591 8968 28.6 
A cross-tabulation of jointly missing data that occurs for more than 1% of the total 
number of patients shows the numbers of jointly missing variables for individual 
cases. It illustrates that marital status and place of residence were missing more often 
than any other paired set of variables (See Table 14). The high percentage of missing 
marital status data might perhaps be attributed to the time-consuming nature of the 
process of extracting data from patient records. Marital status may not be clearly 
reported in medical notes, and therefore registrars might find it difficult to extract. 
The best way to check marital status is via personal identification cards, which are 
usually located at the end of medical records. It is conjectured that information about 
marital status is most likely missed out as a result of the time constraints on the 
active data extraction process and the fact that such data is not easily locatable from 
patients’ records.  
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Table 14: Cross tabulation of missing data analysis for the study cohort
12
 
 
With respect to dependent variables, cases were omitted from the analysis only if the 
stage of cancer at diagnosis was not available, as it would be difficult to 
meaningfully compare unknown tumour stage cases with those in which the stages 
were known. The stage of the cancer at the time of diagnosis was unknown for 1,896 
patients, so these patients were excluded from the analyses. It seems possible that 
cases that had valid tumour stages were better recorded than those with unknown 
stages at diagnosis, and it is possible that estimates could differ if patients with 
unknown stages were added to the analysis.  
As there was no control for missing data, relying on cases with valid stage tumours 
at diagnosis, removing cases with an unknown stage at diagnosis from the analysis 
and keeping the ‘unknown’ category for of all independent variables permitted the 
use of all cases, therefore reducing any bias from complete data analysis because 
missing data was not missed randomly (P<0.001).  
5.4.8.2 Step 2: Descriptive statistics 
Descriptive analysis was used to outline the characteristics of female breast cancer, 
with the Chi-Square (2) test being calculated to determine the unadjusted 
independent effect of important factors—namely age, year of diagnosis, place of 
                                                 
12
 Patterns with less than 1% cases (126 patients or fewer) are not displayed. 
 
Missing Pattern 
Frequency Year of 
diagnosis 
Age at 
diagnosis 
Nationality 
Place of 
residence 
Marital 
status 
Stage at 
diagnosis 
      2115 
      1130 
      683 
      525 
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residence, nationality and marital status—on the stage of breast cancer seen at 
diagnosis, as this could be different from when the analysis is adjusted. The figures 
were investigated in order to locate patterns in the disease. After that, a description 
of the cohort in relation to tumour stages at diagnosis and the factors associated with 
this was provided.  
5.4.8.3 Step 3: Regression analysis  
The associations between the potential factors related to developing breast cancer 
and the stages at diagnosis were examined using ordered logistic regression analysis. 
Logistic regression modalities are multivariable analyses that can help to identify the 
relationship between being diagnosed at a late stage of breast cancer (outcome) and 
the predictors (independent variables), with the independent effect of each variable 
being adjusted to the other covariates (Tabachnick and Fidell, 2013). This form of 
analysis is commonly used in statistics relating to public health and epidemiology 
(Levy and Stolte, 2000), and is useful when the distribution of dependent variables is 
not linear with those of independent variable(s) (Tabachnick and Fidell, 2013). The 
regression analysis looks at how independent variables contribute to the outcome 
(i.e. the stage of the tumour at the time of diagnosis).  
5.4.8.3.1 Ordinal regression  
Ordinal regression is the first choice of method for explaining the association 
between late stage diagnoses of breast cancer and the potential factors associated 
with this. The outcome variable—the stage at diagnosis—is ordered as follows: (1) 
in-situ, (2) localised (3) regional and (4) distant stage. This order is based on the 
tumour’s potential impact on disease progression and survival (Howlader et al., 
2012), and therefore using ordinal regression is recommended (Bender and Grouven, 
1997).  
The benefit of ordinal regression is that it has more power than logistic regression. 
The Proportional Odds Model (POM) (McCullagh, 1980), sometimes referred to as 
ordinal logistics or cumulative odds (Scott et al., 1997), is the most popular model 
used for analysing ordinal data (Bender and Grouven, 1997), and is used in 
epidemiology (Ananth and Kleinbaum, 1997). The POM builds an assumption about 
the relationship between the outcome and independent variables, and presents the 
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results in a clear and simple way (Bender and Grouven, 1997), and it is important 
that the proportional odds assumptions are checked. 
The paralleled logit or log odd surfaces must be tested to ensure that the assumption 
of the POM is valid. If the test of parallel lines is not significant, this indicates that 
the odds ratio is constant across all the cut points of outcome and the stage at 
diagnosis, and it is thus usually considered that the POM is valid. Although POM is 
widely used, it must however be remembered that it is sensitive to sample size 
(Gameroff, 2005).  
An ordinal regression model (Model 1) was built after excluding marital status. The 
model identified variables that significantly influence late-stage breast cancer among 
females. Risk factors and protective factors were then considered. The results of the 
ordinal regression can be misleading if assumptions about the parallel lines of the 
categorical variable are not appropriate (Bender and Grouven, 1997). The test of 
parallel lines was thus examined in Model 1, and it was assumed that the assumption 
about parallel logit surfaces was significant, and therefore that the POM might not 
have been valid and the results could be misleading (see section 5.6.2.1) (Ananth and 
Kleinbaum, 1997).  
There are two options for dealing with assumption violations. The first option is to 
ignore the test of the assumption because the sample size is large, and therefore a 
small violation in the assumption of the parallel line test can be significant. The 
second is to apply separate logistic regression models by fitting partial POMs 
(Peterson and Harrell, 1990).  
The second option was chosen for the analyses and, as a result, four models were 
developed. In model 2, the in-situ stage was excluded (see section 5.6.2.2) and the 
analysis confined to invasive breast cancer because of the uncertainty about the 
potential progress from in-situ to invasive cancer (Erbas et al., 2006). The model 
looked at a group of the total sample in order to reduce the risk of assumption 
violations (Peterson and Harrell, 1990). However, after testing the goodness of fit, 
the POM assumptions seemed to be violated (see Tables 15). Another solution to 
avoid this problem would be to fit a partial POM or else to use binary logistic 
regression models utilising dichotomised responses for ordinal variables (Bender and 
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Grouven, 1998), although this latter solution is not recommended as it would 
produce statistical loss (Gameroff, 2005).  
There was in this initial analysis no intention to examine the interactions between 
factors. The number of interactions between 6 factors will be large and potentially 
complex (West, 2012). If the factors could have been represented by single 
parameters then the number of parameters to represent interactions would be 15, for 
two-way interactions, plus 20 for three-way interactions, plus 15 (4-way), plus, 6 (5-
way), plus 1 (6-way).  That is a total of 64 parameters.  The situation though is more 
complex that this since age needs to be represented with more than a single 
parameter: non-linear effects of age may well be important and to deal with this age 
might be categorised into several, say m, categories requiring m-1 parameters.  There 
are similar problems in handling year of diagnosis where multiple categories will be 
required.  As an initial analysis therefore, only the main effects (the factors) were 
considered.   
The model might have been developed later to include interactions once evidence to 
support relevant interactions had been gathered, for example from the qualitative 
stage of this research.  A much more fruitful approach however was selected, that of 
modelling using a classification tree.  This is detailed in Chapter 8.  Note that the 
classification tree has the advantage of identifying important potential interactions in 
an efficient manner driven from the data.  The intention here is that these can be 
compared to the findings from the qualitative work. 
5.4.8.3.2 Sensitivity analyses 
A sensitivity analysis was conducted to ensure that the POM was valid to examine 
whether the results were consistent. Since the POM’s assumptions were violated, 
separate binary logistic regression models were employed to carefully analyse the 
data and assess the assumptions about the effect of covariates on stage progression. 
The outcome variable was categorised in a dichotomised response. Three models 
were developed. Model 3 was produced to investigate the association between late 
stages of breast cancer (localised, regional and distant), very early stages of it, and its 
in-situ stage. Model 4 was run to investigate the association between late stages 
(regional and distant), early stages, the in-situ stage and the localised stage. Model 5 
investigated the association between covariates among women diagnosed at 
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metastasised stages i.e. very late stages (distant) and those diagnosed at other stages 
(in-situ, localised and regional) (see section 5.6.2.1). After this, the goodness of fit 
was assessed for each model. 
5.5 Ethical considerations 
The joint ethics committee of the Leeds Institute of Health Sciences, the Leeds 
Institute of Genetics, Health and Therapeutics, and the Leeds Institute of Molecular 
Medicine at the University of Leeds reviewed this study on 21 April 2011 (Ref no. 
HSLTLM/10/015; see Appendix B). The SNCR accepted the study application and 
permitted data release and use for this study (see Appendix C). 
Breast cancer data was anonymised during data collection, analysis and reporting. 
Identifiable data, such as patient names, full addresses, and medical record numbers 
were neither requested nor collected. As no personal identifiable data was accessed, 
data was not being linked to individuals, and patient confidentiality was thus 
maintained. The data was stored at the University of Leeds M drive to ensure its 
security.  
5.6 Results  
This section presents the findings of the second phase of this PhD—the quantitative 
study. A general description of the profile of female breast cancer is provided, and 
then the results of the cross-tabulation between the stage of breast cancer stage at 
diagnosis and the covariates—age, diagnosis year, place of residence, nationality and 
marital status—is provided. Finally, ordinal regression and binary logistic regression 
models are presented.  
5.6.1 Results of the descriptive analysis  
This section describes the overall characteristics of the participants in the study of 
female breast cancer in Saudi Arabia during the period 1994–2006 in terms of the 
stage of breast cancer at diagnosis, age, place of residence by region, nationality, 
marital status, and the year that the diagnosis was made. Then the cross-tabulation of 
the stage of breast cancer among female patients by key factors is provided.  
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5.6.1.1 Profile of the 10,663 female breast cancer patients participating in the 
study 
This section gives a general description of the 10,663 patients who were living in 
Saudi Arabia and over the age of 18 when they were diagnosed with a valid stage 
breast cancer between 1994 and 2006.  
The majority of these patients were assumed to be alive at the time of diagnosis, 
except from the five patients who were registered through their death certificates. 
The data produced on breast cancer by the SNCR from death certificates alone is low 
because of the poor reporting of causes of death (Ansary et al., 2012) and the lack of 
follow-ups on cancer patients. 
Of the 10,663 patients, 2.3% were diagnosed at the in-situ stage, with the highest 
percentage of diagnoses being made at the regional stage (51.5%), followed by the 
localised stage (28.6%) and the distant stage (17.7%) (see Table 15). The percentage 
of women by age group varied. Being diagnosed under the age of 51 represented 
65.6% of the cohort with one third of women aged between 41 and 51 years old. The 
percentage for women aged 51 years or older was 34.2% with a 4%  increase in the 
percentage of women aged 51–60 years (19%) compared to those older than 60 
(15.2%).  
Most female breast cancer patients were married at the time of diagnosis (62.5%), 
Saudi nationals (67.5%), and from regions that had advanced oncology care (73.4%). 
There was an increase in the number of cases registered over time, with the number 
of cases nearly doubling by the period 2003–2006 (4,399 cases) from when the 
SNCR started providing data in 1994 (1,904 cases, 1994–1996) (see Table 15).  
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Table 15: Distribution of the 10,663 female breast cancer patients in Saudi 
Arabia by age, marital status, stage at diagnosis, nationality, location and year 
of diagnosis during the period 1994–2006. 
 
 
 
 
 
 
 
 
Variable N (%) Variable N (%) 
Stage at diagnosis Nationality 
In-situ 242 (2.3%) Saudis 7,198 (67.5%) 
Localised 3,047 (28.6%) Non-Saudis 3,328 (31.2%) 
Regional 5,491 (51.5%) Unknown 137 (1.3%) 
Distant 1,883 (17.7%) Years of diagnosis 
Age at diagnosis 1994–1996 1,904 (17.9%) 
18-30 701 (6.6%) 1997–1999 2,041 (19.1%) 
31-40 2878 (27%) 2000–2002 2,319 (21.7%) 
41-50 3424 (32.1%) 2003–2006 4,399 (41.3%) 
51-60 2025 (19%) Place of residence 
Older than 60 1617 (15.2%) Regions with advanced 
oncology care 
7,831 (73.4%) 
Unknown 18 (0.2%) 
Marital status Other regions 2,033 (19.1%) 
Married 6,660 (62.5%) 
Unmarried 1,135 (10.6%) Unknown 779 (7.5%) 
Unknown 2,868 (26.9%) 
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5.6.1.2 Characteristics of the 10,663 female breast cancer patients in relation to 
stage at diagnosis, together with covariates 
The following sections provide descriptions of female breast cancer by stage at 
diagnosis, together with age, year of diagnosis, place of residence, nationality and 
marital status. 
5.6.1.2.1 Characteristics of the 10,663 female breast cancer patients in relation 
to tumour stage and age at diagnosis 
A cross-tabulation of the 10,663 patients’ stages of breast cancer and ages at 
diagnosis shows that women aged 50 years or over were diagnosed at late stages 
more often than younger women. The percentage of distant stage diagnoses were 
higher among older women (19.9%) compared to those aged less than 40 (17.5%), 
with women aged 40–49 having the lowest distant stage diagnoses (15.2%). This 
latter age group also had the highest percentage of regional stage diagnoses (see 
Table 16).  
The association between age and stage at diagnosis was significant (Pearson 
2=23.256, df=9 and P<0.001). However, it was not linear (see Figure 12).   
To provide greater understanding about the age profile of women, age groups were 
cross tabulated by year of diagnosis. This shows that there was decrease in the 
percentage of women diagnosed at 40 years or younger over time while there was 
increase of 4.3% for women aged between 41 and 50 years since 1994. For those 
aged 51 or greater the profile remains similar over time (see Tables 15 and 16). 
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Table 16: Description of the 10,663 female breast cancer patients in relation to 
stage at diagnosis and age (1994–2006) 
 
Table 17: Distribution of the 10,645
14
 female breast cancer patients in Saudi 
Arabia by age and year of diagnosis during the period 1994–2006. 
 
 
 
                                                 
13
 Percentage within a diagnosis year 
14
 The unknown category (n=18) was excluded for this table.  
Age at diagnosis 
Stage at diagnosis 
In-situ 
N (%)
13
 
Localised 
N (%) 
Regional 
N (%) 
Distant 
N (%) 
Less than 40 61 (2%) 911 (29.3%) 1589 (51.2%) 545 (17.5%) 
40–49 89 (2.5%) 1022 (28.9%) 1892 (53.4%) 539 (15.2%) 
50 or greater  91 (2.3%) 1105 (27.6%) 2004 (50.1%) 797(19.9%) 
Unknown 1 (5.6%) 9 (50%) 6 (33.3%) 2 (11%) 
Total 242 (2.3%) 3047 (28.6%) 5491 (51.5%) 1883 (17.7%) 
Year of 
diagnosis 
Under 30 
N (%) 
31–40 
N (%) 
41–50 
N (%) 
51–60 
N (%) 
Older than 60 
N (%) 
1994–1996 
154 
(8.1%) 
557 
(29.3%) 
565 
(29.7%) 
350 
(18.4%) 
278 
(14.6%) 
1997–1999 
151 
(7.4%) 
591 
(29%) 
609 
(29.8%) 
383 
(18.8%) 
307 
(15%) 
2000–2002 
136 
(5.9%) 
626 
(27%) 
762 
(32.9%) 
436 
(18.8%) 
359 
(15.5%) 
2003–2006 
260 
(5.9%) 
1104 
(25.2%) 
1488 
(34%) 
856 
(19.5%) 
673 
(15.4%) 
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Figure 12: Distribution of female breast cancer cases in relation to age and 
stage at diagnosis (1994–2006) 
5.6.1.2.2 Characteristics of the 10,663 female breast cancer in relation to stage 
of cancer and year of diagnosis 
From the time at which the SNCR started collecting data (1994–1996), the 
percentage of women diagnosed with distant stage breast cancer has been reduced by 
nearly half—from 30.1% in 1994–1996 to 15.4% in 2003–2006 (see Table 18). 
Figure 13 shows the changes in the pattern of the disease at the stage at diagnosis. 
Stage at diagnosis appears to be very different during 1994–1996 to the patterns seen 
in later years, where there was a sharp increase in the numbers and percentages of 
cases diagnosed at the regional stage and a decrease in the percentages of cases 
diagnosed at the localised and distant stages, with an overall increase in the numbers 
of cases diagnosed. This indicates decline in late stages at diagnosis from 1994–
1996. There was a significant relationship between stage at diagnosis and years of 
diagnosis (Pearson 2=330.70, df=9 and P<0.001). 
The increase in the number of breast cancer patients might be explained by (the 
combination of) a number of reasons. These include improvement in cancer 
registration over time; the massive improvement in healthcare, which might have led 
to improvements in the detection and diagnosis of breast cancer; the disease itself, 
breast cancer, might have evolved over the period of interest due to changes in diet 
and lifestyle (Al-Foheidi et al., 2013, Alothaimeen et al., 2004) and/or an actual 
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increase in the incidence of breast cancer, especially given population growth. In 
2006, an increase of 5,756,300 in the population has been estimated compared to the 
estimated population in 1994, 17,790,342
15
, when the SNCR started.  
Table 18: Distribution of the 10,663 female breast cancer patients by tumour 
stage and year of diagnosis (1994–2006) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Percentage distribution of the 10,663 of female breast cancer 
patients by tumour stage and year of diagnosis 
 
                                                 
15
 These estimations were calculated based on published data from the Central Department of 
Statistics and Information, Saudi Arabia, http://www.cdsi.gov.sa. 
Year of diagnosis 
Stage at diagnosis 
In-situ 
N (%) 
Localised 
N (%) 
Regional 
N (%) 
Distant 
N (%) 
1994–1996 24 (1.3%) 631 (33.1%) 704 (37%) 545 (28.6%) 
1997–1999 24 (1.2%) 499 (24.4%) 1203 (58.9%) 315 (15.4%) 
2000–2002 49 (2.1%) 651 (28.1%) 1275 (55%) 344 (14.8%) 
2003–2006 145 (3.3%) 1266 (28.8%) 2309 (52.5%) 679 (15.4%) 
Total 242 (2.3%) 3047 (28.6%) 5491 (51.5%) 1883 (17.7%) 
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5.6.1.2.3 The characteristics of the 10,663 female breast cancer patients’ tumour 
stages at diagnosis in relation to their places of residence  
Table 19 shows the variation in the distribution of breast cancer cases in relation to 
the patients’ tumour stages at diagnosis and their places of residence. Breast cancer 
patients that lived in regions with less advanced oncology care had a higher 
percentage of advanced, distant stage tumours (19.6%) compared to those that lived 
in regions with more advanced oncology facilities. A significant relationship 
between regions and tumour stage at diagnosis was found (Pearson 2=177.625, df=6 
and P<0.001 
Table 19: Distribution of the 10,663 female breast cancer patients in relation to 
tumour stage at diagnosis and place of residence (1994–2006) 
 
The univariate analysis was rerun after excluding the unknown category. The result 
indicated an association between stage at diagnosis and place of residence (Pearson 
2=21.888, df=3 and P<0.001). 
 
 
 
 
 
 
 
Place of residence 
Stage at diagnosis 
In-situ 
N (%) 
Localised 
N (%) 
Regional 
N (%) 
Distant 
N (%) 
Regions with advanced 
oncology care  
187 
(2.4%) 
2282 (29.1%) 
4092 
(52.3%) 
1270 
(16.2%) 
Regions without 
advanced oncology care 
37 (1.8%) 514 (25.3%) 
1084 
(53.3%) 
398 (19.6%) 
Unknown 18 (2.3%) 251 (31.4%) 315 (39.4%) 215 (36.9%) 
Total 
242 
(2.3%) 
3047 (28.6%) 
5491 
(51.5%) 
1883 
(17.7%) 
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5.6.1.2.4 Characteristics of the 10,663 female breast cancer patients in relation 
to tumour stage at diagnosis and nationality  
Table 20 represents the study cohort in relation to tumour stage at diagnosis and 
nationality. A greater percentage of non-Saudis were diagnosed at the localised stage 
(30.6%) than Saudis (27.6%). However, a higher percentage of Saudi nationals were 
diagnosed at regional (52.2%) and distant stages (18.1%) than non-Saudis (49.8% 
and 16.9%, respectively). This factor was significantly associated with stage at 
diagnosis (Pearson 2=20.421, df=6 and P<0.002).  
For better accuracy on the effect of marital status, a univariate analysis was 
conducted to investigate the difference between the ‘married’ and ‘unmarried’ 
categories, without including the ‘unknown’ category.  
Table 20: Description of female breast cancer cases in relation to stage at 
diagnosis and nationality (1994–2006) 
 
The univariate analysis was rerun after excluding the unknown category. The results 
indicated an association between stage at diagnosis and nationality (Pearson 
2=16.301, df=3 and P<0.001).  
 
 
 
 
                                                 
16
 Percentages of cases in the respective nationality groups. 
Nationality 
Stage at diagnosis 
In-situ 
N (%)
16
 
Localised 
N (%) 
Regional 
N (%) 
Distant 
N (%) 
Saudis 149 (2.1%) 1987 (27.6%) 3756 (52.2%) 1306 (18.1%) 
Non-Saudi 91 (2.7%) 1019 (30.6%) 1657 (49.8%) 561 (16.9%) 
Unknown 2 (1.5%) 41 (29.9%) 78 (56.9%) 16 (11.7%) 
Total 242 (2.3%) 3047 (28.6%) 5491 (51.5%) 1883 (17.7%) 
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5.6.1.2.5 Characteristics of the 10,663 female breast cancer patients in relation 
to tumour stage at diagnosis and marital status  
The percentages of married women who were diagnosed at localised (27.1%) and 
regional (55.5%) stages were higher than those for unmarried women (26.8% and 
51.6%, correspondingly). On the other hand, the percentage of unmarried women 
that were diagnosed at the distant stage (18.5%) was higher than that for married 
women (15%), as shown in Table 21. There were many patients with an unknown 
marital status, and this group had the highest percentage of distant stage tumours at 
diagnosis (23.4%).  
Through examining the 2, it was found that marital status was significantly 
associated with the stage of cancer at diagnosis (Pearson 2=177.6, df=6 and 
P<0.001). 
Table 21: Description of female breast cancer in relation to tumour stage at 
diagnosis and marital status (1994–2006) 
 
Because of the difficulty in interpreting the results of the univariate analysis, due to 
the high percentage of cases without a valid marital status, the univariate analysis 
was rerun after excluding the ‘unknown’ category (n=2868, 26.9%), as shown in 
Table 20, and the results indicated an association between stage at diagnosis and 
marital status (Pearson 2=12.291, df=3 and P<0.006).  
 
 
                                                 
17
 Percentage within marital group 
Marital status 
Stage at diagnosis 
In-situ 
N (%)
17
 
Localised 
N (%) 
Regional 
N (%) 
Distant 
N (%) 
Married 156 (2.3%) 1807 (27.1%) 3695 (55.5%) 1002 (15%) 
Unmarried 35 (3.1%) 304 (26.8%) 586 (51.6%) 210 (18.5%) 
Unknown 51 (1.8%) 936 (32.6%) 1210 (42.2%) 671 (23.4%) 
Total 242 (2.3%) 3047 (28.6%) 5491 (51.5%) 1883 (17.7%) 
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5.6.2 Results of the regression analyses  
Two POMs were run in the third step of the analysis, and all of the factors included 
(age, year of diagnosis, place of residence and nationality) were found to be 
significantly associated with tumour stage at diagnosis.  
The initial POM tested the independent effect of covariates on tumour stage at 
diagnosis. Marital status was originally included, and was significant only for the 
unknown category. However, it was hard to interpret its effect, given the high 
percentage of cases in the ‘unknown’ category; therefore it was removed from the 
regression analyses (see Appendix D).  
5.6.2.1 Model 1: POM for the effect of covariates on tumour stage at diagnosis 
for the 10,663 female breast cancer patients surveyed 
Ordinal regression analysis was conducted on the tumour stage seen at the point of 
diagnosis as an outcome in relation to the four predictor variables: age, year of 
diagnosis, location and nationality. It included a total of 10,663 patients whose 
tumour stage at diagnosis was known (as described in the ‘missing data analysis’ 
section).  
Table 22 presents the associations of each variable with tumour stage at diagnosis 
using the ordinal regression model and adjusting for other covariates. For all factors, 
a Proportional Odds Ratio (POR) greater than 1 indicates a greater likelihood that the 
variable had an effect on the stage’s progression.  
The risk of being diagnosed at late stages of breast cancer was significantly higher 
among women whom were diagnosed during 1994–1996 (POR=1.303, 95% 
CI=1.160–1.463) and 1997–1999 (POR=1.24, 95% CI=1.125–1.374) when 
compared to those diagnosed during 2000–2002 and 2003–2006. In addition, those 
living in regions with less advanced oncology services were at a greater risk of late-
stage diagnosis (POR=1.214, 95% CI= 1.105–1.333) compared to those living in 
regions with more advanced oncology services. Moreover, the risk of late-stage 
diagnosis was also significantly greater for women aged 50 years or older 
(POR=1.23, 95%, CI=1.506–1.210) compared to those younger than 50 years. 
However, this risk was significantly reduced among non-Saudi nationals (POR= 
0.848, 95% CI=0.778–1.080) in comparison to Saudi nationals.  
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A method that can be used to test the model’s fitness is Pseudo R2, which was low in 
this model (Nagelkerke=1%). This indicates that the model explains a relatively 
small proportion of variation in tumour stage at diagnosis. Such a value is expected, 
as there are many factors associated with late presentation, as described in Chapter 4. 
The McFadden value (0.4%) confirms the possible effect of multiple factors on 
tumour stage at diagnosis, as the model can be better with predictors than without 
them. This stresses the need for phase III of this PhD—the qualitative study—which 
will examine other potential factors likely to be associated with late-stage breast 
cancers at diagnosis.  
The parallel line test provides another way for testing the model’s appropriateness. 
Testing the parallel line at a significance level of 0.05 shows that that the assumption 
of equal odds for each threshold is rejected (in this model, for tumour stage), as P< 
0.001.  
The results of the POMs were presented here regardless of the parallel line test 
because it is very sensitive to large sample sizes (Peterson and Harrell, 1990), like 
those seen in this study (n=10,663). The main effect of the predictors on moving 
from one stage to another is the main interest of this study. Therefore, the results 
from the POMs are worth reporting. However, for POMs to be considered further 
exploration of the models is required. Therefore, another POM was run after the in-
situ cases had been excluded (Model 2), and separate binary logistic regression 
models (3, 4 and 5) were also produced. The results of these models are presented in 
the following section. 
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Table 22: Model (1) POM for factors associated with later breast cancer tumour 
stages at diagnosis for the 10,663 female patients surveyed. 
Factors 
Adjusted ordinal regression 
P POR, (95% CI) 
Age at diagnosis 
Unknown 0.040 0.375, (0.148–0.954) 
Less than 40 0.001 0.830, (0.744–0.926) 
40–49 0.000 0.807, (0.731–0.832) 
50 or greater  1 (Reference) 
Year of diagnosis 
1994–1996 0.000 1.298, (1.155–1.458) 
1997–1999 0.000 1.240, (1.122–1.371) 
2000–2002 0.271 1.055, (0.959–1.160) 
2003–2006 1 (Reference) 
Place of residence  
Unknown 0.025 1.217, (1.025–1.446) 
Other regions  0.000 1.217, (1.108–1.336) 
Regions with advanced oncology care 1 (Reference) 
Nationality 
Unknown 0.639 0.921, (0.656–1.294) 
Non-Saudi 0.000 0.853, (0.782–0.931) 
Saudi 1 (Reference) 
Test for parallel lines: 2=327.090, df=20 & P<0.001 
Pseudo R
2
: Cox and Snell=0.009, Nagelkerke=0.010 & McFadden=0.004 
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5.6.2.2 Sensitivity analysis 
In addition to the main effect analysis, other models (2, 3, 4 and 5) were run to check 
the consistency of the results as well as whether the models are sensitive to the way 
the dependent variables are reported or, in the case of the in-situ, whether the study 
size is large enough to run these models (Von Elm et al., 2007a). The following 
models offer more details about the effect produced by the various factors. 
The second model was produced to assess the predication of late stages for three 
categorical outcomes (localised, regional and distant). The effects of the year of 
diagnosis, place of residence, age and nationality are similar to those seen under the 
first model (see Table 23). Similarly, this model’s fitness was comparable to the first 
model. 
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Table 23: Model (2) POM for factors associated with later tumour stages of the 
10,421 female patients diagnosed with invasive breast cancer 
Factors 
Adjusted ordinal regression 
P POR, (95% CI) 
Age at diagnosis 
Unknown 0.006 0.399, (0.149–1.063) 
Less than 40 0.000 0.820, (0.734–0.917) 
40–49 0.000 0.812, (0.734–0.899) 
50 or greater 1 (Reference) 
Year of diagnosis 
1994–1996 0.002 1.203, (1.069–1.353) 
1997–1999 0.004 1.16, (1.047–1.284) 
2000–2002 0.810 1.012, (0.918–1.115) 
2003–2006 1 (Reference) 
Place of residence  
Unknown 0.009 1.263, (1.060–1.504) 
Other regions  0.000 1.207, (1.097–1.327) 
Regions with advanced oncology care 1 (Reference) 
Nationality 
Unknown 0.412 0.864, (0.611–1.223) 
Non-Saudi 0.001 0.864, (0.791–0.945) 
Saudi 1 (Reference) 
Test for parallel lines: 2=292.857, df=10 & P<0.001 
Pseudo R
2
: Cox and Snell=0.007, Nagelkerke=0.008 & McFadden=0.004 
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The separate logistic models help to ascertain greater details concerning the 
associations evident from the registry data. A binary logistic regression model (3) 
which examined the main effects of age at diagnosis, year of diagnosis, place of 
residence and nationality on very early stage tumours (in-situ, n=242) in comparison 
to other breast cancer stages (n=10421) showed that only the year of diagnosis was 
significantly associated with the tumour stage at diagnosis.  
The risk of being diagnosed at later stages of invasive breast cancer reduced over 
time, from 3.42 (95% CI 2.016–5.827) in 1994–1996, to 2.935 (95% CI 1.897–
4.539) in 1997–1999, to 1.595 (95% CI 1.148–2.215) in 2000–2002, compared to 
2003–2006 (see Table 24). The percentage of women diagnosed at the in-situ stage 
increased in 2003–2006 to more than double those diagnosed at 1994-1999 (see 
Table 25). 
However, when the outcome (tumour stage at diagnosis) was dichotomised to early 
stages (in-situ and localised, n=3,047) vs. late-stages (regional and distant, n=7,374), 
year of diagnosis, place of residence and nationality were significantly associated 
with late stages of breast cancer at diagnosis (see Model 4, Table 26). The risk of 
being diagnosed at a late stage of female breast cancer significantly reduced in 
women diagnosed in or after 2000, for patients living in regions with advanced 
oncology care, and for non-Saudi nationals.  
Model 5 shows the effect of covariates on very late stages of breast cancer at 
diagnosis, namely at the distant stage (n=1,883) vs. other stages (n=8,538). In this 
model, the year of diagnosis, the place of residence, the nationality and the age at 
diagnosis were all significantly associated with very late stages of cancer at 
diagnosis. Strong evidence of an association between older age and stage at 
diagnosis occurs only at the distant stage. Table 27 shows that patients diagnosed 
during 1994–1996 (Odds ratio 2.064 95% CI 1.784–2.387), patients living in regions 
with fewer oncology services (Odds ratio 1.215, 95% CI 1.070–1.380), and patients 
that were Saudi nationals were at greater risk of late stage of breast cancer at 
diagnosis.  
These models (3, 4 and 5) show the differences in effect size of the main effects of 
the covariates on the tumour stage in female breast cancer diagnoses, because the 
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direction is the same. Therefore, there is some validity in these models, which is 
worth reporting.   
Table 24: Model (3) Factors influencing late-stage diagnoses of breast cancer 
for the 10,663 female patients surveyed (1994–2006) (in-situ vs. others) 
Factors 
Adjusted binary regression 
P Odds Ratio (95% CI) 
Age at diagnosis                  0.426 
Unknown 0.273 0.259 (0.023–2.903) 
Less than 40 0.345 1.172 (0.843–1.631) 
40–49 0.764 0.955 (0.709–1.287) 
50 or greater  1 (Reference) 
Year of diagnosis 0.000 
1994–1996 0.000 3.427 (2.016–5.827) 
1997–1999 0.000 2.935 (1.897–4.539) 
2000–2002 0.005 1.595 (1.148–2.215) 
2003–2006 1 (Reference) 
Place of residence  0.141 
Unknown 0.162 0.639 (0.341–1.196) 
Other regions  0.187 1.275 (0.889–1.828) 
Regions with advanced oncology 
care 
1 (Reference) 
Nationality      0.079 
Unknown  0.261 2.627 (0.488–14.15) 
Non-Saudi 0.061 0.762 (0.572–1.013) 
Saudi  1 (Reference) 
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Table 25: Cross tabulation between in-situ stage and years of diagnosis 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Years of diagnosis  In-situ stage at diagnosis N (%) 
1994-1996 24 (9.9%) 
1997-1999 24 (9.9%) 
200-2002 49 (20.2%) 
2003-2006 145 (59.9%) 
Total  242 (100%) 
- 120 - 
 
 
Table 26: Model (4) Factors influencing late stage diagnoses of breast cancer for 
the 10,663 female patients surveyed (1994–2006) 
Factors 
Adjusted binary regression 
P Odds Ratio (95% CI) 
Age at diagnosis                   0.138 
Unknown 0.035 0.343 (0.127–0.929) 
 Less than 40 0.315 0.949 (0.856–1.051) 
40–49 0.351 0.954 (0.864–1.053) 
50 or greater  1 (Reference) 
Year of diagnosis 0.000 
1994–1996 0.037 0.871 (0.765–0.991) 
1997–1999 0.000 1.387 (1.233–1.562) 
2000–2002 0.108 1.094 (0.981–1.220) 
2003–2006 1 (Reference) 
Place of residence  0.001 
Unknown 0.059 1.204 (0.933–1.461) 
Other regions  0.001 1.216 (1.089–1.357) 
Regions with advanced oncology care 1 (Reference) 
Nationality      0.002 
Unknown  0.858 1.037 (0.697–1.544) 
Non-Saudi 0.000 0.838 (0.759–0.925) 
Saudi  1 (Reference) 
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Table 27: Model (5) Factors influencing very late-stage (distant stage) diagnoses 
of breast cancer for the 10,663 female patients surveyed 
Factors 
Adjusted binary regression 
P Odds Ratio (95% CI) 
Age at diagnosis                   0.000 
Unknown 0.813 0.829 (0.177–3.896) 
 Less than 40 0.007 0.844 (0.747–0.955) 
40–49 0.000 0.735 (0.650–0.830) 
50 or greater  1 (Reference) 
Year of diagnosis 0.000 
1994–1996 0.000 2.064 (1.784–2.387) 
1997–1999 0.940 1.006 (0.869–1.164) 
2000–2002 0.542 0.957 (0.831–1.102) 
2003–2006 1 (Reference) 
Place of residence  0.001 
Unknown 0.017 1.309 (1.050–1.630) 
Other regions  0.003 1.215 (1.070–1.380) 
Regions with advanced oncology 
care 
1 (Reference) 
Nationality      0.021 
Unknown  0.135 0.655 (0.377–1.140) 
Non-Saudi 0.014 0.849 (0.746–0.967) 
Saudi  1 (Reference) 
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5.7 Output of phase II 
The regression analyses of the main effects of covariates (age, year of diagnosis, 
place of residence and nationality) on the stage of breast cancer at the point of 
diagnosis were significant. However, as shown from the POMs, the low Nagelkerke 
& McFadden values (presented in Tables 22 and 23) indicate that these models were 
not sufficient to fully explain the reasons for the late stages of breast cancer seen at 
diagnosis. Thus, a qualitative study was conducted to overcome the shortcomings of 
this data collection and analysis. The significance of the role of age, place of 
residence, year of diagnosis and nationality from the quantitative study informed the 
sampling strategy for participants for the qualitative study, which is described in the 
next chapter. 
5.8 Strengths and limitations of the study 
A major strength of this study is that the registering of cancer cases is compulsory in 
Saudi Arabia, and this means that the analysis of the census data provides a general 
picture of female breast cancer across Saudi Arabia. The data collection performed 
in routine data-based studies using such sources and methods can be quick, and a 
large sample can be exacted (Dos Santos Silva, 1999). The SNCR collects cancer-
related data from the entire Kingdom, and as this data collection process is 
compulsory, the data obtained covers almost all of the diagnosed patients. 
However, there are a number of important limitations to this form of research, which 
need to be considered here. First, in routine data-based studies, a limited number of 
variables are available (Dos Santos Silva, 1999). This study used data from the 
SNCR and, as a result, the effects of certain factors could not be measured. For 
example, the time interval between the recognition of symptoms and first medical 
contact is not measured by the SNCR. Neither do they report on screening practices, 
or record any data about the educational levels or backgrounds of patients. 
Therefore, the analysis of factors influencing the stage of breast cancer at the point 
of diagnosis is limited to age, marital status, location, year of diagnosis and 
nationality, and thus potential compounding factors were not available in this data, or 
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in the information produced by routine-data based studies in general (Dos Santos 
Silva, 1999).   
Second, the retrospective nature of this area of the study limits the ability to look 
further for other possible determinants of late stage diagnosis. There is no follow-up 
information available for these patients, and tracking them would not be easy. For 
example, there is no link between the SNCR and the death registry, and therefore it 
would have been necessary to track the patients to produce a survival analysis.  
Third, the pattern of late presentation in recent years could not be analysed using 
SNCR data due to the unavailability of data acquired by it after 2006 when the data 
was collected. Changes in the trend of late presentation for breast cancer since 2006 
are possible, so this represents a further limitation to the use of SNCR data. Al-
Rikabi and Husain (2012) also point out the possibility that there has been an 
increase in the number of breast cancer cases due to increased awareness together 
with a greater uptake of screening services. They found a shift in the distribution of 
breast cancer cases after reviewing breast tissue specimens since 2007. The SNCR 
cancer registration is ongoing, and data for breast cancer cases diagnosed after 2006 
would be available were an application to be submitted for more updated data.  
Fourth, there is no control on data quality and missing data. Thus, SNCR data 
completeness and quality might be an issue (Al-Zahrani et al., 2003). Missing data 
for some factors led to a reduction of the number of cases to those with valid stage 
tumours at diagnosis. The completeness of the data is generally good, however, with 
the exception of marital status. The SNCR tries to improve the quality of its data, 
and has been successful in doing so over time (Al Sayed et al., 2010).  
5.9 Summary   
This Chapter described the quantitative study, which was the second phase in the 
thesis. It identified the main effects of age, year of diagnosis, place of residence, 
nationality and marital status on the stage of female breast cancer seen at the point of 
diagnosis using census cancer data from the SNCR.  
Different logistic regression models (ordinal and binary) were fitted and 
demonstrated the significant association between a number of factors and later stages 
of breast cancer at the time of diagnosis, comprising the increasing age of women, a 
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diagnosis made between 1994–1999, residing in regions with less advanced 
oncology care, and being a Saudi national. The various models applied provide 
details about the association between the covariates and stage at diagnosis.  
The models included factors as main effects only and did not include interactions 
between factors.  Including interactions for the initial analysis without guidance from 
other research would have very greatly inflated the number of model parameters and 
reduced robustness as a consequence. 
Older women were at a higher risk of late stage at diagnosis is in line with literature 
about the association between older age and late presentation of breast cancer 
(Abdel-Fattah et al., 1999, El-Zawawy, 1991, Elzawawy, 1999, Ermiah et al., 2012, 
Ramirez et al., 1999) and late diagnosis (Arndt et al., 2001). Some studies from the 
Middle East however did not support this result (Abdel-Fattah et al., 1999, Al Saad 
and Alsayed, 2012, Mousa et al., 2011, Stapleton et al., 2011) and these studies were 
varied in in how they assess this association (see Chapter 4). Marital status is not a 
useful predictor for late presentation in this study and as indicated in the literature 
(Ramirez et al., 1999) (Abdel-Fattah et al., 1999, El-Zawawy, 1991, Elzawawy, 
1999, Ermiah et al., 2012). The place of residence has been identified as a risk factor 
for advanced breast cancer. The disparity of stage of diagnosis by location has been 
recognised (Nguyen-Pham et al., 2014). 
It is anticipated that reporting of cancer stage changed from 2000 onwards, after it 
was modified by the SEER. This might provide more precise data about late 
presentation compared to the early years of SNCR’s data collection (1994–1999). 
These factors explain some of the characteristics that are linked with late 
presentation for female breast cancer in Saudi Arabia, but Chapters 6, 7 and 8 will 
provide a more in-depth exploration of the reasons for late-presentation.                                                                                       
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Chapter 6 Phase III: Late-presentation female breast 
cancer in Saudi Arabia: a qualitative study 
6.1 Introduction  
This chapter describes the methods used to undertake the third phase of this thesis—
the qualitative study. Its aim is to provide an in-depth contextual understanding of 
the factors that influence late presentation for investigations and diagnoses for 
female breast cancer in Saudi Arabia.  
Public health guidelines in Saudi Arabia are commonly based on evidence gathered 
from epidemiological studies. These studies use quantitative methods to describe 
health problems and to produce generalisable conclusions about health issues. Our 
understanding of the role that social factors play in complex public health issues like 
cancer require comprehensive, in-depth evidence to be attained (Jack, 2006). A 
qualitative approach investigates why and how a problem develops through 
identifying the relevant contextual factors and influences, and is thus able to improve 
our understanding of the reasons for individual behaviours (Jack, 2006). 
A qualitative approach is useful for explaining issues related to help-seeking and late 
presentation for diagnosis with cancer (Smith et al., 2005), and has been successfully 
used in numerous studies (Burgess et al., 2001, Gould et al., 2010, Lam et al., 2009, 
McEwan et al., 2014, Norsa'adah et al., 2012, O'Mahony et al., 2011, Rastad et al., 
2012). While several attempts have been made to explain delays in presenting for 
breast cancer symptoms, as explained in Chapter 4, all of the studies that have done 
so were not conducted in Saudi Arabia.  
Although phase II of this study revealed some of the characteristics of women that 
are connected with a high risk of being diagnosed with breast cancer after the disease 
has reached an advanced stage, it provides neither a holistic view of the current 
causes of late presentation nor an in-depth understanding of this research problem. 
Thus, this qualitative study was used in order to try to fill in many of the gaps in this 
area. This third phase of the thesis informs health professionals, policymakers, and 
the general public about the concerns of potential breast cancer patient identifies, 
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supports for and barriers to timely care, examines factors influencing early 
presentation and provides suggestions for future research in this area. 
6.2 Aim of the study  
This study investigates the factors that influence late presentation for breast cancer 
investigations and diagnoses amongst women in Saudi Arabia. 
6.3 Study objectives  
The main objectives of this study are to: 
 Explore lay-understandings of breast cancer and its progression.  
 Explore the reasons for seeking or not seeking immediate medical care after 
symptoms recognition.  
 Explore the barriers to and the facilitators of the seeking of timely medical 
attention for breast cancer investigations.  
 Map the healthcare-seeking pathway of breast cancer patients. 
 Develop an explanatory model of the factors that influence women in seeking 
medical attention following symptoms discovery. 
6.4 Methods 
6.4.1 Study design  
The third phase of this study used a qualitative research approach. Qualitative health 
research is a special form of qualitative research (Morse, 2011), and is recognised as 
a valid method for obtaining information (Popay and Williams, 1998) on how people 
react to symptoms and seek healthcare (Morse, 2011). It can access information that 
is not accessible through quantitative methods, helping to gather in-depth, detailed 
information from small groups of people, thus generating textual rather than 
numerical data (Holloway, 2005, Patton, 2002).  
6.4.2 Methods of data collection  
Data collection methods can be broadly classified into the two categories of the 
collection of naturally occurring data, which can be done using methods such as 
observation; and data generation through research intervention, which can be done 
using methods such as interviews and focus groups (Ritchie and Lewis, 2003). The 
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observation of naturally occurring data helps to develop an understanding of 
behaviour in context (Ritchie and Lewis, 2003). This study explored the pathways 
available for Saudi women to seek medical care, and the factors that help or impede 
their search. However, it would be difficult to identify participants that are 
experiencing breast cancer symptoms and then simply observe their care-seeking 
behaviours. Moreover, other methods could possibly generate more data. Patton 
(2002) notes that although observing feelings, thoughts and intentions is difficult, 
asking persons about them is possible. Morse (2011) stresses that patients often 
remember significant health-related events, such as illnesses, and that hospitalisation 
is difficult to forget. Patient recall is thus an effective way of gathering material on 
which good qualitative research can be based, because the emotions felt on recall are 
a reflection of the emotions felt when the events happened, and thus interview 
validity is retained (Morse, 2011). 
The main proven methods for retrospectively gathering information on events are 
participant focus groups and individual interviews. Both have been used in medical 
help-seeking studies for cancer, but interviews are more common in this area (Smith 
et al., 2005). Focus groups are often used for the quick and cost effective gathering 
of information (Patton, 2002), and are acceptable in the context of cancer studies 
because participants usually like talking with others who share their health concerns. 
However, the number of questions that can be used in focus group studies are 
restricted by the group structure, and may thus limit the depth of individual 
responses (Patton, 2002). Arranging meeting times suitable for all eligible 
participants can also be problematic. Furthermore, fear of embarrassment may 
prevent people from talking about certain issues in these contexts, so, in practise; the 
individual interview is generally then a preferred method of data collection for such 
studies.  
This study generated qualitative data from individual stories using ‘semi-structured 
interviews’ (Corbetta, 2003), which enable the interviewer to focus the interview on 
issues related to the study whilst simultaneously allowing free conversation to occur. 
The interviewer is able to clarify ambiguities by asking the interviewee follow-up 
questions (Corbetta, 2003). Thus, different participant responses can be clarified as 
actual differences in participants’ reactions to questions, rather than variations 
produced by different interpretations of the wording or a lack of comprehension on 
the part of the interviewees (Barriball and While, 1994). 
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Semi-structured interviews were thus chosen because they were the best suited to 
achieving the aim of this study. Interviews with eligible participants were scheduled 
at the convenience of the patients, who were often able to participate in the study 
before or after visiting the hospital for treatment. Although data collection using one-
on-one interviews may be expensive and time consuming (Teddlie and Tashakkori, 
2009), they provide a more private conversation than focus groups, and allow more 
details to be gathered from each individual (Ritchie and Lewis, 2003). 
In this study, all the participants took part in one interview conducted in spoken 
Arabic—the native language of all the participants. All interviews were conducted 
by the researcher, one-on-one, in a private setting at the oncology centre. The 
collaboration of the KFSH&RC’s oncology centre during data collection and its 
provision of facilities for conducting this research are both greatly appreciated.  
6.4.3 Interview guide  
An ‘interview guide’ approach (Patton, 2002) was used, which comprises a list of 
questions and/or issues to be explored during the interview. The list ensures that the 
interviewer utilises the interview time effectively and covers all the planned topics. It 
also helps keep interviews systematic, comprehensive and focused, whilst allowing 
the interviewer to be flexible during questioning and to explain or to ask about issues 
in more depth (Patton, 2002).  
The interview guide was developed following a thorough literature review (see 
Chapter 4). The guide aimed to capture information on types of symptoms identified; 
perceptions, knowledge, and recognition of symptoms; health-seeking behaviours; 
the social networks of participants; and the length of time that passed between 
respondents discovering symptoms and seeking healthcare. The guide also explored 
facilitators of and barriers to the seeking of medical care, together with women’s 
suggestions for health education and promotion (see Appendix E). Open-ended 
questions were used to obtain participants’ views in a way that minimised “the 
imposition of predetermined responses” (Patton, 2002). 
The interview guide was initially written in English so that it could be discussed with 
the researcher’s supervisors. It was then translated into Arabic, and revised by two 
female medical practitioners who were fluent in both Arabic and English in order to 
ensure the translation’s accuracy. The Arabic version of the interview guide was then 
pilot-tested with a woman who was Saudi by birth before the interviews were begun.  
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No changes were made to the interview guide after the pilot test. Rather, the pilot 
helped to assess what terms or phrases would be most easily understood by the 
participants, and to ensure that no medical or technical terms that could have been 
difficult for the participants to understand were used. In the first four interviews of 
this study, the researcher continued to note which words and expressions best 
conveyed the meaning of the questions, and thus enhanced their cultural 
appropriateness. 
6.4.4 Study participants 
The inclusion criteria for the study were that participants be female, Saudi nationals, 
age 18 or older, and had been diagnosed with breast cancer between two and six 
months before the interview. Patients who had received a cancer diagnosis within 
two months of the interview date were excluded from the research population in 
order to minimise emotional distress, as these patients could still be in the shock 
phase of the disease, and their emotions could also colour their responses compared 
with those of the other participants. Patients who had prior experience of cancer were 
also excluded, as were those with cognitive or psychiatric problems that could 
interfere with their ability to communicate and express their disease experience 
and/or their ability to provide informed consent to be interviewed.   
6.4.5 The sampling strategy  
An innovative form of purposive sampling was undertaken using empirical evidence 
from the quantitative study to select information-rich participants. Factors found to 
be significantly associated with the stage of the tumour at the point of the breast 
cancer diagnosis in Chapter 5 were considered to be relevant characteristics for 
guiding the purposive sampling. These included: stage at diagnosis, age, and place of 
residence.  
(1) Stage of tumour at breast cancer diagnosis 
The tumour stage at diagnosis was used as a proxy of the time between noting 
symptoms and seeking medical care. It was assumed that those who sought medical 
care promptly were more likely to be diagnosed at an early stage. 
Participants with a cross-section of cancer stages—from early and advanced—were 
recruited. Stages I and II were classified as ‘early-stage’ breast cancer, and stages III 
and IV as ‘advanced-stage’ using TNM staging system, as prognosis and survival 
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differ for early- and advanced-stage cases (Sant et al., 2003, Walters et al., 2013b). 
Moreover, the recruitment of participants with cancer at all stages allowed for the 
investigation of similarities and differences in seeking healthcare in relation to stage 
at diagnosis. 
(2) Age 
The systematic review carried out in this thesis presents evidence about the impact of 
age on late presentation for breast cancer investigations from the existing literature in 
the Middle East (see Chapter 4). These findings agreed with the wider literature in 
this area (Ramirez et al., 1999). Moreover, the quantitative study in this thesis––
which gives information specific to Saudi Arabia––confirmed that age has a 
significant effect on the stage of breast cancer at diagnosis. Thus, participants were 
recruited from different age groups in order to capture more information. An age of 
50 is considered to be the boundary between older and younger women because 
routine mammography screening is more likely to be effective from this age (US 
Preventive Services Task Force, 2009). This age precedes the menopause for most 
women. 
(3) Place of residence   
The results from the quantitative study indicated that regions are important 
predictors of how advanced the stage of breast cancer is at the point of diagnosis. 
Thus, one sampling criterion that was used was whether or not the patient resided in 
the Riyadh region or not. This criterion allowed for the exploration that the impact of 
living in a region with advanced oncology care has on health-seeking behaviour.  
The quantitative study in this thesis found nationality (Saudi vs. non-Saudi) to be 
significantly associated with the stage of breast cancer seen at the time of diagnosis, 
with Saudi women being more likely to be diagnosed at later stages of breast cancer 
than non-Saudi women. Since the focus of this study was on Saudi nationals, non-
Saudi women were excluded from the qualitative study.  
The year that the breast cancer diagnosis was made was not considered to be a 
relevant factor since all potential participants would have been diagnosed within 
relatively short period, and thus was not a criterion for sampling participants. The 
time gap between data collection for the qualitative study (2011) and the quantitative 
study (1994–2006) also made a criterion for year of diagnosis unfeasible, as those 
who were diagnosed at very advanced stages in 2006 might not still be alive, and 
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women that were still alive would be less likely to recall events as accurately as 
those diagnosed in the last two to six months.  
Non-significant factors were considered to be non-relevant and therefore excluded. 
For example, marital status had no significant impact on presentation for breast 
cancer investigations in the Middle East (See Chapter 4). It was not associated with 
stage at diagnosis in the quantitative study, and consequently it was not considered 
to be a relevant sampling criterion (see Chapter 5). A married woman was equally as 
likely as an unmarried woman to present late. This is explored further in the 
discussion section (Chapter 8). 
A sampling frame was designed, incorporating stage at diagnosis, age and region of 
residence (see Appendix F). It was designed to recruit a sample of up to 24 
participants, and 19 women were actually recruited, with each participant having 
multiple characteristics, as presented in Table 28. Another four potential participants 
were approached, but refused to participate. A description of the participants is 
provided in Chapter 7 – the results chapter. 
Table 28: Characteristics of the study sample based on the sampling frame 
Characteristics Number of 
participants  
Early stages, younger than 50 years and from Riyadh 
region 
2 
Early stages, younger than 50 years and from regions 
other than Riyadh 
1 
Early stages, 50 years or older and from Riyadh 
region 
3 
Early stages, 50 years or older and from regions other 
than Riyadh 
1 
Advanced stages, younger than 50 years and from 
Riyadh region 
3 
Advanced, younger than 50 years and from regions 
other than Riyadh 
4 
Advanced, 50 years or older and from Riyadh region 2 
Advanced stages, 50 years or older and from regions 
other than Riyadh 
3 
- 132 - 
 
6.4.6 The study setting  
The study took place in a single health institution—the KFSH&RC in Riyadh, Saudi 
Arabia. This institution has one of the most advanced oncology centres in the 
country, and accepts referrals of national and international cancer patient. The 
institution provides tertiary level healthcare, and is accredited by the World Health 
Organization as a collaborating centre for cancer prevention and control 
(KFSH&RC, 2011). A multidisciplinary team conducts patient assessment and 
treatment according to disease-specific guidelines there (Mohiuddin, 2011), and the 
clinical sections comprise medical oncology, radiation oncology, adult 
haematology/oncology and bone marrow transplantation, palliative care, and a 
research unit (Mohiuddin, 2011). The KFSH&RC hosts the SNCR and the Cancer 
Registry of the GCC countries (KFSH&RC, 2011).  
According to the KFSH&RC Tumour Registry (2012), a hospital-based registry that 
has operated since mid-1975 up through 2011, the institution treated 72,557 cancer 
patients. Patients were mainly referred from the Riyadh (35.5%), Eastern (14.8%), 
and Makkah regions (11.5%) (Mehmood et al., 2012).   
During 2011, when the data collection for this qualitative study was conducted, a 
total of 2,527 cancer cases were diagnosed at KFSH&RC, with 1,436 of these being 
females. Breast cancer was the dominant type of female cancer, constituting 16.7% 
of the total cancer cases, male and female, in 2011. Among females, breast cancer 
comprised 38% of all cancer cases. Looking at the general referral pattern of cancer 
patients to KFSH&RC in relation to location, most female breast cancer cases were 
referred from the Riyadh region (39.7%), followed by the Aseer (10.3%) and Eastern 
regions (9.6%) (Mehmood et al., 2012). 
Participants for the current study were selected from this institution because it is one 
of the largest oncology centres in Saudi Arabia, and it was considered likely that a 
sufficient number of participants for the study could be recruited from the 
institution’s referrals. KFSH&RC accepts cancer patients from throughout the 
country, so despite varying referral patterns, any eligible patient from these regions 
was offered the opportunity to join the study. This reduces the risk of attaining an 
insufficient number of study participants and a bias toward recruiting patients only 
eligible for specific healthcare services (see Chapter 2). 
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Generally, the oncology team was very supportive and friendly with both the patients 
and the researcher. Given their heavy workload, they were very helpful and 
answered all the researcher’s questions concerning their patients’ journeys through 
diagnosis and treatment.  
6.4.7 Data collection  
Nineteen participants agreed and signed consent forms to participate in the study 
between September and December 2011. Within qualitative studies, this sample size 
is considered sufficient to draw evidence (Guest et al., 2006), and is within the range 
of sample sizes used in published qualitative studies on cancer help-seeking (Smith 
et al., 2005). A small sample size is common in qualitative research due to the 
intensiveness of the data collection and analysis process (Popay and Williams, 
1998). The in-depth nature of this qualitative research allows the gathering of a large 
amount of data from participants, whose numbers were restricted based on the time 
available for the data collection. Moreover, at the end of the study, saturation was 
reached with this number of interviewees, and a larger group would most likely have 
yielded no new information. 
Eligible participants were identified by hospital staff members—usually either by the 
patient’s oncologist or the breast cancer nurse acting as the patient’s caregiver. The 
oncology centre was visited at times when potential participants could be met. The 
hospital contact would meet the researcher with a list of patients, and the researcher 
would then select potential study participants who met the sampling criteria. The 
hospital contact would then approach the selected patients and introduce the 
researcher to those that showed interest in the study. An information sheet (see 
Appendix G) which describes the study was given to potential participants. Interview 
dates and times were then arranged at the convenience of each willing participant. 
Each interview began with the researcher welcoming the study participant and 
introducing herself in order to build rapport, to put the interviewees at ease, and to 
establish natural conversation (Kvale, 2007). Each participant was told that her 
experience with the disease was valuable for understanding late presentation for 
investigations and diagnoses, and that the researcher would not judge her experience 
in any way (Patton, 2002). 
After this, the study objectives would be described, including the various ethical 
standards that the study upheld (such as maintaining the patient’s confidentiality and 
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anonymity), and the topics that would be covered in the interview. The purpose of 
audio recording would then be explained, and the participant’s written consent would 
be requested. The participant would also be asked if she had any further questions.  
The participant signed a consent form (see Appendix H) on the day of the interview 
and in the presence of the researcher before the recorded interview started. If the 
participant agreed, the interview was audio recorded; otherwise, the interview was 
recorded by hand in written notes. Five participants agreed to their interviews being 
audio recorded. During the other interviews, the participants’ answers to questions 
were written out by the researcher while they were talking. Decisions—about not 
audio record interviews—were respected without any requests for justifications 
being made. Even though the confidentiality of the interviews was explained to all 
the participants, perhaps women might refuse audio recordings because they have 
little awareness about or familiarity with interviews in qualitative research and audio 
recording for research purposes.  
As Long (2005) has noted, Saudi culture emphasises the value of personal trust, and 
the Saudi public is suspicious about the credibility of ideas and opinions expressed in 
the media. The participants in this research might have linked the idea of audio 
recording with media interviews, and there is a possibility that they may have felt 
they would have to be more careful about what to say if the interviews were audio 
recorded.  
Some women might be careful when they talked about their personal experiences 
even if their interviews were not audio recorded.  For such cases, extra reassurance 
and explanations about confidentiality and the use of these data for research purposes 
were provided. For example, one participant interrupted the interview and asked 
about the confidentiality of the data, even though her interview was not being audio 
recorded and confidentiality was explained thoroughly earlier. She was reassured 
again that all data would be anonymised, and an example was given to her: even the 
names of the healthcare facilities that the women first visited would be anonymised. 
After this reassurance, she then talked more freely.  
At the beginning of the recorded interviews, background demographic information 
was collected, comprising the woman’s age, marital status, number of children, 
education, employment, and family history of breast cancer or other types of cancer. 
The questioning did not follow the same sequence in each interview, nor did it 
always follow the sequence laid out in the interview guide. Interviews usually 
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continued with an open question like “Please tell me about the first symptoms you 
noticed”. Participants’ conversations were followed to ensure that the interview 
remained focused on issues related to symptoms and healthcare-seeking behaviour. 
Most questions were open-ended in order to encourage the participant to talk, with 
probes and follow-up questions being used to clarify new issues that arose. For 
example, when participants were asked about barriers to seeking medical care, some 
participants had not considered the existence of barriers before, so the researcher 
tried to clarify by giving examples, such as transportation to a health facility or 
holding other responsibilities.  
Leading questions were rarely used with the participants. The purpose of leading 
questions is to ascertain whether an event or issue is pertinent (Kvale, 2007). For 
example, if a woman spoke of seeking care at a health facility, and the researcher 
was not sure which facility she meant, the participant would be asked if she meant a 
PHC or a private clinic. 
At the end of the interview, the participants were asked if they had anything they 
would like to add, and the times that each interview started and ended were noted.  
6.4.8 Data analysis  
‘Applied thematic analysis’ (Guest et al., 2012) was used to analyse the qualitative 
data. This method of analysis was chosen because it provides a systematic, credible, 
and transparent way of identifying relevant themes from qualitative or textual data. It 
is currently the predominant method for analysing data in research projects with an 
applied qualitative focus (Guest et al., 2012).  
Qualitative data analysis is a complex and lengthy process because participants 
responses are neither systematic nor homogeneous (Patton, 2002). Thematic analysis 
seeks to recognise patterns or themes in the data (Braun and Clarke, 2006), using a 
phenomenological approach to investigate perceptions and lived experiences. The 
method characterises and then summarises these for the purpose of applying the 
findings to the research question. Thus, applied thematic analysis is used for applied 
research projects that aim to provide practical solutions to problems (Guest et al., 
2012). 
6.4.8.1 The analysis process  
The analysis explores the textual data with the aim of build a coherent and consistent 
story from it. To achieve this, common features were identified through a series of 
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steps, and these features defined by using themes. The themes emerged in response 
to textual data from participants’ interviews that represented shared ideas (Guest et 
al., 2012). The data analysis involved four stages: familiarisation, text segmentation, 
re-contextualisation, and writing up. 
(1) Familiarisation 
The first stage of the data analysis began with the researcher becoming fully familiar 
with the data (Patton, 2002). This process commenced during the data collection 
phase, through the researcher’s interaction with the participants, and developed 
further through listening to their interviews and writing up the field notes (Braun and 
Clarke, 2006). After the last interview was completed, the process of transcribing 
each audio recording and writing up the written interviews was performed. During 
transcription, the data was coded, with a number being assigned to each participant 
in order to preserve informants’ anonymity and to ensure that no data was able to 
lead back to them. For audio-based data, the accuracy of each transcript was checked 
against the audio or written recording before the analysis commenced.  
The analysis of the data focused on the research question that this applied qualitative 
study was designed to explore the barriers and facilitators that exist for the seeking 
of medical care after the self-recognition of breast cancer symptoms has occurred. 
The anonymous transcripts and notes were read and re-read in order for the 
researcher to become familiar with the data. This stage was helpful for understanding 
the study context and detecting differences in the women’s narratives. At the end of 
this first stage, a map was drawn up for each participant, referred to as a “medical 
care-seeking pathway”. This step helped to identify general and specific themes and 
topics (Ritchie and Lewis, 2003).  
(2) Text segmentation 
The second stage of the data analysis involved text segmentation, which is an 
analysis mapping tool that allows the assessment of data quality and helps in 
exploring themes in terms of their similarities, differences, and inter-relations (Guest 
et al., 2012). The text from each transcript was broken into segments, and the data 
was coded by assigning a code to each segment. A code describes the component of 
a theme and sets its boundaries, whereas a theme represents a general feature 
occurring in the data (Guest et al., 2012). 
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Qualitative data was systematically coded by importing one transcript at a time into 
NVivo (version 9), a software package for qualitative data analysis (QSR 
International Pty Ltd, 2010) that assists in the management of non-numeric data by 
facilitating data organisation, retrieval and tracking.  
To limit the possibility of the loss of content, the transcripts were analysed in their 
original Arabic forms, and the data was broken into text segments by identifying a 
beginning and an end point for each segment of each transcript. During this text 
segmentation and coding, the question ‘‘what does this text means to me?’’ (Guest et 
al., 2012) was recurrently considered. The process of text segmentation resulted in 
numerous codes, and was continued until no further codes were created.  
To ensure consistency in coding, three randomly chosen transcripts were translated 
from Arabic into English, and the researcher’s two supervisors independently coded 
the three English transcripts. The researcher’s and the supervisors’ coding of the 
three transcripts were then compared, and after consensus on the coding of each 
transcript was achieved, the codes of the remaining transcripts were reviewed. A 
codebook was used to systematically sort texts during text segmentation and coding. 
This is “a structured compendium of codes that includes a description of how codes 
are related to each other” (Guest et al., 2012 p.50).  
As the analysis became more complicated, it moved from being purely descriptive to 
becoming analytical through answering another question ‘‘what specific instances of 
meaning exist in this text?’’ (Guest et al., 2012 p.53). The codebook assisted in 
grouping the codes to develop a shared concept or theme. Table 29 provides some 
examples of the codes used in the codebook. The codes were sorted into potential 
themes by juxtaposing the codes and quotes from all interviews that shared a similar 
theme. Themes, with brief descriptions, were drafted for codes that shared a central 
idea.  
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Table 29: Example of codes definition from the codebook 
Suggested code Definition of elements  
Breast cancer awareness  Use this code for discussions of women’s 
knowledge about breast cancer prior to 
diagnosis with it.  
This can include quotes about what they 
knew, what they did not know, and their 
sources of knowledge.  
Misconceptions related to breast cancer Use this code for discussing women’s 
mistaken ideas and misunderstandings of 
facts related to breast cancer and the 
importance of seeking healthcare 
immediately after the discovery of 
symptoms. Examples can include quotes 
about misconceptions about breast 
cancer, the seeking of healthcare, and the 
sources of these misconceptions.  
Displaying data was used to enhance the understanding of the connections and 
explanations beyond data description (Bazeley, 2009, Miles and Huberman, 1994). 
Medical care-seeking pathway maps were also used to identify possible barriers and 
facilitators that existed for the women through identifying similarities and 
differences in their characteristics, mainly with respect to stage at diagnosis, age, and 
place of residence. The code book was modified during the analysis process as new 
information and thoughts emerged.  
(3) Re-contextualisation 
Re-contextualisation analysis is the process of theory building that is used during the 
refinement of data and involves linking the themes into concepts (Tesch, 1990). This 
step increased the complexity of the analysis by asking a third question: ‘‘are there 
patterns of relationship among instances of meaning in this text?’’ (Guest et al., 2012 
p.53).  
The themes emerged from the data were finalised after looking at the similarities and 
differences across all the transcripts. Of particular interest were comparisons 
between the women’s stories, as variations in opinions were expected among the 
- 139 - 
 
interviewed women. Where possible, negative cases were studied to enrich the 
analytical process—a negative case being one that does not fit with or contradicts the 
general pattern of the data (Guest et al., 2012, Patton, 2002).   
Memos were written during the data analysis to record the analyst’s thoughts about 
the factors that may have influenced the late-presentation for breast cancer 
investigations by the participants. These memos assisted in understanding the 
connections and relationship between themes that emerged from the data.  
In addition, the researcher’s discussions with supervisors that have extensive 
experience in qualitative research assisted in clarifying the main themes (concepts). 
In order to locate the main themes, differences in women’s experiences of seeking 
medical care were compared and contrasted in relation to stage at diagnosis, age and 
place of residence. These comparisons revealed differences in, for example, how the 
seeking of medical-care varies between older and younger women with breast 
cancer. The narrative map of medical care-seeking for each participant pointed to 
events and possible factors that facilitated or impeded the seeking of healthcare. 
These maps helped to reveal the relationship between themes.  
Each theme was then compared and assessed to ensure that, together, they presented 
a coherent story. During this process, new themes were created and revised, and 
extra data was recorded. A model was developed for this study, showing the 
relationship between themes experienced by at least one of the nineteen participants. 
A clear idea of the main themes was produced, together with an overall story shown 
by the data.  
(4) Writing up 
The written story of the qualitative findings is the final product of the research 
process, where data is used to tell a coherent story (Sandelowski, 1998). The writing 
up commences from the initial stage of the analysis and continues through each stage 
in which the findings are compared and contrasted and the theory is built (Ryan, 
2006). Writing up the qualitative findings formed part of the data analysis of this 
study. Women’s narratives were examined to determine each theme and how they 
related to others, and this helped to generate a study model (Bradley et al., 2007). 
The analysis process used a combination of inductive and deductive approaches, and 
was influenced by both data and empirical evidence. 
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6.4.9 Validity and reliability  
Validity and reliability are important for judging the quality of qualitative studies in 
multidisciplinary research (Patton, 2002). In particular, the demonstration of validity 
and reliability is necessary for persuading others that the research findings are worth 
paying attention to (Lincoln and Guba, 1985).  
In relation to qualitative research, validity involves “assessing what one is intending 
to assess” (Guest et al., 2012 p. 80). ‘Credibility’ (Lincoln and Guba, 1985) is 
commonly used in qualitative research to denote validity. The validity of the 
methodology of qualitative research is important, especially for applied research, 
where the findings might have an impact on policy formation.    
Reliability, on the other hand, refers to “an ability to measure consistently” (Black 
and Champion, 1976 p.232), and qualitative research generates issues concerning 
reliability because a large amount of “interpretation goes into defining the data items 
(i.e. codes) as well as applying the codes into chunks of text” (Guest et al., 2012 
p.11). It is important for qualitative research to demonstrate reliability because it 
helps to enhance validity.  
In order to enhance credibility, various options for assessing the research problems 
were reviewed (see Chapters 3 and 4), and a study design was developed. Following 
the analysis of the quantitative data, a set of criteria was developed for the purposive 
sampling strategy (see Chapter 5).  
The quantitative analysis aimed to discover which factors are associated with late 
presentation for breast cancer investigation and diagnosis. The characteristics that 
were likely to be possessed by women diagnosed at an advanced disease stage had 
been found at the macro level, and thus representative voices at the micro level could 
be selected. The qualitative analysis aimed to discover why and how the phenomenon 
of late presentation occurs through understanding women’s beliefs, thoughts and 
behaviours about the seeking of medical care when breast cancer symptoms are 
recognised. The qualitative approach could assist in understanding the phenomenon 
in this context through listening to representative experiences. By applying findings 
from the quantitative study to the qualitative study, findings from the qualitative 
analysis could thus be made more representative of the entire population, and 
therefore more generalisable, than if quantitative data had not been used. 
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Audio recordings of the interviews and verbatim transcriptions were included in the 
study design in order to improve the accuracy of the data (Halcomb and Davidson, 
2006). However, this part of the study design was only partially utilised, since many 
of the participants refused to be audio recorded during their interviews. In this thesis, 
all the quotes from participants come from the audio recordings, while the content 
from written narratives is presented in the form of summarised statements. Thematic 
analyses of texts aimed to identify shared ideas, and this can be achieved even if 
verbatim transcription is not used, as verbal data can be captured by other methods, 
including verbatim transcription (Halcomb and Davidson, 2006). 
The data was analysed by the researcher, who is Saudi Arabian by origin and birth, 
and it was important that the coders also had a proper understanding of the culture. 
Multiple coders were used to confirm coding and ensure inter-rater reliability 
(Barbour, 2001, Creswell and Plano Clark, 2011, Guest et al., 2012), with three 
transcripts being coded and analysed independently by two supervisors (JL and BP) 
to ensure the consistency of the coding. Differences in coding were resolved by 
consensus, although before arriving at a consensus, any differences were explored as 
a way of enriching the analysis (Potrata, 2011).  
The data analysis was performed using the Arabic transcripts after the researcher and 
the supervisors had undertaken the calibration exercise. Thus, all the coding and the 
analysis of the transcripts were undertaken before the translation was conducted. The 
interviews were translated into English at the report writing-up stage, which involved 
working closely with a professional translator to ensure that the intended meanings 
and contexts were reproduced in the English translation (Nes et al., 2010). 
6.5 Ethical considerations  
The joint ethics committee of the Leeds Institute of Health Sciences; the Leeds 
Institute of Genetics, Health and Therapeutics; and the Leeds Institute of Molecular 
Medicine at the University of Leeds reviewed this study on 21 April 2011 (Ref no. 
HSLTLM/10/015) (see Appendix B). I applied for local ethical approval in Saudi 
Arabia from the research ethics committee at KFSH&RC on 21 July 2011 (see 
Appendix I). The ethics committee at KFSH&RC follows research ethics 
requirements similar to those of the National Health Service. The ethical practice in 
this study is in line with the ethical practice adopted by the School of Medicine at the 
University of Leeds, and it was audited on 19 February 2014 (see Appendix J). 
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The recruitment of breast cancer patients needed to be handled with care, especially 
when women were first approached, as they were undergoing treatment. In this 
study, female breast cancer patients who had been diagnosed within the last two 
months were not approached, as they were probably still in the shock phase, which 
counted against approaching them both in relation to how they would be able to 
manage performing interviews that soon after diagnosis and in terms of how their 
emotional states could have influenced their responses. During the interviews, the 
researcher explained to the participants that they were free to talk about whatever 
they thought was relevant, and that they could withdraw from the study at any time.  
In addition, the voluntary nature of their participation was explained. One potential 
participant changed her mind about wanting to participate in the study on the day of 
the interview. All of the women were also told that a decision to not participate 
would not affect the standard of care they received or their relationship with their 
healthcare providers.  
Because the target sample was that of recently diagnosed breast cancer patients, the 
effects that the research could have on the interviewees were considered. Although 
emotional distress is possible in this kind of study, the literature has not been able to 
detect any “harm” from the use of interviews in such studies (Potrata, 2010), even 
when unstructured interviews are used (Corbin and Morse, 2003). In fact, it has been 
found that participants in unstructured interviews are far more likely to experience 
relief than distress after discussing distressing experiences (Corbin and Morse, 
2003). Nevertheless, a risk management plan was drawn up to deal with the 
possibility that a patient might lose her ability to continue the interview due to 
emotional distress, even after providing informed consent. In such a case, the 
participant would be asked if she wanted to continue, to take a break, or to end the 
interview. The interviewee would be informed that they would not need to provide 
any explanation for their decision, whatever it was; that there would be no negative 
consequences for their future care; and that their decision would be respected. If the 
interviewee needed emotional support, standard hospital procedures and regulations 
for dealing with distress would be followed. 
All the study participants were able to communicate in a generally calm manner, and 
were positive in their responses to the researcher. None of the interviews ended in 
tears or emotional distress. Data was stored on the University of Leeds M drive, 
which is secured and backed-up in password protected files. Data sets are made 
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anonymous by the removal of identifiers, with each participant being given a 
number, and any further data that might give clues to the participant’s identity being 
either excluded in the analysis or altered through anonymisation. All the data 
presented in this thesis was gathered from participants.  
6.6 The researcher’s role and status 
I am a Saudi female, born and raised in Riyadh, Saudi Arabia. As a public health 
specialist, I am extremely enthusiastic about developing interventions to improve 
early presentation for investigations and diagnoses for female breast cancer. I was 
brought up with supportive parents, who have always helped their children take care 
of themselves and find ways to improve their lives. Many members of my family 
work as health specialists, and we have always supported one another in our work, 
sometimes discussing issues in health such as revisions of health guidelines and 
policies, various continuing education courses, health campaigns, and advances in 
breast cancer care, detection and treatment. Personally, I have used both public and 
private healthcare in Riyadh, and am thus aware of many of their strengths and 
weaknesses.  
Before starting this thesis, I received training at the KFSH&RC in women’s health in 
general, and in breast cancer in particular (2004). I observed breast cancer clinics 
that provided in- and out-patient cancer care, including chemotherapy, radiation 
therapy, physiotherapy and palliative care. As a health educator, I have also been 
actively engaged in designing educational materials and participating in breast 
cancer awareness campaigns. I have also met numerous breast cancer patients in this 
role, and been able to discuss their experiences in discovering the disease. In the 
research for this thesis, I was thus able to understand participants’ initial feelings 
when doctors told them about their diagnosis, and I was aware of the need to be 
careful when speaking with them to avoid making them upset. In addition, I tried to 
improve my interviewing skills by practising with my supervisors, and by discussing 
and actively engaging in qualitative data analysis using NVivo software (QSR 
International Pty Ltd, 2010) before commencing the data collection phase.  
Being an ‘insider’ researcher who is a member of the research population, 
community, or study group can be valuable (Kanuha, 2000). For this study, I shared 
the participants’ culture, which helped in the data collection phase as I was well 
situated to gain acceptance and bond with the participants (Dwyer and Buckle, 
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2009). One risk with being an insider researcher is the potential for the researcher’s 
insider status to jeopardise the validity or trustworthiness of the study (Kanuha, 
2000). However, as a researcher who studies in the UK and has read the literature on 
the topic, I have an aspect of the outsider’s perspective as well.  
Dwyer and Buckle (2009) suggest that instead of considering the researcher’s nature 
in terms of binary opposites (as either an insider or outsider), there is also a space 
between the two perspectives that can be held, which allows the researcher to be 
both an insider and outsider at the same time. The most important aspect of the 
researcher’s position is that she be open, honest and able to correctly represent 
participants’ experiences (Dwyer and Buckle, 2009), and I made several attempts in 
this study to limit researcher bias and the lack of participant trust that may have been 
held towards me because of my position. During the data collection, I tried to 
encourage familiarity, and dressed in traditional female Saudi clothing
18
 in order to 
avoid any misunderstandings about my role, as well as to make it clear that I was not 
part of the medical team. This way, participants could better understand my role as a 
researcher, and also understand that talking with me would not affect their healthcare 
provision. Being able to speak with participants in a similar language and similar 
dialects was very helpful, and some women spoke about their experiences using 
words and phrases that I am familiar with. 
After conducting an interview, I would then reflect on what had transpired during it, 
and kept a record of these reflections on the analysis process, which were helpful in 
separating my feelings and personal experiences from those of the participants 
(Kanuha, 2000). Thus, bias during data analysis, writing up, and interpretation was 
reduced. As far as possible, I tried to make sense of what the women had said during 
the interviews, looking through the lenses of the participants rather than my own. In 
addition, my supervisors—who had outsider perspectives—provided comments and 
feedback during the data analysis and writing up, so bias from being insider 
researcher should be minimal (Hewitt-Taylor, 2002). 
 
                                                 
18
 During data collection, I wore a black abaya. 
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6.7 Summary  
This chapter described the methods used in the qualitative study, the third phase in this 
PhD. Overall description of the study, its aim, objectives and design is provided. 
Furthermore, details about the process of data collection were given together with the 
analysis methods. Ethical issues and the role of the researcher were explained. The 
following chapter presents the results of this study. 
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Chapter 7:  Seeking medical care and breast cancer 
investigations: women’s narratives 
7.1 Introduction 
The previous chapter explained the methods that were used for conducting the 
qualitative study. This chapter presents the findings on what happens after women 
discover breast cancer symptoms, seek medical attention and receive their diagnosis.  
The qualitative data analysis revealed five important areas concerned with breast 
cancer in women in Saudi Arabia: the discovery of breast cancer symptoms; 
knowledge, barriers and misconceptions; seeking others’ advice; healthcare and 
help-seeking; and diagnosis and discussion on late help-seeking or late presentation.  
Quotations and narratives from the participants’ interviews appear throughout this 
chapter. In addition, late presentation is defined in relation to the study context, and a 
model for explaining it is proposed. Finally, the results of the study are summarised, 
together with its overall role in this thesis.  
7.2 A description of the participants 
Nineteen women agreed to be interviewed for the study, and the interviews lasted 
from twenty-one to sixty minutes. The participants were divided into two groups 
based on the stage of their breast cancer at diagnosis. Seven participants were 
diagnosed at early stages
19
 and twelve at late stages. Ten of the nineteen came from 
within the Riyadh region, and the participants’ ages ranged from twenty-seven to 
sixty-one years. The analysis classified the participants in this study as either 
younger (below fifty years, n=10) or older (fifty or above, n=9). Some of these 
women were younger than forty years of age (n=6), forty years is officially 
recommended that women begin mammography screening in Saudi Arabia (see 
Chapter 2).  
All participants were married, except from two, who were divorced, and participants 
had a number of children ranging from zero to ten. The majority of participants 
                                                 
19
 For clinical tumours, early stages comprise stages I and II and late stages comprise stages III and 
IV. 
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(n=13) were housewives, with four in employment
20
 and two retired. Eleven 
participants had a university education or diploma, whilst six had received some 
formal education, and two had no formal education. Fourteen participants had no 
family history of breast cancer, but seven of these had a family history of other types 
of cancer. 
The length of time from self-discovery of symptoms to first medical facility sought 
ranged from zero days to more than a year. Nine of the participants took less than 
three months to seek medical care. The nineteen participants were purposively 
selected so that there were variations in stage at diagnosis, age, and place of 
residence in order to provide a diverse range of characteristics and views that would 
allow the research questions of this thesis to be answered.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
20
 The term “employment” denotes full-time employment, since formal part-time employment is rare 
in Saudi Arabia. 
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Table 30: Description of the study participants 
Characteristics Early stages Late stages  Total 
Total number 7 12  19 
Age  
Range 27-58 years 31-61 years 27-61 
Younger than 50 
years 
3 7 10 
50 years or older 4 5 9 
Marital status 
Married  7 10  17 
Unmarried  0 Two were divorced 2 
Education level  
Did not receive 
formal education 
0 2 2 
Primary  1  2  3 
Elementary  1 1 2 
Secondary  0 1  1 
Diploma  One  Two  3 
University  Four  Four  8 
Number of 
children  
0-10 1-7 0-10 
Place of residence 
Living in Riyadh 
region 
5 5 10 
Living outside 
Riyadh region 
2 7 9 
Employment 
Employee 3 1 7 
House wife 3 10 13 
Retired  1 1 2 
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Characteristics Early stages Late stages  Total 
Breast cancer  1  4 5 
Other cancers 5 2 7 
Estimated Time to presentation  
Less than three 
months 
4 5 9 
More than three 
months  
3 7 1
0 
 
7.3 Breast cancer symptoms, awareness and medical care-seeking 
This section discusses the participants’ decisions to seek medical investigations. 
Almost all of the women in this study identified a lump in their breast before being 
diagnosed with breast cancer, and of the three who did not find a lump; one was 
diagnosed without symptoms following mammography screening, whilst two 
detected changes in their breast size and colour.  
Whereas those diagnosed early showed few symptoms other than a lump in the 
breast, those diagnosed at a late stage frequently had other breast cancer symptoms, 
such as an increase in breast size, an inverted nipple, skin thickness and redness, or 
an underarm lump. In addition, older participants often had comorbidities (such as 
gallstones or rheumatoid arthritis) that could mask breast cancer symptoms, and 
would seem more bothersome than a painless breast lump. Most of the women this 
older group were only diagnosed with breast cancer after they sought help for their 
comorbidities. For example, one older woman detected an increase in breast size, but 
because she experienced no accompanying pain and did not detect a lump, she 
thought that there was no point in going to the doctor with this issue. Her breast 
cancer was only diagnosed during a surgical consultation for gallstones when the 
surgeon saw a bluish, reddish discoloration near the nipple, and immediately referred 
her to a breast cancer specialist (Participant 17, late stage). 
Younger women who were diagnosed with a late stage cancer often associated 
changes in their breast with reproductive health issues, such as miscarriage, 
breastfeeding or pregnancy. For example, a younger woman who had given birth 
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nine months before discovering a breast lump talked about her thoughts when she 
discovered the lump as follows: 
I thought that it [the lump] might disappear. Sometimes the breast 
hardens because of menstruation. Two days before menstruation a 
woman feels that her breast is hard and sometimes painful. So I 
thought that maybe the pain was related to breastfeeding. I 
breastfed my child for a month from the right breast, and she did 
not breastfeed from the left breast. It [the left breast] was slightly 
larger than the other one and she did not latch onto it at all. So I 
thought that maybe it [the increased size of the left breast] was 
milk collection. It did not occur to me that it could be a disease.  
(Participant 15, late stage) 
The younger participants, who tended to be diagnosed with earlier stages of breast 
cancer, were more likely to seek medical help soon after detecting changes in their 
breast than the older cohort. However, although they understood that the changes 
might be abnormal, they did not necessarily relate them to breast cancer. For 
example, one younger woman detected a lump in her breast and asked those close to 
her for their opinions before eventually seeking medical help, but none of those she 
asked mentioned breast cancer (Participant 15, late stage). 
The women were also frequently unaware of possible breast cancer symptoms other 
than a breast lump. For example, they failed to link an underarm lump or changes in 
breast size with breast cancer, with one participant explaining that she had seen a TV 
programme about breast cancer, but that she did not get worried about the lump in 
her underarm because she did not remember any mention of that symptom in the 
programme:  
I did not know that the underarm had any association with it 
[breast cancer]. I mean, I saw on TV, when they talked about breast 
cancer, about breast lumps, and so on. Perhaps they talked about it 
[underarm lumps], but I missed it.  
(Participant 2, late stage) 
Those who seemed to be more aware about breast cancer, and who interpreted their 
symptoms as potentially serious, had a variety of reasons for seeking prompt 
diagnosis. For example, nearly three years before her diagnosis, one participant’s 
sister told her about breast cancer symptoms and breast self-examination. Her 
sister—an educational supervisor—had attended a course on breast cancer and, after 
finishing the course, she had taught her family members about breast cancer and how 
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to perform breast self-examination, sharing written materials about breast cancer that 
illustrated signs and symptoms with them. When the participant herself detected an 
olive-size lump while taking a shower, she immediately linked this symptom to 
breast cancer. Because she suspected breast cancer, she promptly sought medical 
care (Participant 5, early stage). 
Another participant attributed the lump in her breast to a physical injury. She later 
recognised the importance of seeking medical advice when her colleague found a 
lump during her postpartum period and was diagnosed with breast cancer. She 
believed that her colleague’s experience prompted her to seek medical investigations 
to check whether or not the lump she had found was malignant (Participant 1, early 
stage). She was not the only participant who was alerted about the possibility of her 
own breast cancer through somebody else’s experiences. One younger woman did 
not feel a lump in her breast, but rather noticed vein and chest tightness after her 
miscarriage. She thought it might be a benign tumour, because her sister’s friend had 
similar symptoms and received that diagnosis. She decided to seek medical care 
immediately, to confirm that her symptoms were not dangerous (Participant 9, early 
stage).  
In addition, periodic mammograms sometimes revealed breast cancer. An older 
participant who had undergone a hysterectomy and periodic mammography 
screening talked about her experience of receiving a coincidental diagnosis of breast 
cancer. 
Every year I do a mammogram. Nine months before I discovered 
the disease, I had a mammogram and all the cells were normal. I 
went to a female doctor because I had a little inflammation; I had 
had a hysterectomy because I had … and a benign tumour that they 
sampled and found was not malignant. But I had itching … and I 
went to the female doctor.  
(Participant 4, early stage) 
The participant and the doctor spoke after the clinical examination, and the following 
is an account of this conversation, as recalled by the participant: 
Participant: Could you do a breast examination [mammogram]? 
Doctor: You did it nine months ago.  
Participant: Yes. 
Doctor: You don’t need it. Wait for a year. 
Participant: Since you did the clinical examination, let’s do one too 
[a mammogram]. 
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(Participant 4, early stage) 
This participant knew about breast cancer from her relatives, brochures, TV, the 
general media and books. She later explained that insurance is an important 
consideration in seeking medical care: 
This factor [medical insurance] helps a woman to go [to get 
healthcare] with confidence that she will get a quick appointment. 
She will be comfortable about the care because people [health 
workers] are providing a lot of care.  
(Participant 4, early stage) 
Perhaps this participant was aware of breast cancer for other reasons, and not only 
because she received a free mammogram. Rather, she may have learned more about 
breast cancer because her comorbidity increased her risk of the disease. 
Several participants sought medical care promptly because they believed that the 
lump in their breast was abnormal. For example, one younger participant sought 
medical care because she found a lump, though she knew little about breast cancer.  
I noticed a lump in my breast when I took a shower one day. I felt 
that this was something strange. First I asked my sisters, my family, 
like that [sic], but they did not think it important. Then, I tried to 
read and went to the nearest health centre.  
(Participant 15, late stage)  
Other younger women also sought medical advice after discovering what they 
perceived to be an abnormal breast lump, although they were not aware that it could 
be cancer. However, not all of these women were diagnosed at an early stage.  
Generally, the women who were diagnosed at early stages were those who were 
more aware about breast cancer, regardless of age, and thus more likely to associate 
their symptoms with breast cancer. Many of these women were more aware about 
breast cancer because of those around them: one had a sister who had attended a 
course on breast cancer and taught her; two had friends with similar symptoms; and 
two were aware that they should seek medical attention immediately because their 
children had been diagnosed with benign or malignant tumours. Those who did not 
interpret their symptoms as serious, or did not realise that the symptoms could 
indicate breast cancer, were less likely to seek medical care promptly because of 
their misconceptions about breast cancer or because they did not disclose their 
concerns to and discuss them with significant others. 
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7.4 Barriers, misconceptions and medical care-seeking 
Besides a lack of awareness about breast cancer, women might have encountered 
barriers or held misconceptions that could interfere with comprehending the risk of 
breast cancer or seeking prompt medical investigations.  
Because a strict gender binary is the social norm in Saudi Arabia, it would be 
reasonable to expect that transportation issues, distance to the healthcare facility, 
marital status, and the gender of the healthcare provider represent important barriers 
to seeking timely help. Surprisingly, this study found that most women, whether 
diagnosed in early or late stages of breast cancer, said they encountered no such 
barriers while seeking medical care. Interestingly, none of the participants reported 
problems with transportation, with an older participant noting that there were several 
ways to reach the healthcare facility: going with a personal driver, with their 
husband, or with their children, for example (Participant 1, early stage).  
The analysis detected no notable differences in healthcare-seeking behaviours 
between the participants based on where they lived. Additionally, none of the 
participating women reported being deterred from seeking medical care based on 
their healthcare provider’s gender, or because they could not obtain permission from 
a legal guardian (usually a husband or close male relative). On the contrary, most 
women talked about being encouraged by male relatives, including their husbands 
and sons, to get appropriate medical advice and investigations, and reported received 
support from them throughout their treatment (n=16). 
7.4.1 Commonly encountered barriers and misconceptions 
This study did, however, find several misconceptions that delayed the participants in 
seeking medical attention. Many participants tended to seek help only after they 
started to experience pain in relation to their breast cancer symptoms, believing that 
if there was no pain, the condition was not serious. This was particularly common 
among older participants, who were frequently the ones diagnosed at late stages. For 
example, one older participant was diagnosed at a late stage of breast cancer only 
after she could no longer tolerate the pain and sought emergency medical treatment 
(Participant 7, late stage). Another older participant sought medical care in order to 
get a painkiller for the pain in her breast.  
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It looks like a ball [the lump], then I thought I will go [to healthcare 
facility] maybe they will give me something, an antibiotic. A day 
later I went to the Primary Health Care.  
(Participant 19, late stage) 
Another misconception of participants—mostly held by younger women this time—
was that they would not get cancer if they had breastfed their children. 
Consequently, even when they noticed a symptom like a breast lump, they thought 
that it could not be breast cancer. One example of this was Participant 14 (late stage), 
who did not stop breastfeeding until she had been diagnosed. Healthcare workers 
may foster this belief, as this participant explained that her healthcare worker 
initially believed that her lump was associated with her recent breastfeeding practice. 
This misconception was encountered in male relatives as well. One young woman 
diagnosed at a late stage reported that both she and her husband thought that 
breastfeeding would prevent breast cancer (Participant 18, late stage). Two 
participants held the mistaken belief that fever is a symptom of breast cancer. One, a 
younger participant, mentioned that she had not experienced any fever, and therefore 
believed that she did not have breast cancer (Participant 16, early stage). 
These were not the only misconceptions about breast cancer that might have 
interfered with seeking medical care quickly. The study found that some women 
misunderstood the risk of breast cancer, with one participant believing that if a 
woman had not had Hormone Replacement Therapy (HRT) she could not get breast 
cancer. This participant had a sister that had used HRT and later been diagnosed with 
breast cancer, and thought that the HRT had caused the breast cancer:  
I thought about one thing. I did not continue with gynaecology 
after menopause. I was supposed to have replacement for that 
hormone—oestrogen. I did not have follow-up appointments at all 
after my menstrual period stopped. This is what I thought I 
neglected.  
After menopause, my sister was prescribed patches to stick on her 
thigh to replace hormones—oestrogen [the sister was later 
diagnosed with breast cancer]. As a consequence, I was afraid that 
they [the patches] were the main cause of the tumour. I did not 
follow up [and visit a gynaecologist until much later after 
menopause], and look at me now! [The participant also has a 
diagnosis of breast cancer, despite not using HRT.] 
(Participant 7, late stage) 
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Once women noticed their symptoms, some may have considered the possibility of 
receiving a cancer diagnosis and been frightened about the potential consequences of 
the disease’s progression, complications and/or death. In some cases, this may have 
motivated medical care-seeking. For example, an older woman said that her fear of 
the disease and of losing her health led her to seek medical care (Participant 11, early 
stage). However, in other cases, fear of the impact of the diagnosis itself and its 
repercussions may be immobilising. For example, an older participant talked about 
fearing a breast cancer diagnosis in terms of being concerned about her children, her 
self-image, and about how she would look after surgery. This likely slowed down 
her seeking of medical care, and she only in fact decided to raise her concerns with 
her doctor after seeking care for something else (Participant 13, late stage).  
7.5 Symptoms disclosure 
Many women, particularly younger ones, disclosed their health concerns to 
significant others (usually family members) after noticing bodily changes. Some, 
mostly younger women again, mentioned talking about their symptoms with others 
who then encouraged them to seek medical care, whilst only a few women, mainly 
from the older group, did not tell anyone about their symptoms before they were 
diagnosed. For example, one younger participant that was diagnosed with breast 
cancer during pregnancy explained that her husband is the person she is closest to. 
He was worried about her when her symptoms started to worsen, and encouraged her 
to seek medical help (Participant 12, late stage). 
After discovering their breast cancer symptoms, the participants sometimes delayed 
telling anyone about them. For example, an older participant waited to talk about her 
symptoms with her son, who immediately encouraged her to seek a medical 
diagnosis. She mentioned that he had expressed a wish that she had talked about her 
concerns earlier when she first noticed them (Participant 3, late stage). Advice from 
significant others is thus a very important factor, which can prompt or delay the 
seeking of medical help.  
Many respondents reported carefully balancing the advice they received and their 
own opinions about seeking medical help. For example, an older woman disclosed 
concerns to her daughter about a lump, who promptly encouraged her to seek 
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medical care. However, possibly as a result of her own misconceptions, she did not 
follow her daughter’s advice: 
Yes, I talked to my daughter. She is the person closest to me. She 
said, “Go. Go” [to healthcare]. But I did not go immediately.  
(Participant 7, late stage)  
The respondents mostly reported receiving immediate support and encouragement 
once they had disclosed their symptoms to third parties, regardless of when they 
disclosed their concerns to significant others.  
7.6 Healthcare, help-seeking and diagnosis 
The healthcare provision that is available might influence the time it takes for 
women to seek medical investigations and care for breast cancer. Several participants 
believed that the attention and care provided by health professionals had an impact 
on their decisions to seek medical investigations (both in public and private 
medicine). A younger participant explained that free healthcare and quicker 
appointment times would have encouraged her to seek healthcare more promptly 
(Participant 10, late stage), whilst an older participant believed that having private 
health insurance encourages medical care-seeking because the health facilities 
covered by private insurance provide more attention and care than public healthcare: 
I went [to the hospital] covered by the medical insurance. My sister 
has a medical file in the hospital and she took time and tried to go 
there. So this factor [medical insurance] helps a woman to seek 
medical care and to be confident and not worried. She will get an 
appointment quickly and feel cared for [by the health workers]. 
(Participant 4, early stage) 
However, not all women can afford to pay for insurance, or are eligible for it. The 
majority of participants relied on public healthcare, and thus the quality of healthcare 
on offer could have influenced their decisions about which health facilities to visit. 
An older participant talked about the long waiting time for an appointment as a 
barrier to seeking medical care: 
What led me to not seek help immediately [from the hospital] is 
the waiting time. [A] long waiting time, that is why I did not go 
quickly. I prefer to tolerate [the problem] and not to go unless it’s 
something very severe.  
(Participant 7, late stage) 
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Seeking medical care is only the beginning of the patient’s journey in breast cancer 
investigations, diagnosis and treatment. After the participants sought care, they 
experienced important differences in their diagnoses and treatments, with health 
professionals’ reactions to concerns varying in relation to the age of the women. For 
older women, an early diagnosis of breast cancer sometimes resulted from women 
raising concerns about breast cancer symptoms during medical appointments for 
something else. One older participant decided to raise concerns about a lump during 
a follow-up appointment for other health concerns in a hospital, and was diagnosed 
with breast cancer (Participant 1, early stage). The health professional responded 
promptly to her concern.  
Conversely, whilst younger women tended to seek medical care promptly, some 
were misdiagnosed by healthcare professionals who believed that their conditions 
were benign, or ascribed their symptoms to other conditions, such as hormonal 
changes that occur after giving birth or breastfeeding. One younger woman who 
sought medical care promptly after she felt a lump was misdiagnosed by her doctor, 
who explained that her lump was related to her current breastfeeding. This woman 
reported that the doctor reassured her that she would not get breast cancer because 
she breastfed her baby. After eight months, the participant went to the same doctor 
because the lump had increased in size. The doctor was surprised and referred her to 
a specialist, who then diagnosed her with breast cancer (Participant 14, late stage). 
Another younger woman who sought medical care after being alerted to the presence 
of a lump in her underarm by her husband was told by her doctor that it was not a 
serious health issue, and that it could not be cancer because it was too small—not 
even being obvious if she raised her arm. The doctor reassured her that the lump 
could be related to her sleeping position. Later, the woman discovered another lump 
in her breast. Uncomfortable with the doctor’s diagnosis, she sought another 
physician’s opinion.    
I went to the doctor [the second one] in the hospital and when I 
met the doctor, she said “you will be referred to see what this lump 
is—if it is normal or abnormal”.  
(Participant 2, late stage) 
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7.7 Discussion: Late help-seeking or late diagnosis 
In this study, participants were asked to report the time interval between becoming 
aware of their symptoms and seeking medical investigations for them. The time from 
self-discovery of symptoms to seeking medical investigations ranged from zero days 
to more than one year. The length of the period varied between participants 
diagnosed at early and late stages, being shorter among women diagnosed at early 
stages (zero days to six months) compared to those diagnosed at late stages (less than 
one week to more than one year).  
The estimate of the length of time that it took patients to seek medical care 
investigations depended on the presence of breast cancer symptoms at the time the 
patient interpreted these symptoms as abnormal. Because this study gathered details 
about when participants noticed symptoms and sought medical investigations 
through face-to-face interviews, and considered the events during the process of 
medical care-seeking, this period represented a valid data source (Andersen et al., 
2009).  
In accordance with other studies, this study defined prompt care-seeking as that 
occurring within three months of the patient first noticing symptoms (Ramirez et al., 
1999). Where there was a shorter period between symptoms recognition and seeking 
medical attention—i.e. less than three months—this did not necessarily translate to 
an early stage diagnosis. Nor did a delayed seeking of medical investigations (more 
than three months) necessarily lead to a late stage diagnosis.  
Including participants with both early and late stages of breast cancer, and from 
different age groups in the investigation of treatment-seeking and diagnosis provided 
new insights into how to define late presentation. For example, there were two older 
women that took nearly six months before they sought medical attention, but were 
diagnosed at an early stage of breast cancer. In contrast, there were two younger 
women who sought medical help less than three months after noticing symptoms, but 
were diagnosed at an advanced stage of breast cancer. One of these was pregnant, 
and the other one had a benign breast tumour at first.  
Surprisingly, one of the women from the older cohort was diagnosed with breast 
cancer even though she had frequent mammography screening. The length between 
her negative mammogram and her positive one was nine months (Participant 4, early 
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stage), which is less than the recommended period for performing periodic 
mammography screening. 
Thus, there is not a straightforward relationship between the length of time after 
recognising symptoms to seeking medical investigations and the expected outcome 
(stage at diagnosis). Within the study context, tumour aggressiveness could be one 
mediator of this relationship, however. The role of tumour aggressiveness (or grade) 
was not examined in this study, but the breast cancer literature in Saudi Arabia 
indicates that Saudi women have a greater tendency to develop late stage tumours 
than Swiss women (Al-Kuraya et al., 2005). Tumour aggressiveness might explain 
the reason that late stage diagnoses where made after only a short period had elapsed 
between noticing symptoms and seeking medical investigations in this study. The 
criteria of ‘length of time to seek medical investigations’ might thus need revising 
for assessing late presentation in relation to Saudi women with breast cancer.   
Younger women tended to seek medical investigations for breast cancer more 
quickly than older women in Saudi Arabia. Nevertheless, some younger women 
were diagnosed at a late stage. Being diagnosed at a late stage after immediately 
seeking medical investigations upon discovering breast cancer symptoms is 
something that a patient could have done nothing practicable to prevent. Such cases 
of rapid disease progression may be related to (i) the healthcare system—the patient 
was misdiagnosed at an earlier appointment; or (ii) biological factors —Saudi 
nationality is a risk factors for developing aggressive breast cancer (Al-Kuraya et al., 
2005). When late stage diagnoses are made in younger women who have sought 
medical investigations quickly, they are thus more likely to be related to healthcare 
or biological factors.  
The analysis of the older cohort of women shows that their behaviour in seeking 
medical care is a more dominant factor in determining the disease stage than the 
healthcare system itself is. For older women, late presentation or late stage diagnoses 
are more likely to arise from patient-related factors. This may, in part, be attributed 
to the fact that the older women tended to be less aware about breast cancer and held 
more misconceptions, such as those bodily changes are not serious if they are not 
painful, and thus there is no reason to seek medical investigations for them. In 
addition, this cohort often had comorbidities that might have led them to prioritise 
when to seek medical care. The period of time it took them to seek medical care was 
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frequently shortened by speaking to (significant) others about their symptoms, and 
their decisions might also be affected by their previous knowledge or experiences of 
others with breast cancer. Moreover, healthcare professionals reacted more 
positively to older women’s concerns about breast cancer symptoms, and were more 
likely to promptly refer them to specialists or suspect the possibility of breast cancer 
than they were with the younger cohort. 
There is thus a need to rethink the assessment of late presentation for female breast 
cancer in the context of Saudi Arabia, and to be more open to the role of socio-
cultural factors and healthcare on the stage at diagnosis. It appears that women who 
take longer to seek medical care do not intend to delay, and therefore that it is unfair 
to either blame them or label them as ‘late presenters’. In addition, some women 
who promptly seek medical care are diagnosed at late stages, thus we should also be 
aware of the role that healthcare may play in the phenomenon of late diagnosis.  
As there is no precise way to quantify patient delay (Andersen et al., 2009), and due 
to the contextual and biological factors that influence breast cancer in Saudi Arabia, 
using ‘stage at diagnosis’ does however remain a valid indicator of late presentation, 
regardless of how long the patient has taken to seek medical investigations.  
7.8 The study model 
This study data shows that numerous factors influenced women’s medical care-
seeking behaviours. A central factor in this study is age, as Figure 14 shows. 
Generally, both younger and older women displayed poor knowledge about breast 
cancer, with some having no knowledge about it before their diagnoses were made. 
The knowledge they did have about breast cancer was often incomplete, and did not 
necessarily come from official healthcare or educational resources, or from public 
health campaigns. The lack of prior knowledge about breast cancer is more apparent 
among older women, who were often only diagnosed with cancer because they had 
presented for the treatment of other health problems, or because it was detected 
during opportunistic screening. In this context, it is understandable that women 
might not realise their symptoms indicate breast cancer. This incorrect interpretation 
of symptoms may increase for patients who have numerous misconceptions about 
the disease. For older patients, the misconception that any symptoms need to be 
painful before medical care-seeking is indicated was prominent. For the younger 
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participants, a lack of awareness about breast cancer did not stop them from seeking 
medical investigations, but it may have affected the speed at which they sought 
investigation. For example, they might link their symptoms to other potential 
problems, such as a benign breast tumour.  
For some women, a fear of cancer negatively impacted upon their timely care-
seeking, although this was not common in this study. Many women in the study, 
particularly those in the younger cohort, tended to speak about their symptoms to 
family members. Some of them sought opinions from women who had experience of 
benign or malignant breast tumours, and reported that these third parties had helped 
them to think about their symptoms and decide what actions to take. Most of them 
sought out medical investigations promptly, even though some of them had not 
suspected the possibility of breast cancer. Some older women, however, did not 
disclose their concerns immediately to others, or at all. As a result, they did not 
receive any encouragement to seek medical care. Nonetheless, it is possible that even 
if they were encouraged to seek timely medical diagnoses, they might not do so 
because of the misconceptions they held.  
Once women came into contact with healthcare facilities, the health professionals’ 
reactions often varied in relation to their age. Health professionals reacted positively 
in undertaking breast cancer investigations for older women, even when the patients 
did not identify breast cancer symptoms. In contrast, health professionals’ reactions 
to younger women were not always positive, with some younger women being 
misdiagnosed due to the presence of other reproductive health issues that could have 
interfered with clinical breast examinations, and diagnostic tests such as 
mammogram not being used. Such misdiagnoses, together with the biological 
features of breast cancer among the study participants (Al-Kuraya et al., 2005), 
might have had negative consequences on the stage of breast cancer seen at the point 
of diagnosis.  
Women’s education is not recorded by the SNCR; therefore its main effect on late-
stage at diagnosis was not examined in the quantitative analysis or used to 
purposively recruit participants in this study. In the literature review, it was seen that 
education had been found to influence late presentation, with women who promptly 
seek medical care tending to be better educated and more aware of breast cancer (see 
Chapter 4). There may be a link between being better educated and more informed 
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about breast cancer (and therefore more aware about its symptoms and the need to 
detect it at early stages). However, the qualitative analysis indicated that education is 
a confounding factor to age. Most women knew that the presence of a lump could 
indicate breast cancer, but were not aware about other breast cancer symptoms, such 
as underarm lumps, changes in breast colour, and inverted nipples. The women’s 
narratives indicated that none of them had an advanced knowledge about breast 
cancer. Mostly, they sought medical care as a result of opportunistic factors, such as 
having a son diagnosed with cancer or a relative who knew about breast cancer. 
Younger women tended to be better educated than older ones, with main difference 
between them being the added misconception prevalent among the older cohort that 
if a symptom does not hurt it is not serious and so there is no need to visit a doctor. 
The figure 14 below shows the different ways in which age can impact on 
investigations and diagnoses for breast cancer. 
 
 
 
 
 
 
 
 
Figure 14: Factors influencing late-presentation breast cancer 
7.9 Discussion of the study findings 
Various models for understanding the late presentation of breast cancer have been 
proposed and adopted (see Chapter 3), the most recent being the Model of Pathways 
to Treatment (Walter et al. 2012) – a refinement of  the Andersen Model of Total 
Patient Delay (Andersen et al., 1995) providing a theoretical approach for studying 
cancer diagnosis and treatment. 
The Model of Pathways to Treatment (Walter et al., 2012) describes four main time 
intervals involved in seeking medical diagnosis and treatment in terms of beginning 
and end points. These comprise: the appraisal interval – the time between detection 
Age  
Healthcare   
Lack of awareness and misconception  
Disclosure   
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of symptoms to perceiving the need for medical consultation; the help-seeking 
interval – the time between the patient perceiving the need for a medical consultation 
to his first contact with healthcare providers; the diagnosis interval – the time 
between the patient’s first medical consultation and their receiving a diagnosis; and 
the pre-treatment interval – the period between the patient receiving their diagnosis 
and treatment commencing. This model also recognises the processes within each 
interval and the how the lengths of these intervals could be affected by the patients, 
the healthcare system or the disease itself (Walter et al., 2012). 
In this study, the time taken to present was measured from the self-recognition of 
symptoms to first medical contact, thus considering the ‘appraisal interval’ and the 
‘help-seeking interval’ (Walter et al., 2012) as a single interval. 
The process of presentation for healthcare was understood to involve the recognition 
of symptoms as abnormal (but not necessarily related to breast cancer), the 
monitoring and self-management of these symptoms, talking to others, and seeking 
medical care. It is important to note this process did not progress in a linear or 
identical manner among all of the participants. The factors that influenced the 
participants’ pathways to presenting for healthcare investigations can be split into the 
categories below. 
(i) Patient-related factors: As shown in the study model (Figure 14), age is an 
important factor associated with presentation. A lack of breast cancer awareness 
together with misconceptions about it interfered with patients’ recognitions of the 
seriousness of their symptoms and the possibility that they could be related to breast 
cancer. Talking to third parties and receiving family support might speed up the 
process of presenting for healthcare investigations. These factors are also identified 
in the literature (McEwan et al., 2014, Rastad et al., 2012, Smith et al., 2005). 
Married and unmarried women talked about receiving family support – including 
from husbands, sisters, brothers and children. Perhaps this could explain why 
married and unmarried women were equally likely to be at risk of having advanced 
stage tumours at the time of diagnosis, as the quantitative analysis showed.  
(ii) Disease-related factors: It is possible that time to presentation and stage at 
diagnosis are influenced by tumour characteristics as there is a chance that Saudi 
women might experience highly aggressive tumours (Al-Kuraya et al., 2005). The 
biology of tumours is not a factor that is commonly addressed in qualitative research. 
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Future research could further investigate whether a longer presentation time – more 
than three months – is associated with more advanced stages of cancer at diagnosis, 
and if this varies according to age groups among Saudi women.  
(iii) Healthcare-related factors: while women talked about issues related to quality 
of care, the findings revealed additional factors related to healthcare professionals 
themselves, not just the time taken to present to healthcare. These were linked to the 
‘diagnostic interval’ – the time from first medical consultation to diagnosis (Walter 
et al., 2012). The results indicated that that age of women might impact on timely 
diagnosis, with younger women being more likely to be misdiagnosed while older 
women receive timely diagnoses. That is, being younger is positively associated with 
healthcare provider delay (Ramirez et al., 1999). Studies in the Middle East indicated 
that the misdiagnosis of breast cancer occurred in the Middle East, but the patient’s 
age was not specified in these studies (McEwan et al., 2014, Rastad et al., 2012).  
The three main factors that contributed to late-presentation for breast cancer in this 
study – patients, the healthcare system and disease-related aspects – concur with 
those proposed by the Model of Pathway to Treatment.    
7.10 Strengths and limitations of the study 
Qualitative research is often considered to not be generalisable or context specific 
(Firestone, 1993). By using mixed methods, this research has attempted to 
ameliorate this limitation. Participants were recruited purposively—that is, they were 
recruited on the basis of possessing characteristics that might be associated with the 
stage of breast cancer at the time of diagnosis, and these characteristics were located 
through the quantitative study (phase II) of this research. Data was thus gathered 
from women with a variety of characteristics in order to enrich the analysis. 
During the data collection phase, the researcher talked to women—both formal and 
informal participants—about their experiences with breast cancer. These discussions 
revealed that patients that had been diagnosed a long time before the discussion 
might not remember the chain of events that led them to seek treatment in detail, 
especially when they were older patients. In addition, such patients were likely to 
prefer talking about the problems they were currently facing rather than their breast 
cancer diagnoses. Because of this, recently diagnosed participants (within six months 
of diagnosis) alone were recruited. Another limitation of the study is that not all the 
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interviews were audio recorded, which resulted in an inconsistent presentation of the 
data.  
The study participants were recruited from only one major hospital. It is thus 
possible that the sampling reflects the referral patterns of the hospital rather than the 
Saudi Arabian healthcare system in general. However, because the sample was based 
on quantitative findings, it is more likely than not that it is representative.  
It is important to note that the women who were interviewed in this research were 
those who reached the hospital. This means that the data provides no insights into 
women who do not manage to receive treatment or the issues that this cohort faces. 
7.11 Linking the qualitative results with the quantitative data 
This study reveals the factors that influence women’s late presentation for 
investigations into breast cancer in Saudi Arabia. It has found that there is an 
interaction between women’s age and their timely seeking of medical care. 
Specifically, late presentation in older women is more likely to be related to patient 
factors (such as breast cancer awareness and misconceptions, disclosure of 
symptoms to family or peers, and the presence of comorbidities) than to issues 
within the healthcare system (such as medical practitioner error), which is more 
common feature of late presentation in younger patients.  
The quantitative findings presented in Chapter 5 showed that age was significantly 
associated with late stages of cancer at diagnosis, but did not provide clear-cut 
information about the interactions between the variables and the stage at diagnosis. 
This inspired me to reanalyse the quantitative data in order to better understand how 
age interacts with other factors and affects the stage at diagnosis. The next chapter 
presents this analysis.   
7.12 Summary 
Women with poor knowledge about breast cancer, or who did not consider their 
symptoms to be serious or to indicate breast cancer, tended to take longer to seek 
medical care.   
Women frequently depended on non-medical sources for information about breast 
cancer, including significant others or people who had undergone breast disease 
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investigations. Thus, since the incidence of breast cancer in Saudi Arabia is low, 
awareness about breast cancer is likely to be very low.  
As a consequence of this lack of awareness, women with breast cancer might not 
seek medical care promptly, and thus increasing awareness about symptoms, early 
detection and screening may encourage women to seek medical care more promptly, 
as one older participant suggested (Participant 6, early stage). In addition, women 
might have misconceptions or fears that might prevent them from seeking medical 
care. Although the increase in breast cancer campaigns may have made women more 
aware about breast cancer, it is clear that there are still numerous misunderstandings 
and misconception, relating to risks and protective factors in particular.  
The participants in this study often relied on their families for advice and support 
about whether to seek medical care. Those who disclosed their concerns and 
received proper advice were more likely to follow that advice and seek medical care 
immediately. This pattern was seen frequently amongst the older participants, 
whereas younger participants tended to seek medical care more promptly, but were 
more likely to have their breast cancers missed or misdiagnosed at their early stages 
by healthcare professionals. 
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Chapter 8 Phase IV: Integration of findings and discussion 
8.1 Introduction  
This thesis applied a mixed methods design including quantitative phase of data 
collection and analysis followed by a qualitative phase of data collection and 
analysis (See Chapter 3).  
The first phase was a literature review of published research on causes of late 
presentation of breast cancer in the Middle East (see Chapter 4). This phase revealed 
the need for further study. It also helped determine which methods could employed 
to explore the issues which it disclosed, primarily lack of evidence of regarding late 
presentation of female breast cancer in Saudi Arabia and the Middle East. 
Consequently, the quantitative work first explored the general pattern of late 
presentation and the factors associated with it at the macro level. This stage of the 
research informed the qualitative phase, especially its framing sample which enabled 
the qualitative work to focus on issues of age and knowledge of breast cancer, and be 
less concerned about factors such as marital status. 
The sequence of data collection and analysis to investigate the study problems 
revealed factors associated with late stages disease at diagnosis of breast cancer. 
Following a complete analysis of the quantitative data, qualitative data more deeply 
elaborated these reasons for late presentation of breast cancer, refining and 
explaining the quantitative results especially around age. 
This chapter interprets these thesis results. Following a complete analysis of the 
quantitative and qualitative data separately, the investigation then restructured the 
data to provide a clearer picture using meta-inferences. A ‘Meta-inference’ refers to 
an interpretation drawn from both quantitative and qualitative data (Teddlie and 
Tashakkori, 2009).  
This chapter starts with a fuller description of meta-inferences and how they have 
been applied. Then, it describes the data integration (section 8.3) and findings 
integration (discussion, section 8.4).  
- 168 - 
 
8.2 Meta-inference  
The process of meta-interference began with a question: how can the quantitative 
results and qualitative results be linked to achieve the thesis aim?  
Meta-inferences explore whether the addition of qualitative data provides a better 
understanding of the study problem than do quantitative data alone (Creswell and 
Plano Clark, 2011). The process of meta-inference included two steps. The first step 
was data integration, in which each study’s results informed the other studies, as 
described in Chapter 3.  
The second step was findings integration, combining the results of both the 
quantitative and qualitative analyses in the discussion section (Creswell and Plano 
Clark, 2011) to illustrate reasons for late presentation of female breast cancer. 
Findings integration has been implemented when explanatory sequential mixed 
methods have been used (Ivankova et al., 2006). It allows factors associated with late 
presentation of female breast cancer to be identified. It also helps provide further 
insight into how these factors might interact. Narrative interviews clarified the 
statistical findings. In addition, published findings, both quantitative and qualitative, 
on late presentation of female breast cancer in the Middle East enriched the 
understanding of the thesis results and the mixed methods meta-inference (see Figure 
15). The following sections describe each step in the meta-inference process. 
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Figure 15: Process of meta-inference 
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8.3 Step 1: Data integration  
This thesis comprises three main studies: a systematic review, a quantitative study 
and a qualitative study. The systematic review informed the thesis methods (see the 
study design section 3.4.1 in Chapter 3). The quantitative study then informed the 
qualitative data sampling (see Chapter 6). Findings from the qualitative data indicate 
potential differences in causes of late presentation for younger and older female 
breast cancer patients (Chapter 7). The findings benefited from the increased 
understanding offered by the qualitative study and the opportunity it gave to revisit 
the quantitative data to explore how various factors, particularly age, interact with 
each other by using a classification decision tree (as illustrated in Figure 15).  
8.3.1 Rationale for using a classification decision tree analysis 
In multivariable analysis, several variables are used to predict or explain a single 
variable as the outcome. A classification decision tree is a type of multivariable 
analysis, much like other statistical methods such as regression analysis (West, 
2012). The distinctive feature of the classification decision trees is that it 
acknowledges interactions between factors that other methods often ignored to 
reduce complexity (Camp and Slattery, 2002). The qualitative results suggest that 
factors are associated with late presentation is different. The hierarchical nature of 
classification trees allows further understanding of the interaction between variables 
(West, 2012). This structure helped in identifying subgroups with observed higher 
and lower risk of advanced stages at diagnosis within the total cohort (n=10,663). 
Additionally, the classification decision trees are flexible and can be used for 
continuous variables, categorical variables or a mixture of both of them (West, 
2012).  
Decision tree analysis creates sequential divisions of the cohort into subgroups based 
on the value of the independent variable for each division. The split (or division) is 
based on the purity of the subgroups, with the variable that produces the most pure 
subgroups chosen for the split. The splits end when a subgroup of the cohort 
becomes completely pure or when further splitting would result in branches 
containing less than a defined minimum number (West, 2012).  
Since the qualitative data suggested that interaction between covariates might be 
important, especially interactions with age, this suggest to re-think about the 
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quantitative data and running a decision tree analysis to better understand the 
interactions of variables (Breiman et al., 1984) associated with the disease stage at 
breast cancer diagnosis. Breiman et al. (1984) explain that classification analysis is 
often used with the intention to provide accurate understanding and improved 
prediction. A good decision tree provides insight into the predictive structure. The 
size of the quantitative study is large (n=10,663) although to run a classification 
analysis with a large sample size is not as important as whether the association 
between the variables tested is different (Breiman et al., 1984). The complexity of 
late presentation of breast cancer suggests that greater richness may well be achieved 
from a classification analysis. 
The outcome variable was stage of cancer at diagnosis, which is a categorical 
variable, based on disease progression: in-situ, localised, regional or distant (SEER, 
2013). The decision tree analysis treated this as an ordinal variable. Table 31 
describes the independent variables and how they were handled in the analysis. All 
variables were treated as they were in the previous quantitative analysis (see Chapter 
5), except for age, which was used as a continuous variable to provide flexibility in 
the analysis: the classification will select more optimal cut points. Missing categories 
were treated as missing values. Decision trees often use the following technique: if a 
variable is missing for a split then the split is made using a surrogate (or proxy) 
variable. 
Table 31: Description of independent variables 
 
 
 
 
 
 
  
 
 
 
 
 
 
Independent variable Measure 
Age Continuous 
Nationality Nominal 
(Saudi nationals and  non-Saudi) 
Years of diagnosis  Nominal 
(1994–1996, 1997–1999, 2000–
2002 and 2003–2006) 
Place of residence  Nominal  
(Regions with advanced 
oncology care and other regions) 
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8.3.2 Statistical analysis  
The classification decision tree analysis used SPSS software version 20 (IBM Corp., 
Released 2011). The Chi-Squared Automatic Interaction Detector (CHAID) (Kass, 
1980), a powerful and popular method to divide data into homogenous groups 
(StatSoft, 2013), partitioned data into subsets to best describe dependent variable 
(Kass, 1980). This method of splitting the data chooses the most significant variables 
rather than the most explanatory. It does not consider the nature of the variable, for 
example, ordinal or nominal, or the number of categories included (Kass, 1980). 
CHAID runs in steps to find the best partition for each dependent variable. It then 
compares the dependent variables and selects the best one, subdividing the data 
based on dependent variables (Kass, 1980). 
Exhaustive CHAID, a modified CHAID algorithm, was selected for analysis 
(StatSoft, 2013). Other algorithms might not suit the purpose of the study as some 
work best for continuous outcomes or spilt the data into a binary tree (StatSoft, 
2013).  
Development of the decision tree included all female breast cancer patients for 
whom stage at diagnosis was known (n=10,663). Table 32 describes the parameters 
for tree development. The maximum permitted tree depth was five, which was 
chosen to facilitate simpler interactions and avoid over-fitting, but the fit was only 
four deep.    
Table 32: Description of parameters used in the Exhaustive CHAID 
 
  
 
 
 
 
 
 
8.3.3 Results  
Figure 16 reproduces the decision tree which had nine nodes besides the root node. 
Node 0, the root node (outcome variable), shows the number and percentage of 
women diagnosed with breast cancer in each cancer stage (ordinal variable). The 
Parameter Value  
Maximum tree depth 5 
Minimum parent node 100 
Minimum child node 50 
Significance threshold for splitting node 0.05 
Results tree depth 4 
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final row in the root node indicates the size of the entire cohort (n=10,663). The 
variables that tested for significance were year of diagnosis, nationality, location and 
age, resulting in data set split into four levels with nodes 1–9.  
This decision tree revealed four predictors associated with late stages at breast cancer 
diagnosis: year of diagnosis (diagnosed before 2000 or in 2000 or later), nationality 
(Saudi or non-Saudi national) and location (living in regions with access to advanced 
oncology care, or living in other regions) and age (≤ 42 years, between 42–58 years 
or above >58 years).  
The analysis yielded year of diagnosis as a predictor for the split at the root node 
(P<0.001, 2= 45.295, df=1). Women diagnosed with breast cancer before 2000 
were at higher risk of being diagnosed at advanced stages
21
 (70.1%, n=2,767) and 
very advanced stages (21.8%, n=860) compared to those diagnosed in 2000 or later 
(68.5%, n=4,607) and (15.2%, n=1,023) respectively. This finding indicates that 
good progress has been achieved since 2000 in disease stage at presentation. Node 2 
is a terminal node as there is no further splitting under it.  
For women diagnosed between 2000 and 2006, analysis yielded their nationality as 
the second level predictor. Saudi nationals were at greater risk of being diagnosed at 
late stages (70.4%, n=3,392) and very late stages (16.2%, n=780) than were non-
Saudi nationals (63.9%, n=1,215) and (12.8%, n=243) respectively (P<0.001, 2= 
29.087, df=1). No further splitting among non-Saudi patients occurred. Thus, one 
focus of research should be to investigate the reasons for late presentation of breast 
cancer in the Saudi cohort. 
Among Saudi women, location split the tree further. Late stage at diagnosis was less 
likely in regions with advanced oncology care namely Riyadh, Makkah and Eastern 
Saudi Arabia, compared to other regions in the Kingdom (P<0.001, 2= 21.428, 
df=1). In regions with advanced oncology care, the percentages of Saudi nationals 
diagnosed at late stages (68.6%, n=2,501) and very late stages (15.5%, n=565) were 
lower than in regions with less access to advanced oncology care: 76.2% (n=891) 
and 18.4% (n=215) respectively. 
Among Saudi women diagnosed since 2000 and living in regions with advanced 
oncology care, age split the tree. Women over 58 were at higher risk of very late 
stages at personation (21.1%, n=173) than women between 42 and 13.1% (n=199) or 
                                                 
21
 Advanced stages means regional and distant stages and very advanced stages means distant stages. 
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younger than 42 (14.7%, n=193), (P<0.021, 2= 15.776, df=2). Additionally, women 
older than 58 or 42 and younger were at higher risk for late stages diagnosis (70.5%, 
n=578) and (69.9%, n=917) respectively, compared to those aged between 42 and 58 
(66.3%, n=1,006).  
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Figure 16: Classification tree of factors associated with stage at diagnosis (1994–
2006). 
Root node 
Terminal node 
Level 1 
Level 2 
Level 3 
Level 4 
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Table 33: Description of terminal nodes associated with advanced stages at 
diagnosis of female breast cancer (1994-2006) 
Level 
Node 
number 
Percentage 
of cohort 
Sample 
size 
Description 
Higher risk of advanced stages at diagnosis 
1 2 37% 3945 Women diagnosed before 2000 had a 
higher risk of late stages at diagnosis. 
3 6 11% 1169 Saudis women diagnosed with breast 
cancer in 2000or later and who did not 
live in Riyadh, Makkah or Eastern 
regions that have advanced oncology 
had a higher risk of late stages at 
diagnosis. 
4 7 12.3% 1312 Saudis women diagnosed with breast 
cancer in 2000 or later, who live in 
regions with advanced oncology care 
(namely Riyadh, Makkah or Eastern 
regions) and  ≤42 years old had a 
higher risk of late stages at diagnosis. 
4 9 7.7% 820 Saudis women diagnosed with breast 
cancer in 2000 or later; living in 
Riyadh, Makkah or Eastern regions; 
and >58 years old had a higher risk of 
very late stages at diagnosis. 
Lower risk of late stages at diagnosis 
2 4 17.8 1901 Non-Saudi nationals diagnosed with 
breast cancer in 2000 or later had lower 
risk of late stage at diagnosis.  
4 8 14.2 1516 Saudi women diagnosed in 2000 or 
later, living in regions with advanced 
oncology care and aged 42-58 years 
had a lower risk of late stage at 
diagnosis. 
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8.3.4 Discussion of the classification decision tree  
From a public health perspective, identifying the groups with a high risk of late 
presentation
22
 of breast cancer is vital to reduce advanced stage at diagnosis of breast 
cancer in Saudi Arabia. The decision tree analysis helps identify characteristics of 
subgroups of women at higher or lower risk of advanced stages of breast cancer at 
diagnosis during 1994−2006 (see Table 33) who are those living in regions with less 
advanced oncology care, women aged 42 years or younger and those aged 58 years 
or more. The decision tree is a valuable statistical tool to assist medical decisions 
(Podgorelec et al., 2002) and identify at-risk groups (Lemon et al., 2003). In cancer-
related research, this method has been used effectively to examine the interaction of 
risk factors for colon cancer (Camp and Slattery, 2002) and to identify target groups 
for colorectal screening (Ishikawa et al., 2013).  
Generally, as expected, the decision tree analysis yielded results consistent with 
evidence from the quantitative study (as described in Chapter 5). It identified the 
same explanatory factors, but there were also interactions. The classification tree 
was used as a complementary (rather than a confirmatory) tool to the regression 
analysis in the quantitative study. It aided further understanding about the interaction 
of main effects variables associated with advanced stages at diagnosis.  
Regression models are widely used to examine the association between dependent 
and independent variables. Lemon et al. (2003) suggest that the lack of wide 
application of the classification decision tree to identify high-risk groups for specific 
intervention can be ascribed to lack of awareness of the method’s utility and 
uncertainties of its statistical properties. 
Some anticipate that the results from logistic regressions and classification decision 
trees could vary because they work in different ways. Regression models allow for 
investigating the main effects—the association between dependent and the 
independent variable—while holding the confounder effect (Lemon et al., 2003). In 
addition, such models can test the interaction between variables, though interpreting 
results can be difficult, especially if three or more variables are included (Lemon et 
al., 2003).  
                                                 
22
 At higher risk of advanced stages at diagnosis if breast cancer symptoms recognised compared to 
the general public. 
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A strength of the classification decision tree is its visual presentation of the 
subgroups of women, which could assist clinicians in identifying target groups at 
risk of advanced stages at diagnosis. The decision tree splits data based on 
homogeneity between groups. The root node sample will be larger than subsequent 
node samples. This issue should be considered during the interpretation of findings 
(Camp and Slattery, 2002).  
The current limited evidence in Saudi Arabia about characteristics of women with 
higher risk of late presentation demands innovative methods to generate evidence. 
This thesis is exploratory in nature; however, the consistency of results across the 
various types of statistical methods may reflect the internal validity of the research.  
8.4 Step 2: Findings integration  
This thesis applied an explanatory mixed methods approach to explore potential 
factors associated with late presentation of breast cancer in Saudi Arabia.  
Phase I was a systematic review that identified the gap in existing knowledge in 
some parts of the world, such as the Gulf states (see Chapter 4), and then identified 
variables of interest at first naïve, the quantitative study in Phase II looked at the 
breast cancer data and found the main effect of age, year of diagnosis, place of 
residence, nationality and marital status (see Chapter 5). Phase III a qualitative study, 
provided further understanding of the contextual factors. It showed the complexity of 
the problem and the possibility of interaction between variables. Age was an 
important characteristic that helped elaborate differences in participants’ stage at 
diagnosis. Older participants were different from younger one in reasons of late 
presentation (see Chapter 7). Phase IV began its evidence integration by revisiting 
the quantitative data to examine the interaction between variables and stage at 
diagnosis using classification decision tree analysis. The results of the tree analysis 
showed that women with breast cancer were diagnosed at different stages and did not 
form homogenous groups: the factors influencing the different subgroups varied. The 
qualitative study also shows this heterogeneity. The next step in making meta-
inferences is findings integration and discussion. This section presents the main 
results from this mixed-methods thesis and their contribution to the exiting literature. 
A discussion of methodological considerations and implications follow, before the 
chapter concludes with recommendations for future research and practice. 
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8.4.1 Contextualising the concept of late presentation of female breast 
cancer 
The definition of breast cancer delay introduced by Pack and Gallo (1938) has been 
widely adopted in the delay literature. It focuses on the time between first 
recognition of symptoms and first medical contact. This definition has been widely 
used to explore factors associated with delay both in breast cancer studies using 
quantitative methods  (Ramirez et al., 1999) and those using qualitative methods to 
further understand how these factors interact (Smith et al., 2005). Andersen (2011) 
argued that the term ‘‘delay’’ is inappropriate to describe retrospectively the  process 
of patients seeking help because it implies poor behaviour if the patient took a long 
time was taken to seek medical attention. The complexity of the process of 
recognising breast cancer symptoms and seeking medical care may not acknowledge 
the social aspect in seeking health care (Andersen, 2011). 
Breast cancer is a complex, heterogeneous disease and certain types of breast cancer 
may present differently from others (Li et al., 2005). The variation in defining delay 
or late presentation (as discussed previously in section 1.5, Chapter 1) indicates the 
complexity of measuring and examining factors associated with these constructs. It 
could be defined according to delay avoidance, time delay, sources of delay and 
stage at diagnosis. The time delay, the one above, is the most widely used. 
This thesis did not use the variable of time to seek medical care. Instead, analysis 
used stage at diagnosis which brings new questions about how late presentation 
could be reasonably defined in the study context of Saudi Arabia. It is not that the 
role of time in seeking medical care for cancer prognoses or for the breast cancer 
patient’s life after the experience of bodily changes is not recognised as important or 
relevant in this thesis. Saudi women are different in their presentation of breast 
cancer. Their younger age at diagnosis and the biological characteristics of their 
breast cancer raise questions about using time to seek medical care as an indicator 
for better breast cancer outcomes.  
Patients must have clear clinical criteria to know when to seek medical care. For 
example, a month, two months or three months from noticing any changes in the 
breast and first medical contact for investigation. With such criteria, a woman who 
experiences breast cancer symptoms will know better when to seek medical care to 
avoid late presentation. The lack of consensus in Middle Eastern studies in defining 
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late presentation, as section 4.5, Chapter 4 illustrates does not indicate the presence 
of such clear criteria yet. 
In a clinical perspective, tumour progression can be assessed biologically by 
evaluating tumour aggressiveness. In the study context, tumour aggressiveness 
requires attention as Saudi women are more likely to develop an aggressive tumour 
than women in the West (Al-Kuraya et al., 2005). Thus, when defining late 
presentation, rate of tumour growth must be considered to avoid labelling a woman 
who sought medical care promptly, but was diagnosed at late stage as a ‘late 
presenter’: in this case, advanced stage diagnosis was out of the woman’s control.  
This thesis used ‘‘stage at diagnosis’’ to define late presentation (as described in 
section 1.5.5) in the quantitative analyses as a proxy to time seek medical care. It 
assumed that women who were diagnosed at early stages were more likely to have 
sought medical care promptly.  
The lack of consensus in defining late presentation between Middle Eastern studies, 
which Chapter 4 describes, made comparisons between the studies difficult. Using 
stage at diagnosis to define late presentation would enable better comparison 
between studies from the Middle East and the world.  
Furthermore, using the stage at diagnosis overcomes the SNCR’s lack of recoded 
time to seek medical care and controls for the effect of tumour growth by making 
stage at diagnosis an outcome of both seeking medical care and the speed of tumour 
growth. Stage at diagnosis is a valid and widely used indicator to assess cancer 
prognosis and guide cancer care (Coleman et al., 2011). In this thesis, this variable 
helps demonstrate the characteristics of women with breast cancer who were 
diagnosed at various stages and predict which women are at risk of advanced stages 
at the time of diagnosis or presentation. Thus, using the stage at diagnosis may 
provide better evidence to guide future breast cancer care and help set priorities, 
especially if national mammography screening is enacted. 
The use of time to seek medical care was problematic as breast cancer tumours 
sometimes progress so quickly. This problem also appears in the qualitative study. 
In-depth analysis of the qualitative data provided further understanding about the 
concept of late presentation. Analysing the length of time to seek medical help and 
stage at diagnosis revealed that longer time to seek care (more than three months) 
does not necessarily mean that the patient will be diagnosed at a late stage, 
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particularly among older women. In contrast, seeking medical help within fewer than 
three months does not necessarily guarantee an early stage at diagnosis, especially 
among younger women. Although this finding was based on only 19 breast cancer 
patients, it is in line with study conducted in Saudi Arabia that found no association 
between delay in seeking investigation and breast cancer prognosis (Ibrahim, 1990) 
and studies compared between pregnant and non-pregnant women with breast cancer 
(Ezzat et al., 1996, Ibrahim et al., 2000). 
Integrating time to seek diagnosis and treatment into future research on late 
presentation in a large cohort will help confirm this issue and provide an estimate of 
the appropriate period of time before seeking care for the study context. With this 
knowledge, health professionals and education campaigns can better inform women 
about the risk of advanced stages at diagnosis and how soon they should seek help 
for symptoms.    
8.4.2 Discussion of factors associated with late presentation of female 
breast cancer 
Late presentation of breast cancer is an under researched area in Saudi Arabia and 
the Middle Eastern countries when compared to international literature. The 
systematic review illustrated that such literature in this part of the world is limited 
and is a new area for research, as investigations began in the 1980s (see Chapter 4). 
The review found no such studies conducted in Saudi Arabia and indicated that late-
presentation breast cancer is a complex health problem with multiple associated 
factors.  
This section discusses the findings integration from this mixed methods study. As 
Chapter 3 discusses, the study was designed to address multiple objectives from a 
variety of perspectives. A mixed methods approach can increase and enhance 
understanding more than when a single research approach is used. Teddlie and 
Tashakkori (2009) explain that this increase is possible by integrating the results 
from quantitative and qualitative studies and by exploring possible agreement or 
disagreement between study results.   
This mixed methods study addressed a gap in the breast cancer literature. It also 
provides strong evidence to help understand the associations and interactions 
between year of diagnosis, nationality, place of residence, age and marital status, as 
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well as their effect on stage at diagnosis using a quantitative approach; this thesis 
also explored the contextual factors underlying this interaction qualitatively. 
 A ‘‘mixed methods matrix’’ that can display evidence from both quantitative and 
qualitative data was used to triangulate
23
 the results (O'Cathain et al., 2010), as Table 
34 shows. The left column demonstrates factors examined by the classification 
decision tree. The rest of the columns describe whether findings from decision tree 
analysis and thematic analysis were in agreement, offered complementary 
explanations, or contradicted each other. In addition, there is a comment column 
which offers more explanation on certain issues.  
Key results from the decision trees analysis helped develop the meta-inferences, as 
informed by the qualitative results. These results emphasised the interaction between 
stage at diagnosis and several variables. Moreover, contextual data from the 
qualitative analysis expanded understanding about the interaction of these factors, 
which was further enriched by the findings from the wider literature.  
Yet, making direct comparison between the findings from a quantitative 
classification decision tree and the qualitative data can be misleading without 
acknowledging differences in perspectives between data. The quantitative data 
represent factors associated with late stages at diagnosis from the perspective of the 
healthcare system. The qualitative data, however, represent the patients’ perspective. 
The meta-inference attempts to produce a clearer picture of factors associated with 
late presentation of female breast cancer. This facilitates both interpretation of the 
findings and making recommendations. The following sections discuss each factor 
separately.  
                                                 
23
 The term ‘triangulation’ here is used to describe the data integration which means results have been 
used to draw a complete picture of the study problem. O'cathain, A., Murphy, E. & Nicholl, J. 2010. 
Three techniques for integrating data in mixed methods studies. BMJ, 341, c4587. 
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Table 34: Mixed methods meta-inferences matrix 
 
 
 
Factors 
Findings integration of factors associated with late stages at diagnosis 
Findings agree 
(convergence) 
Findings offer 
complementary 
information 
Findings appear to 
contradict 
Comment 
Year of 
diagnosis  
 Quantitatively   Not applicable qualitatively  
Nationality   Quantitatively   Not applicable qualitatively because the target 
population is Saudi nationals only 
Place of 
residence by 
region 
 Quantitatively   Qualitatively These findings appear to be contradictory because 
the time gap between conducting the two studies  
Age   Quantitatively  
 Qualitatively 
 Qualitatively  Both show that age associated with late 
presentation. The qualitative offers further details 
about this difference.  
Marital status   Quantitatively Qualitatively  It is about family support  
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8.4.2.1 Year of diagnosis  
The decision tree analysis shows there was improvement in stage at diagnosis over 
time (1994–2006). The tree first splits women with breast cancer into two groups, 
based on the year of their diagnosis; those diagnosed in 1994−1999 and those 
diagnosed in 2000–2006. Those diagnosed from 2000–2006 had a better stage at 
diagnosis profile than those diagnosed in earlier years. Furthermore, the decision tree 
found no further splits for those diagnosed between 1994 and 1999. This means that 
women were equally likely to receive a late-stage diagnosis during 1994–1999, 
regardless of their other characteristics. 
The massive improvement in healthcare in Saudi Arabia in recent years may explain 
the improvement in early stage at diagnosis since 2000 in the 2000–2006 cohort. 
Differences according to diagnosis year were not observed in the qualitative study as 
all of the qualitative participants were diagnosed in the same year. However, one 
woman interviewed explained that healthcare quality is improving. She was talking 
about quick referral for one of her children, who had cancer, to oncology specialist 
compared to the past (Participant 16, late stage).  
Al-Rikabi and Husain (2012) suggest an increase in mammography screening due to 
greater awareness of breast cancer may explain the increase in diagnosis of benign 
tumours since 2007 comparison to 2000–2007. Screening facilities and breast cancer 
awareness activities are increasing (Abulkhair et al., 2010b, Akhtar et al., 2010) and 
this is in line with the strategic plan of the Ministry of Health (Ministry of Health, 
2012a). However, the qualitative study did not support the assumption that the 
awareness about breast cancer is improving as will be discussed in section 8.4.2.4.  
8.4.2.2 Nationality  
The second factor that showed significant association with late-stage diagnosis in the 
classification decision tree was nationality. The tree splits women based on their 
nationality (Saudi vs. non-Saudi) for those diagnosed since 2000. Non-Saudi women 
had lower percentage of later-stage, and distant stage diagnoses compared to their 
Saudi counterparts. Furthermore, the tree identified different characteristics among 
Saudi and non-Saudi women in stage at diagnosis.  
Quantitative literature in this area has pointed out differences in late presentation by 
ethnicity (Ramirez et al., 1999). Because this thesis focuses on breast cancer 
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outcomes in Saudi Arabia, non-Saudi nationals were not the primary population of 
concern in this study. Nevertheless, the difference identified between these groups 
raises further concerns about late presentation among the Saudi population and 
questions about the reasons for such differences between Saudi and non-Saudi 
women.  
The difference could be biological, socio-cultural, related to healthcare or an 
interaction of all of these (Lyratzopoulos et al., 2012). The biological factor could 
explain the reasons of late-stage diagnosis as non-Saudi nationals are diverse 
however; its association with late-stage diagnosis was not examined in this study. 
Participants in the qualitative study were Saudi nationals. They revealed 
sociocultural factors that interact with seeking treatment and a diagnosis of breast 
cancer. It would be interesting to conduct future research to examine the potential 
differences and similarities between different nationalities living in Saudi Arabia. 
The following sections, however, explain other factors related to late-presentation 
female breast cancer among Saudi nationals. Section 8.4.2.3 explain the association 
between place of residence and late presentation, section 8.4.2.4 explain the role of 
age and other factors and section 8.4.2.5 explain the reasons that marital status is not 
predictor of late stage diagnosis among female breast cancer.     
8.4.2.3 Place of residence  
For Saudi women diagnosed with breast cancer since 2000, the tree spilt further 
based on their place of residence. Women who lived in regions with less available 
oncology care, regardless of age, had higher percentages of later stages at diagnosis 
compared to those who lived in regions where advanced oncology care was 
available.  
The majority of advanced oncology services are located in three regions: Riyadh, 
Makkah and Eastern regions. Other regions have health services which provide 
cancer diagnosis and care (Al-Eid and Garcia, 2012, Al-Eid and Manalo, 2011, 
Ibrahim and Ezzat, 2010), however, quality may vary (Ibrahim and Ezzat, 2010). 
Alghamdi et al. (2013) conducted an observational study estimating the ASIR on the 
Kingdom based on data from the SNCR for breast cancer patients diagnosed between 
2001 and 2008. They found that the Eastern, Makkah and Riyadh regions had the 
highest ASIRs and they are the regions where advanced oncology services are 
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located. The variation in access to cancer care across the Kingdom may be linked to 
the variation in the incidence of breast cancer. Regions with lower incidence of 
breast cancer such as Jazan region, with ASIR of 4.8 (Alghamdi et al., 2013) may be 
less likely to have advanced breast cancer care.  
The qualitative data analysis found no notable differences between women’s 
experiences based on where they live. The qualitative absence of a relationship 
between place of residence, seeking help and diagnosis does not necessarily imply 
contradiction between the quantitative and qualitative findings. This difference could 
be due to differences in the times in data collection between the qualitative and 
quantitative studies. With continuing improvement in healthcare in Saudi Arabia, the 
observed differences according to place of residence may have become considerably 
less pronounced. Repetition of the quantitative analysis using more recent breast 
cancer data from the SNCR could confirm this explanation. 
Ideally, PHC access should be equal through the Kingdom, so if a woman wants a 
doctor to investigate and diagnose suspicious breast symptoms, PHC should be 
available. However, the autonomous nature of healthcare across the regions may lead 
to variation in health needs and quality of healthcare.  
As discussed in Chapter 6, the interviewed participants were recruited from a single 
oncology centre. Although breast cancer patients are referred from all regions in the 
Kingdom, the data represents the experiences of those women who sought healthcare 
at this specific facility. Perhaps those women who sought treatment at local facilities 
due to convenience may have had other experiences in seeking healthcare. Future 
research using qualitative methods should recruit participants from all regions to 
explore if location is an important predictor of later stages at diagnosis. 
8.4.2.4 Age  
As highlighted in the systematic review in Chapter 4, previous studies in the Middle 
East have shown the effect of older age on late presentation of breast cancer (Abdel-
Fattah et al., 1999, El-Zawawy, 1991, Elzawawy, 1999, Ermiah et al., 2012). This 
agrees with findings from the rest of the world (Ramirez et al., 1999) However, the 
review presented in Chapter 4 did not uncover more detailed explanations about 
which age groups are at higher risk or estimates of the effect.  
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The classification decision tree analysis showed that age is one of the important 
factors associated with late-stage breast cancer diagnosis. This is in contrast to some 
studies from the Middle East, based on a sample of 1,232 women diagnosed with 
breast cancer, that age was not associated with late diagnosis of breast cancer 
(Abdel-Fattah et al., 1999, Al Saad and Alsayed, 2012, Mousa et al., 2011, Stapleton 
et al., 2011).  
The quantitative study assessed the association between age and tumour stage based 
on the SEER staging. The Middle Eastern studies used different criteria and methods 
to assess the association between age and late presentation and late diagnosis (as 
described in section 4.5.1). The classification tree offers a more sophisticated tool for 
exploring the issue of age than the first analysis run in Chapter 5. 
The relationship between age and stage at diagnosis was not linear; it was more 
complex than merely looking at binary categories of younger vs. older women. The 
decision tree splits age into three groups (age 42 years or younger, between age 42 
and 58 and over 58). The risk of being diagnosed at a later stage, especially at the 
distant stage, was higher among women older than 58. These age groups were more 
varied than those either in the previous quantitative (Chapter 5) or qualitative 
(Chapter 7) analyses. Both show that age is an important predictor of late-stage 
diagnosis although the definition of the age groups differs slightly. This last detail is 
less important than the identification of older women and younger women as high 
risk groups. The notion that age interacts with other factors, which the qualitative 
study found strengthened in the decision tree analyses. This demonstrates the value 
of data integration.         
Furthermore, the tree shows that middle aged women (between 42 and 58) had the 
least risk of later stages at diagnosis. Women younger than 42 were at higher risk of 
later-stage diagnoses compared to middle aged ones.  
The literature offers a strong support to the thesis findings of an association between 
older age and late presentation of breast cancer (Ramirez et al., 1999). Partridge et al. 
(2012) evaluated the relationship between age, time to presentation for diagnosis and 
stage at diagnosis for 21,818 women diagnosed with breast cancer, in the US. They 
found that being younger (less than or equal to 40) was not an independent predictor 
of a delay of diagnosis of more than 60 days. Younger age can only modestly more 
likely to associate with a later stage at diagnosis (Partridge et al., 2012). They also 
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found that women diagnosed based on their symptoms identification—not based on 
screening—were more likely to delay, both women younger than 40 (OR, 3.31; 95% 
CI, 3.08–3.56) and older women (OR, 4.31; 95% CI 4.05–4.58), compared to those 
diagnosed through screening.  
Elkum et al. (2007) compared the clinical characteristics and outcomes of women in 
Saudi Arabia with breast cancer aged 40 years or younger with those older women. 
Based on 867 subjects, they found that younger women have a worse prognosis than 
older ones. They suggested researching the interaction between the genetic and 
environmental factors to improve treatment for Saudi women.  
The qualitative study was conducted before the classification decision tree analysis. 
As such, the women’s interviews were not analysed based on the three age groups (≤ 
42, 42-58 and >58 years old). The analysis divided subjects into those aged 50 and 
older and younger than 50 on early and late stage and the analysis and showed 
consistent difference between younger and older women.  
While age is associated with stage at diagnosis, its effects shown in the classification 
tree─ appears among Saudi national women, diagnosed with breast cancer since 
2000, who were living in regions with advanced oncology care. Women at risk of 
later stage diagnoses, with the risk being greater among older ones─ as shown 
quantitatively─ however; the qualitative study shows that the mechanisms vary.   
Many studies conducted in Saudi Arabia show that public awareness about cancer 
and breast cancer is poor (Alam, 2006, Amin et al., 2009, Dandash and Al-
Mohaimeed, 2007, Ibrahim et al., 1991b, Jahan et al., 2006, Mahfouz et al., 2013, 
Ravichandran et al., 2010, Sait et al., 2010). Two studies from the Middle East found 
an association between lack knowledge about breast cancer and delay (Corbex, 2009, 
Harirchi et al., 2005).  
The qualitative study confirms a lack of awareness among women with breast cancer 
and the presence of some misconceptions that may interfere with seeking medical 
examination quickly. The misconceptions were different for older and younger 
subjects. Among older women, who often have other comorbidity, the misconception 
that if a symptom (a lump) is not painful, it is not serious and if the changes are not 
serious, seeking medical care is not necessary, was strongly present. Thus, older 
women frequently did not recognise the initial symptoms as serious enough to seek 
medical care which consequently resulted in delay in presentation for investigation. 
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Furthermore, older women’s other health concerns might also decrease their 
attention to the presence of seriousness of breast cancer symptoms. In addition, older 
women were more likely to wait and tolerate pain than to express their concerns 
about abnormality immediately to someone else who might direct them to medical 
attention. 
Younger women recognise breast symptoms—not necessarily related to breast 
cancer— and because of their interpretation that these symptoms are abnormal they 
are more likely to be proactively seeking medical care promptly. However, the lack 
of awareness and misconceptions they had such that once a woman breastfed her 
children, she will not get breast cancer together with the presence of reproductive 
health issues lessen the recognition that these symptoms are serious and could be 
related breast cancer. Misdiagnosis among younger women when they sought 
healthcare promptly could be a reason for late stage diagnosis.  
Literature from the Middle East suggests that lower education levels are associated 
with late presentation of breast cancer (Abdel-Fattah et al., 1999, Ermiah et al., 2012, 
Harirchi et al., 2005, Montazeri et al., 2003).  However, the heterogeneity in defining 
late presentation and education categories hindered conclusions about what level of 
education is associated with increased risk of late presentation. The quantitative 
analysis did not examine the association between education and stage at diagnosis 
because the SNCR does not recorded level of education. Therefore, the main effect 
remains unclear in the study context. The qualitative study gives more insights into 
the association between age, education and late presentation; with education possibly 
confounding age, awareness and misconceptions play a fundamental role in late 
presentation. If level of education influences late presentation, then it is expected that 
those who are educated will be more aware about breast cancer from credible 
sources therefore, they will be informed what to do if they detect symptoms. 
However, this was not always the case in the qualitative data. The difference 
between women is the difference in their interpretation that the symptoms are serious 
and need medical consultation. This might explain why Mousa et al. (2011) did not 
find an association between education attainment less than a bachelor’s degree and 
late presentation, while other studies, which included illiteracy found an association 
between education and late presentation (Abdel-Fattah et al., 1999, Ermiah et al., 
2012, Harirchi et al., 2005, Montazeri et al., 2003).  
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Younger women consider the presence of breast cancer symptoms to be abnormal 
and, therefore, may seek medical help promptly. But due to a lack of awareness and 
the presence of reproductive health issues, they do not necessarily link these 
symptoms to the possibility of breast cancer.  
Frequently, the late stage at diagnosis among younger women could also result from 
misdiagnosis by clinicians. The younger age is one of the risk factors for provider 
delay in breast cancer (Ramirez et al., 1999). Misdiagnosis is an issue that has been 
reported in qualitative studies across the Middle East but it was not clear if this an 
issue among younger, older women or both (McEwan et al., 2014, Rastad et al., 
2012). It is not surprising that health workers may lack sufficient knowledge about 
breast cancer’s burden in Saudi Arabia as the majority are expatriates.   
A recent study in the UK indicated low awareness of the risks associated with age 
effect on presentation time and high perceived barriers to symptomatic presentation. 
This was not the case in Denmark, also a developed country (Forbes et al., 2013). In 
the qualitative data, lack of awareness was a fundamental issue, both among older 
and younger women. This finding is supported by several studies which suggested 
the low breast cancer awareness among women (Al-Mulhim, 2001, Alam, 2006, 
Amin et al., 2009), men (Al-Amoudi and Abduljabbar, 2012) and health workers in 
Saudi Arabia (Al-Amoudi et al., 2010).  
Greater effort should be given to raising awareness about breast cancer and the value 
of early stage diagnosis. Moreover, specific attention needs to be given to address 
the misconceptions found in this thesis found. Even though more focus should be on 
women such awareness campaigns should target everyone in the Kingdom, but with 
more emphasis on women. Because this research demonstrates that (significant) 
others, including men, have an important role in directing a woman to seek medical 
help. It is therefore important that the population is aware of breast cancer, its 
symptoms and importance of seeking early help. Additionally, more effort is needed 
to increase awareness among health professionals of the epidemiology of breast 
cancer and how to assess symptom severity. The differences in the biological nature 
of breast cancer among older and younger women should also be considered. Older 
women are at greater risk of developing breast cancer (US Preventive Services Task 
Force, 2009) while younger women are at greater risk of developing larger tumours 
(Zabicki et al., 2006). This study did not explore the role of cancer grade. More 
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research is needed to explore the role of tumour grade, adjusted for age, to determine 
its effect on late presentation. 
Additionally, research into genetic mutation might provide greater understanding of 
what groups are more at risk of developing the disease and should receive special 
attention when they raise concerns about breast abnormalities. Also, if there is a 
specific mutation(s) (like BRCA1 and BRCA2 which is more likely to affect women 
of a particular, Middle Eastern descent). Family history is a vital characteristic, 
especially among older patients that could be integrated into patients’ care and 
referral (Vig et al., 2013). Interventions could target increasing awareness of genetic 
the susceptibility to breast cancer. Amin et al. (2012) pointed out the potential 
impact such research could have as women in Saudi Arabia are interested in genetic 
testing despite having poor knowledge about the association between genetic factors 
and breast cancer (Amin et al., 2012).  
Health workers need to be aware of potential communication barriers with older 
patients, as well as unfamiliarity with cancer signs among younger ones, to avoid 
multiple medical consultations before referring patients to a hospital for cancer. Even 
when a woman presents with a symptom like breast lump, a GP’s first contemplated 
diagnosis may not be breast cancer. In the UK for example, a GP may only diagnose 
one patient with breast cancer each year. Malignancy may not be the first thing a GP 
consider (Hamilton, 2009), especially for patients with less risk of cancer such as 
younger women. With no checklist or guidelines for referral at the GP level, this 
problem become worse, especially in the absence of national screening. 
Another feature that might be associated with late presentation and could differ with 
age is disclosure of the symptoms. Older women were more likely not to tell 
someone else about the symptoms. Symptoms disclosure is one of the key theme in 
qualitative research in this area (Smith et al., 2005). Discussing breast cancer 
symptoms with someone else may encourage seeking medical care for breast cancer 
diagnosis and help women to make connections between the symptoms they have, 
possibility of illness and the need to see a doctor. 
8.4.2.5 Marital status  
Quantitatively, marital status was not associated with advanced stage at diagnosis. 
Previous studies also illustrated that being unmarried was not associated with late 
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presentation (Ramirez et al., 1999). In the Middle East, marital status is more likely 
not be associated with late presentation (Abdel-Fattah et al., 1999, El-Zawawy, 1991, 
Elzawawy, 1999, Ermiah et al., 2012) as Chapter 4 explains.  
There was no attempt to include marital status in the recruitment strategy of the 
qualitative study as the quantitative part did not identify it as an important factor. 
Explanations from the qualitative results confirm quantitative findings and 
demonstrated that marital status was not as important as receiving proper support in 
seeking medical care promptly once a woman disclosed her health concerns to 
significant others.  
The discussion of findings from this study helps to understand the problem of late-
presentation breast cancer; the following section discusses the application of 
methods in relation to making the inference. 
8.4.3 Adopting mixed methods approach in this study 
The process of meta-inference follows a course from the beginning of research ideas; 
through data collection, analysis and results; to inference generation and 
interpretation. The thesis adopted a mixed methods approach, which is very organic 
and shows an integrated relationship between the thesis phases. The results from one 
method informed, enrich and strengthen the evidence generation of the other and 
thereby enhance the integration and generalisability of the thesis findings. 
In mixed methods ‘‘Legitimation’’ (Onwuegbuzie and Johnson, 2006) is a term used 
to denote validity. The inference validity and rigor in this thesis has been given 
consideration.   
The mixed methods approached followed a sequence of phases started inductively by 
the systematic review (phase I) without predetermined models to explain the 
problem. Because of the lack of models applied in contexts similar to Saudi Arabia 
(see section 3.4.1, Chapter 3). The systematic review did not help in prioritising the 
variables to be examined or in estimating their effect, even when the studies were 
current. Rather, the review gave an indication of which factors might be involved in 
late presentation of breast cancer in Saudi Arabia.   
The nature of this review encouraged the inductive generation of evidence. This was 
grounded in quantitative data assessed in phase II, which was based on a large cohort 
of 10,663 patients representing the intended population—Saudi females. Such a large 
cohort enhances the power of the study (as explained in section 5.4.6). This study 
- 193 - 
 
uses secondary data and, as such, there was no control over the type and process of 
data collection. Data collected by the SNCR informs cancer control in the Kingdom. 
It focuses on specific clinically based useful information. Ideally, a greater depth of 
information is required to understand quantitatively the research problem in more 
detail. 
The more in-depth understanding could be achieved using qualitative methods. 
Phase III takes advantage of qualitative methods to understand the variation in time 
to presentation for healthcare and diagnosis among Saudi women with breast cancer. 
To better comprehend the reasons for late presentation, Phase III included findings 
from the quantitative analysis into sampling of women with breast cancer based on 
factors that appeared clinically relevant. 
The data gathered qualitatively in Phase III through interviews are individually 
based. They thus provide detailed information about women’s experiences with 
symptom recognition and medical help-seeking. The sampling of the qualitative 
study was guided by generalisable findings from the quantitative study. Often, 
qualitative studies are context specific, with reliability is given less attention than 
validity because these studies don’t aim to replicate findings and because 
unstructured strategies are used in data collection (Guest et al., 2012). This thesis 
attempted to enhance reliability (Chapter 6), as well as the consistency in findings 
between the qualitative study (Chapter 7) with other qualitative studies in the Middle 
East (McEwan et al., 2014, Rastad et al., 2012). Despite use of different interview 
guides, the indications that reliability can be maintained in qualitative research. 
In qualitative research, establishing good relationship with the participants is crucial 
to facilitating open discussions (Patton, 2002). The researcher tried to establish a 
good relationship with participants while conducting interviews that discussed 
difficult issues related to their diagnosis with breast cancer (As described in Chapter 
6). Narratives from 19 women with breast cancer enlarged the context of data on the 
presentation time to healthcare facility and stage at diagnosis. Great understanding 
the context-specific factors revealed the complexity of late presentation and a notion 
of the interaction between factors that may shape late presentation. Qualitative 
analysis pointed out that age might be an important factor which interacts with 
healthcare, awareness and misconceptions and symptoms disclosure. Thus, further 
quantitative analysis explored this interaction in Phase IV.  
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A potential problem in mixed method studies is that the inference can be different if 
the order of the quantitative and qualitative investigations reversed (Onwuegbuzie 
and Johnson, 2006). This thesis minimised that legitimation threat by revisiting the 
quantitative data. The sequence of evidence was quantitative  qualitative  
quantitative, which yields consistent results.  
Furthermore, the inference generated two balanced views. The quantitative analyses 
represent the outsiders’ views while the qualitative analysis represents an insider 
view (Onwuegbuzie and Johnson, 2006). Thus, this mixed methods study provides a 
balanced perspective. Discussion with the thesis supervision team, who have 
extensive experience in quantitative, qualitative and mixed methods research, has 
helped maintain this balanced view.   
Implementing the thesis design (Figure 7) involved learning and applying different 
research methods and skills, as well as, creative thinking focused on the thesis’s aim. 
The thesis phases were carried out sequence, with each phase conducted, reported 
and summarised alone and in relation to the broader thesis aim before beginning the 
next phase. The inference in this thesis was generated by combining, comparing and 
contrasting evidence from each phase and explaining the differences, limitations and 
strengths.  
At a phase level, the thesis discussed the strengths and limitations of each study 
separately. Chapter 4, section 4.7 discussed the systematic review, Chapter 5, section 
5.8 discussed the quantitative study and Chapter 6, section 7.10 discussed the 
qualitative study strengths and limitations.   
At the thesis inference level, the inference (conclusion) was drawn from these 
studies effectively to answer the research questions. The components of the thesis 
design are consistent in terms of methods and sequence. Inference rigor is 
strengthened as the results from each study proved consistent with each other 
(Onwuegbuzie and Johnson, 2006). In general, the inference is in line with scholars’ 
conclusions in this area, but the thesis inference offers a more detailed and 
sophisticated exploration of the issue.  
Transferability means the extent to which a conclusion applies in other contexts, 
time, settings or groups (Teddlie and Tashakkori, 2009). The systematic review 
concludes that that there is a need to investigate the problem of late presentation of 
female breast cancer in Saudi Arabia. The quantitative analysis concludes that year 
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of diagnosis, age, nationality and place of residence significantly associated with 
late-stage of diagnosis. The qualitative analysis goes beyond the systematic review 
and the quantitative findings and demonstrates that there were other issues might 
influence late presentation. The meta-inference from the three studies offers a more 
generalisable and meaningful findings than those that could be afforded by each 
study alone. 
In terms of policy and practice recommendations, the more similar the setting and 
context to the study population the more likely that the inference is transferable 
(Teddlie and Tashakkori, 2009). The inference drawn by the thesis was limited to 
available and accessible evidence in the literature and the cancer registry data. 
Additionally, qualitative results reflected issues related to late presentation from only 
one health institution. It is possible that other factors might interact with late 
presentation and lead to different inference. Additionally, with the rapid changes in 
Saudi Arabia in terms of population density, lifestyle and healthcare, it is possible 
that the inference might not remain valid for long. Continuous research could help 
identify differences in late presentation overtime. 
8.4.3.1 Reflections on conducting a mixed methods study 
Prior to conducting this thesis, I had quantitative research experience but having 
clinical experience as a health educator stressed the importance of understanding 
patients’ behaviour in order to help them achieve better health outcomes.  
This study had multiple objectives, which required diverse methods. A mixed 
methods study was an ideal research approach to supply that diversity. However, the 
challenge in implementing this approach was to learn and conduct the various 
methods from multiple perspectives. This required training in research methods, 
reading about conducting different types of research, conducting study phases in 
sequence, and surveying late-presentation literature, together with supervisory 
meetings assisted me learning how to conduct mixed methods research.  
Prior to data collection, I gained insights from the process of applying for ethical 
approval of the research by thinking about the benefits of the research and its risks 
for me and the participants.  
One question that raised my interest during this study was what are the factors 
associated with late presentation? The quantitative study uses secondary data from 
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the SNCR, a valid and useful source for generating powerful results. The systematic 
literature search shows that that the SNCR data have not been used before to assess 
the problem of late-presentation. The analysis was conducted and validated by using 
various regression methods. However, interpreting the results was not simple. 
Discussions with my supervisor and reading the literature helped me to overcome 
these difficulties. The results successfully answered part of the question above. 
I acknowledge the value of using qualitative research to uncover issues that are not 
examined quantitatively. During the planning of the qualitative study, I thought 
about how to purposively sample women. There were many ways to do so, and 
discussions with my supervisors highlighted the risks and benefits of each, but 
ultimately I faced the challenge of deciding which to use. By reading the mixed 
methods literature, I realised that I needed to carefully choose participants to ensure 
rigor in in the mixed methods inference. Therefore, I thought about linking the 
general picture with representative voices by applying the findings from the 
quantitative study into a sample of the qualitative work.   
When I interviewed the participants, I realised the need to incorporate their views 
into the research. However, analysing their narratives was challenging and time 
consuming. By doing the analysis systematically, based on standards of qualitative 
data analysis and with the support and guidance of my supervisors, I was able to 
overcome the challenge in analysing and writing up qualitative findings.  
The qualitative study had two outcomes. The first was a model of factors influencing 
late presentation among Saudi females with breast cancer. The second was becoming 
a mature researcher, looking at the problem from different perspectives and research 
approaches. My thoughts on the research problem evolved by performing 
quantitative and qualitative sections in sequence. I viewed each section as a puzzle. 
However, there still seemed to be a few pieces missing in the picture. 
To understand why late presentation occurred, I needed to revaluate how I viewed 
the quantitative data. Because every behaviour is a result of the interaction of 
multiple factors, I asked myself, what factors are associated with late presentation 
and how do they are interact? The flexibility of mixed methods and the richness of 
the data collected allowed me to revisit the quantitative data to investigate this 
interaction. 
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The decision tree clearly illustrates several characteristics of women who were at 
higher and lower risk of late-stage diagnosis. The consistency between the findings 
of the two quantitative analyses methods—logistic regression and the classification 
decision tree— enhances the validity of the quantitative results. As described in 
Chapter 3, the analysis was an ongoing process. Each phase undertook a series of 
analysis steps in which both the data and the analysis methods were investigated to 
ensure validity. Furthermore, the consistency between quantitative and qualitative 
findings enhances inference rigor.  
The inference generation that combined the results of the systematic review, the 
quantitative and qualitative work was challenging because of the difference in 
perspectives each approach has. As I focused on the thesis aim and objectives, I was 
able to synthesise the evidence. Writing up the findings integration increased my 
ability to view the wider picture, allowing me to complete the puzzle and draw the 
conclusions. The journey of conducting this mixed methods thesis was enjoyable and 
rich in teaching me research skills that I would never have gained using a single 
research alone. 
8.5 Thesis implications  
The ‘‘pluralism of perspectives’’ has great value in helping to answer mixed-
methods enquiry and suggesting practical solutions (Onwuegbuzie and Johnson, 
2006). This pluralism could be related to research approaches as described in 
Chapter 3, or to the nature of data collected. In this mixed methods study, the data 
presents two perspectives: the medical perspective of the cancer registry data and the 
patient perspective in the interviews regarding patients’ experiences in seeking 
healthcare. Understanding the problem from both perspectives is necessary because 
medical services are offered to people, their views and opinions are needed to build 
evidence to improve breast cancer service delivery.  
This study could be the start of achieving a better understanding of late-presentation 
female breast cancer in Saudi Arabia and more appropriate, customised services to 
be offered. The thesis findings indicated two areas for recommendations to improve 
the early presentation of female breast cancer: healthcare and research.  
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8.5.1 Recommendations for healthcare  
The focus of this study was to reduce the time before presentation to healthcare and 
late-stage diagnosis for women who are alerted by breast cancer symptoms. 
Healthcare policymakers and professionals need to be aware of the characteristics of 
women who are at higher risk of late-stage diagnosis to act positively toward early 
detection of breast cancer. The high risk groups are those who are living in regions 
with less advanced oncology services, women aged 42 or less, and greater than 58 
years.  
In the literature, evidence is limited about interventions that effectively increase the 
early presentation of cancer (Austoker et al., 2009). Although there is moderate 
evidence in the literature indicates that individual-based interventions to promote 
awareness are effective for a short time, their effectiveness on early presentation is 
unclear (Austoker et al., 2009). 
The lack of awareness and misconceptions found in this study indicate the need for 
more generic parts, aimed at raising awareness about breast cancer among all women 
and incorporate messages about breast cancer, symptoms, risk factors and the 
effectiveness of early detection. In addition, messages need to be tailored to 
overcome misconceptions detected depending on age.  
Older women need to be more aware that it is not necessary that serious symptoms 
are painful and that they should visit a doctor, painless lump might be serious and 
thus, needs immediate medical investigation. For younger women, they need to 
know that breast cancer could be a diagnosis for a lump even during pregnancy, 
breastfeeding or postpartum therefore. Consequently, they should investigate the 
lump soon after recognition. Because the family has an important role in seeking 
medical care, breast cancer awareness programmes should also target all family 
members, both male and female.  
Channels and venues to disseminate breast cancer messages need to target older and 
younger women. For example, younger women can be reached in malls and older 
women can be reached in Qur’an learning and memorising circles.  
The variation between healthcare professionals and the public in health literacy may 
create a gap in understanding messages about breast cancer (Manning and Dickens, 
2006). More effort is needed to ensure that breast cancer messages in public health 
campaigns can be understood by laypeople. For example, the concept of a risk factor 
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should be better explained to public, such as the association between HTR, 
breastfeeding and breast cancer. Because the qualitative data showed that women 
understood the effect of breastfeeding as absolute, not as probability, same occurred 
with the HTR.   
The gap between health professionals and laypeople in understanding the principle 
of a risk factor needs to be considered in developing future breast cancer awareness 
programmes. Such a gap has been identified in the UK, with possible solutions being 
inclusion of dialogue and debate about the risk of breast cancer (Chiu et al., 2009).  
Mansell et al. (2011) reviewed 22 studies on interventions to reduce cancer delay in 
referral from PHC to secondary care and none of them assess the effect of 
intervention on referral delay reduction. They found limited evidence on 
interventions regarding education, audit and feedback, diagnostic and assessment 
tools, specific skills training were found in specific outcomes.     
Healthcare professionals especially, those working in the PHCs need to be aware 
about breast cancer epidemiology in Saudi Arabia, including the younger age seen at 
diagnosis and the risk of late stages at diagnosis. More attention is needed in regions 
with less advanced oncology facilities. Establishing a breast cancer risk assessment 
tool and diagnostic algorithms can be used at the PHC level could assist in clinical-
decision making to facilitate timely diagnosis of breast cancer. 
These guidelines need to be adapted to the needs and epidemiology of Saudi female 
breast cancer. For example, these guidelines can set time limits in referral from PHC 
and appointments in breast clinic for diagnosis. Training in how to implement the 
guidelines with guidance on health facilities which offer diagnostics services may 
explained to GPs who may not familiar with location of breast cancer services. 
8.5.2 Recommendations for research 
The thesis suggests many areas for future research to improve our understanding 
about what might contribute to late presentation. Its studies focused on patient-
related factors and the role of the health professional. Future research needs to focus 
on factors related to the healthcare system related factors and delve further into the 
diagnosis and treatment. Additionally, it should explore tumour aggressiveness, a 
biological factor, on the time to seek medical care and diagnosis.  
For each breast cancer patient, health professionals could record the time intervals 
from symptoms recognition to seeking medical care to diagnosis and finally to 
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treatment (if appropriate). This would help to establish the magnitude of the problem 
concerning delays in presentation, diagnosis and treatment, and to identify areas in 
which improvements in cancer care could be made. More analysis of late 
presentation and survival also needs to be undertaken in future research. For 
instance, it would be in the interests of both the public and stakeholders to know how 
many deaths might be avoided if late presentations or diagnoses were to be reduced.  
It would also be beneficial for health promoters to address the lack of breast cancer 
awareness among the public. This could be achieved by assessing levels of public 
awareness about breast cancer, together with the wide distribution of misconceptions 
that exist, especially those addressed in this thesis. Researchers in the field of health 
promotion could use a validated tool such as the Cancer Awareness Measure 
(Stubbings et al., 2009) to assess public levels of awareness about breast cancer and 
evaluate the impact of awareness campaigns.  
For healthcare professionals − who are in direct contact with potential breast cancer 
patients − research needs to uncover the extent of, and reasons for, late diagnosis. 
Failure of the doctors to recognise breast cancer among younger women during the 
first medical consultation is reported in this thesis. Future research could investigate 
the association between breast cancer symptoms, age and the accuracy of diagnosis. 
Auditing cases of late diagnosis by GPs and late referrals from PHCs could be used 
as an indicator to improve breast cancer care. Future research could investigate the 
variation in the quality of cancer care across regions of Saudi Arabia and its impact 
on late presentation and diagnosis. 
The experience and knowledge of specialists involved in breast cancer might guide 
the implementation of cancer care polices. Focus groups could provide a useful tool 
for collating the knowledge of GPs, health promoters and specialists on current good 
practices and their opinions on areas that require improvement in late presentation, 
diagnosis and treatment.   
The growth of contextual understanding is important as the explanatory, quantitative 
data. This thesis uncovered the important role of factors beyond demographics. 
Future research could test the distribution of factors shown in the qualitative study 
and their main effect on late presentation. Such research is vital due to the rapid 
changes in healthcare services and population demography.  
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Future research should focus on the age group, 42 or younger, between 42 and 58 
and greater than 58, which was identified in classification tree. 
In addition, differences between Saudi and non-Saudi female breast cancer patients 
need to be explored to guide future policies for breast cancer care.  
Given the complexity of the research problem, future research needs to search for the 
best methods for understanding late presentation and diagnosis. Findings from the 
qualitative study indicated that stage at diagnosis is an effective and practical 
parameter that should be used in future research in Saudi Arabia. Future research 
could use the same parameter and investigate the interaction of other factors on late 
presentation of female breast cancer.  
The quantitative data indicated positive changes in stages at diagnosis from 19994 to 
2006. Future research needs could assess whether this trend has continued in recent 
years and if there are differences in late-stage diagnosis across regions. 
This thesis focused on female breast cancer. Future research could investigate late-
presentation of other types of cancer or male breast cancer and then compare them to 
female breast cancer. Such research would benefit from mixed methods research to 
generate evidence.   
8.6 Thesis strengths and limitations 
The strengths and limitations of the individual studies are described in Chapters 4 
(systematic review), Chapter 5 (quantitative study), and Chapter 7 (qualitative 
study). This section describes the strengths and limitations of the overall thesis 
One of the major strengths of this thesis was its use of a mixed methods design to 
understand late presentation of female breast cancer from multiple perspectives using 
different research strategies. Using systematic review to examine the extent to which 
the problem has been studied was powerful in guiding further steps in this research. 
It helped in assessing the research needs and choosing methods appropriate and 
applicable methods to the study context. As described in Chapter 3, section 3.4, the 
application of an explanatory sequential study design was able to meet the thesis 
objectives. It assisted in answering the thesis questions and confirmed the results in a 
chronological order.  
The quantitative data from SNCR were able to provide insights into the associations 
and interactions with advanced stage at diagnosis on a national level. Using data for 
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breast cancer patients diagnosed during 1994–2006 enhanced the generalisability of 
the findings. In addition, the qualitative study in this thesis provided an in-depth 
understanding of contextual factors related to late presentation. It gave a 
complementary and context-specific understanding that, though not generalisable 
alone, when triangulated with the quantitative results makes all the results more 
likely to be generalisable.   
Findings from the qualitative work aided in the interpretation of the quantitative 
results and raised questions about the interaction effect on stage at diagnosis. This 
led to re-analysis of the quantitative data to enhance evidence integration. The 
process by which the evidence on risk factors for late presentation of female breast 
cancer was developed is a platform for innovative investigations, with each phase 
drawing inference from previous ones and, thereby, more likely to reflect reality, 
especially when there is consistency in the results.  
However, there are some limitations. Data gathered for the quantitative and 
qualitative work were different in samples and periods. Participants recruited in the 
qualitative study were different from those in quantitative study. This could raise an 
issue in the validity of the findings (Creswell and Plano Clark, 2011). However, both 
samples represent the same population, female breast cancer patients in Saudi 
Arabia. Moreover, there is a gap of five years between the quantitative data 
(1994−2006) and the qualitative data (2011). A better picture could have been drawn 
if both studies had been conducted during the same period.  
8.7 Conclusion 
This study provides an understanding of factors associated with late presentation of 
female breast cancer among Saudi nationals. A mixed methods research design was 
used by implementing a series of phases; systematic review, quantitative study, 
qualitative study, revisit of the quantitative data and evidence integration. 
The thesis results support the idea that late presentation is a complex issue and has 
multi factors. The inference drawn from this study shows characteristics of women at 
high risk of late presentation resulted from the integration of quantitative and 
qualitative data.  These characteristics include living in areas with less oncology 
services, being older than 58 or 42 years or younger as shown in the classification 
tree analysis. Furthermore, contextual understating of the reasons of late presentation 
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was gained from the qualitative study especially in relation to the variation between 
younger and older women. The lack of awareness among women and the presence of 
misconceptions interfere with timely seeking medical care. But, talking to some else 
speed the seeking process. In addition, the qualitative study elaborated the role of 
healthcare in supporting early stage at diagnosis.   
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Appendix A: Systematic review searching  
Searching data bases 
Database: BIOSIS Previews <1969 to 2014 Week 26> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     "breast cancer*".m_titl. (104589) 
2     limit 1 to human (99398) 
3     breast carcinoma*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (26307) 
4     breast neoplasm*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (131168) 
5     breast tum?r*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (14997) 
6     2 or 3 or 4 or 5 (186328) 
7     Middle East*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (7085) 
8     Eastern Mediterranean*.mp. [mp=abstract, biosystematic codes, original language book 
title (non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (3645) 
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9     Saudi*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (11309) 
10     Kuwait*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (3114) 
11     Qatar*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (838) 
12     Bahrain*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (627) 
13     Oman*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (2804) 
14     Emirate*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (1253) 
15     Egypt*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (22191) 
16     Sudan*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
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geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (10655) 
17     Algeria*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (5728) 
18     Morocco*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (9216) 
19     Tunis*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (9906) 
20     Libya*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (2033) 
21     Palenstin*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (0) 
22     Leban*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (3795) 
23     Iraq*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
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equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (5246) 
24     Syria*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (17241) 
25     Yemen*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (2333) 
26     Iran*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (27533) 
27     Jordan*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (7485) 
28     7 or 8 or 9 or 11 or 12 or 13 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
or 25 or 26 or 27 (136740) 
29     delay*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (288932) 
30     Late present*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (758) 
31     ealry present*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
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equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (0) 
32     postpon*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (4549) 
33     wait*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (17186) 
34     hesitat*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (777) 
35     defer*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (20456) 
36     early stage*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (86201) 
37     late stage*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (19434) 
38     advance* stage*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (17382) 
- 230 - 
 
39     late action*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (24) 
40     ealry action*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (0) 
41     29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 (442273) 
42     Help seeking behavi?r.mp. [mp=abstract, biosystematic codes, original language book 
title (non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (332) 
43     Waiting time*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (2370) 
44     motivat*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (48845) 
45     Priorit*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (43421) 
46     consultation*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (16434) 
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47     health service* use*.mp. [mp=abstract, biosystematic codes, original language book 
title (non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (661) 
48     access to care*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (1541) 
49     symptom* attribution*.mp. [mp=abstract, biosystematic codes, original language book 
title (non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (48) 
50     Symptom* duration*.mp. [mp=abstract, biosystematic codes, original language book 
title (non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (1353) 
51     sick role*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (112) 
52     seek* advice*.mp. [mp=abstract, biosystematic codes, original language book title 
(non-english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (165) 
53     barrier*.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (136643) 
54     time factor.mp. [mp=abstract, biosystematic codes, original language book title (non-
english), book title (english), chemicals & biochemicals, concept codes, diseases, 
- 232 - 
 
geopolitical locations, gene name, major concepts, miscellaneous descriptors, methods & 
equipment, organisms, parts, structures & systems of organisms, sequence data, super 
taxa, title, time, taxa notes] (907) 
55     (Seek* or ask* or Look* near care or attention or assist* or help*).mp. [mp=abstract, 
biosystematic codes, original language book title (non-english), book title (english), 
chemicals & biochemicals, concept codes, diseases, geopolitical locations, gene name, 
major concepts, miscellaneous descriptors, methods & equipment, organisms, parts, 
structures & systems of organisms, sequence data, super taxa, title, time, taxa notes] 
(703258) 
56     42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 
(925227) 
57     41 or 56 (1332017) 
58     6 and 28 and 57 (107) 
Database: Embase <1996 to 2014 Week 21> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     breast cancer.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(248897) 
2     breast carcinoma*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(41238) 
3     breast neoplasm*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(6512) 
4     breast tum?r*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (51761) 
5     1 or 2 or 3 or 4 (285270) 
6     Middle East.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (8240) 
7     Eastern Mediterranean*.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (1271) 
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8     Saudi*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (11786) 
9     Kuwait*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (3052) 
10     Qatar*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1253) 
11     Bahrain*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1020) 
12     Oman*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1791) 
13     Emirate*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (2216) 
14     Eygpt*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (3) 
15     Sudan*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (5003) 
16     Algeria*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (2415) 
17     Morocco*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (4454) 
18     Tunis*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (7380) 
19     Libya*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1082) 
20     Palenstin*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (0) 
21     Leban*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (3489) 
22     Iraq*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (6607) 
23     Syria*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (6558) 
24     Yemen*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1345) 
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25     Iran*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (33139) 
26     Jordan*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (5283) 
27     6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 
22 or 23 or 24 or 25 or 26 (98947) 
28     delay*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(310656) 
29     Late present*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(2352) 
30     Early Present*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(890) 
31     postpon*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (6677) 
32     wait*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (41846) 
33     hesitat*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (1728) 
34     defer*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (21112) 
35     early stage*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (94413) 
36     late stage*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (19288) 
37     advance* stage*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(27809) 
38     early action*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (195) 
39     late action*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (19) 
- 235 - 
 
40     28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 (506244) 
41     Help seeking behavi?r.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (4810) 
42     Waiting time*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(7528) 
43     motivat*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (95229) 
44     Priorit*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(5718189) 
45     Consult*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(111699) 
46     health service* use*.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (2284) 
47     access to care*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(6961) 
48     symptom* attribution*.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (116) 
49     Symptom* duration*.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (2723) 
50     sick role.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] (209) 
51     seek* advice*.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(614) 
52     barrier*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
(170625) 
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53     (Seek* or ask* or Look* near care or attention or assist* or help*).mp. [mp=title, 
abstract, subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] (1596341) 
54     41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 (6968090) 
55     40 or 54 (7208273) 
56     5 and 27 and 55 (710) 
Database: Global Health <1910 to 2014 Week 20> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     breast cancer.m_titl. (9904) 
2     breast carcinoma*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(999) 
3     breast neoplasm*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(433) 
4     breast tum?r*.mp. [mp=abstract, title, original title, broad terms, heading words] (475) 
5     1 or 2 or 3 or 4 (11033) 
6     Middle East.mp. [mp=abstract, title, original title, broad terms, heading words] (64402) 
7     Eastern Mediterranean*.mp. [mp=abstract, title, original title, broad terms, heading 
words] (718) 
8     Saudi*.mp. [mp=abstract, title, original title, broad terms, heading words] (6529) 
9     Kuwait*.mp. [mp=abstract, title, original title, broad terms, heading words] (1538) 
10     Qatar*.mp. [mp=abstract, title, original title, broad terms, heading words] (453) 
11     Bahrain*.mp. [mp=abstract, title, original title, broad terms, heading words] (400) 
12     Oman*.mp. [mp=abstract, title, original title, broad terms, heading words] (901) 
13     Emirate*.mp. [mp=abstract, title, original title, broad terms, heading words] (934) 
14     Eygpt*.mp. [mp=abstract, title, original title, broad terms, heading words] (5) 
15     Sudan*.mp. [mp=abstract, title, original title, broad terms, heading words] (7907) 
16     Algeria*.mp. [mp=abstract, title, original title, broad terms, heading words] (3629) 
17     Morocco*.mp. [mp=abstract, title, original title, broad terms, heading words] (4318) 
18     Tunis*.mp. [mp=abstract, title, original title, broad terms, heading words] (5026) 
19     Libya*.mp. [mp=abstract, title, original title, broad terms, heading words] (1174) 
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20     Palenstin*.mp. [mp=abstract, title, original title, broad terms, heading words] (0) 
21     Leban*.mp. [mp=abstract, title, original title, broad terms, heading words] (1907) 
22     Iraq*.mp. [mp=abstract, title, original title, broad terms, heading words] (3654) 
23     Syria*.mp. [mp=abstract, title, original title, broad terms, heading words] (2685) 
24     Yemen*.mp. [mp=abstract, title, original title, broad terms, heading words] (1481) 
25     Iran*.mp. [mp=abstract, title, original title, broad terms, heading words] (24826) 
26     Jordan*.mp. [mp=abstract, title, original title, broad terms, heading words] (2998) 
27     6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 
22 or 23 or 24 or 25 or 26 (88802) 
28     delay*.mp. [mp=abstract, title, original title, broad terms, heading words] (43482) 
29     Late present*.mp. [mp=abstract, title, original title, broad terms, heading words] (381) 
30     Early Present*.mp. [mp=abstract, title, original title, broad terms, heading words] (125) 
31     postpon*.mp. [mp=abstract, title, original title, broad terms, heading words] (1325) 
32     wait*.mp. [mp=abstract, title, original title, broad terms, heading words] (4494) 
33     hesitat*.mp. [mp=abstract, title, original title, broad terms, heading words] (541) 
34     defer*.mp. [mp=abstract, title, original title, broad terms, heading words] (2679) 
35     early stage*.mp. [mp=abstract, title, original title, broad terms, heading words] (12436) 
36     late stage*.mp. [mp=abstract, title, original title, broad terms, heading words] (2892) 
37     advance* stage*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(2517) 
38     late action*.mp. [mp=abstract, title, original title, broad terms, heading words] (3) 
39     early action*.mp. [mp=abstract, title, original title, broad terms, heading words] (39) 
40     28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 (68460) 
41     Help seeking behavi?r.mp. [mp=abstract, title, original title, broad terms, heading 
words] (31) 
42     Waiting time*.mp. [mp=abstract, title, original title, broad terms, heading words] (711) 
43     motivat*.mp. [mp=abstract, title, original title, broad terms, heading words] (11078) 
44     Priorit*.mp. [mp=abstract, title, original title, broad terms, heading words] (17766) 
45     Consult*.mp. [mp=abstract, title, original title, broad terms, heading words] (17483) 
46     health service* use*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(471) 
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47     access to care*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(1334) 
48     symptom* attribution*.mp. [mp=abstract, title, original title, broad terms, heading 
words] (4) 
49     Symptom* duration*.mp. [mp=abstract, title, original title, broad terms, heading words] 
(212) 
50     sick role*.mp. [mp=abstract, title, original title, broad terms, heading words] (25) 
51     seek* advice*.mp. [mp=abstract, title, original title, broad terms, heading words] (173) 
52     barrier*.mp. [mp=abstract, title, original title, broad terms, heading words] (24371) 
53     time factor*.mp. [mp=abstract, title, original title, broad terms, heading words] (252) 
54     (Seek* or ask* or Look* near care or attention or assist* or help*).mp. [mp=abstract, 
title, original title, broad terms, heading words] (171344) 
55     41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 
(227148) 
56     40 or 55 (285843) 
57     5 and 27 and 56 (81) 
Database: Ovid MEDLINE(R) <1946 to May Week 3 2014> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     breast cancer.m_titl. (101334) 
2     limit 1 to humans (98510) 
3     breast carcinoma*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (23605) 
4     breast tum?r*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (12767) 
5     breast neoplasm*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (215891) 
6     2 or 4 or 5 (218966) 
- 239 - 
 
7     Middle East.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (8255) 
8     Eastern Mediterranean*.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] (999) 
9     Saudi*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (9935) 
10     Kuwait*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (2965) 
11     Qatar*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (663) 
12     Bahrain*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (609) 
13     Oman*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1313) 
14     Emirate*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1555) 
15     Eygpt*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1) 
16     Sudan*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (7151) 
17     Algeria*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (2917) 
18     Morocco*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (4660) 
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19     Tunis*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (7365) 
20     Libya*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1190) 
21     Palenstin*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (0) 
22     Leban*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (3691) 
23     Iraq*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (6538) 
24     Syria*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (9581) 
25     Yemen*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1502) 
26     Iran*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (16773) 
27     Jo.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1058) 
28     7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
or 23 or 24 or 25 or 26 or 27 (82258) 
29     delay*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (365094) 
30     Late present*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1754) 
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31     ealry present*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (0) 
32     postpon*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (6731) 
33     wait*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (36029) 
34     hesitat*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1575) 
35     defer*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (24623) 
36     early stage*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (88824) 
37     late stage*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (18725) 
38     advance* stage*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (22584) 
39     late action*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (23) 
40     ealry action*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (0) 
41     29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 (548897) 
42     Help seeking behavi?r.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] (376) 
- 242 - 
 
43     Waiting time*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (5635) 
44     motivat*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (101189) 
45     Priorit*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (62183) 
46     Consult*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (121298) 
47     health service* use*.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] (1945) 
48     access to care*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (5492) 
49     symptom* attribution*.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] (94) 
50     Symptom* duration*.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] (1768) 
51     sick role*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (11286) 
52     seek* advice*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (495) 
53     barrier*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (153257) 
54     time factor*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] (1001384) 
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55     (Seek* or ask* or Look* near care or attention or assist* or help*).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] (1263475) 
56     42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 
(2553808) 
57     41 or 56 (2970886) 
58     6 and 28 and 57 (203) 
Database: PsycINFO <1806 to May Week 4 2014> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     breast cancer.m_titl. (4953) 
2     breast carcinoma*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (80) 
3     breast neoplasm*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (6871) 
4     breast tum?r*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (72) 
5     1 or 2 or 3 or 4 (7039) 
6     Middle East.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (1581) 
7     Eastern Mediterranean*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (75) 
8     Saudi*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (1119) 
9     Kuwait*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (757) 
10     Qatar*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (183) 
11     Bahrain*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (176) 
12     Oman*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (252) 
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13     Emirate*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (475) 
14     Eygpt*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (2) 
15     Sudan*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (544) 
16     Algeria*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (393) 
17     Morocco*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (502) 
18     Tunis*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (436) 
19     Libya*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (146) 
20     Palenstin*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (0) 
21     Leban*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (1306) 
22     Iraq*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (3122) 
23     Syria*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (919) 
24     Yemen*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (205) 
25     Iran*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (3077) 
26     Jordan*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (2186) 
27     6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 
22 or 23 or 24 or 25 or 26 (15752) 
28     delay*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (60941) 
29     Late present*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (55) 
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30     Early Present*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (78) 
31     postpon*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (1741) 
32     wait*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (12151) 
33     hesitat*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (1469) 
34     defer*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (2766) 
35     early stage*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (10569) 
36     late stage*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (1497) 
37     advance* stage*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (1037) 
38     late action*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (2) 
39     early action*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (68) 
40     28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 (89959) 
41     Help seeking behavi?r.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (4327) 
42     Waiting time*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (832) 
43     motivat*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (128634) 
44     Priorit*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (22380) 
45     Consult*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (40257) 
46     health service* use*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (1912) 
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47     access to care*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (1848) 
48     symptom* attribution*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (130) 
49     Symptom* duration*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (264) 
50     sick role*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (452) 
51     seeking advice*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (115) 
52     barrier*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original 
title, tests & measures] (41162) 
53     time factor*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (444) 
54     (Seek* or ask* or Look* near care or attention or assist* or help*).mp. [mp=title, 
abstract, heading word, table of contents, key concepts, original title, tests & measures] 
(618557) 
55     41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 
(788802) 
56     40 or 55 (856477) 
57     5 and 27 and 56 (23) 
Recent queries in pubmed  
Search Query 
Items 
found  
#19 
Search ((((((((((((((((delay) OR late present*) OR early present*) OR 
postpon*) OR wait*) OR hesitat*) OR defer*) OR early stage*) OR late 
satge*) OR advance* stage*) OR late action) OR early action)) OR 
((((((((((((((help seeking behavior) OR waiting time) OR motivat*) OR 
priorit*) OR consult*) OR health service use) OR access to care) OR 
symptom* attibution*) OR symptom* duration*) OR sick role) OR seek* 
advice*) OR barrier*) OR time factor) OR (seek OR ask OR look near care 
OR attention OR help OR assistance)))) AND (((((((((((((((((((((Middle East) 
OR Eastern Mediterranean) OR Saudi*) OR Kuwait*) OR Qatar*) OR 
Baharain*) OR Oman*) OR Emirate*) OR Egypt*) OR Sudan*) OR 
Algeria*) OR Morocco*) OR Tunis*) OR Libya*) OR Palestin*) OR 
Leban*) OR Iraq*) OR Syria*) OR Yemen*) OR Iran*) OR Jordan*)) AND 
((((breast cancer) OR breast neoplasm) OR breast carcinoma) OR breast 
tumor) 1121  
#18 
Search (((((((((((((delay) OR late present*) OR early present*) OR postpon*) 
OR wait*) OR hesitat*) OR defer*) OR early stage*) OR late satge*) OR 
advance* stage*) OR late action) OR early action)) OR ((((((((((((((help 
seeking behavior) OR waiting time) OR motivat*) OR priorit*) OR 2294224  
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consult*) OR health service use) OR access to care) OR symptom* 
attibution*) OR symptom* duration*) OR sick role) OR seek* advice*) OR 
barrier*) OR time factor) OR (seek OR ask OR look near care OR attention 
OR help OR assistance)) 
#16 
Search (((((((((((delay) OR late present*) OR early present*) OR postpon*) 
OR wait*) OR hesitat*) OR defer*) OR ealry stage*) OR late satge*) OR 
advance* stage*) OR late action) OR ealry action 96558  
#15 
Search (((((((((((((help seeking behavior) OR waiting time) OR motivat*) 
OR priorit*) OR consult*) OR health service use) OR access to care) OR 
symptom* attibution*) OR symptom* duration*) OR sick role) OR seek* 
advice*) OR barrier*) OR time factor) OR (seek or ask or look near care or 
attention or help or assistance) 2124387  
#5 
Search ((((((((((((((((((((Middle East) OR Eastern Mediterranean) OR 
Saudi*) OR Kuwait*) OR Qatar*) OR Baharain*) OR Oman*) OR 
Emirate*) OR Egypt*) OR Sudan*) OR Algeria*) OR Morocco*) OR 
Tunis*) OR Libya*) OR Palestin*) OR Leban*) OR Iraq*) OR Syria*) OR 
Yemen*) OR Iran*) OR Jordan* 330563  
#4 
Search (((breast cancer) OR breast neoplasm) OR breast carcinoma) OR 
breast tumor 285057  
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Description of studies selection  
No. Study  possible Title 
and 
abstract 
Full 
article/study 
Eligibility  Inclusion Included  
1 (Abdel-
Fattah et 
al., 1999) 
1 Perhaps Yes  Yes Included  1 
2 (Abdelhadi, 
2008) 
2 Perhaps Yes No  Did not 
examine the 
factors 
associated 
with late-
presentation 
breast 
cancer 
 
3 (Aboserea 
et al., 
2011) 
3 Perhaps Yes No   
4 (Abuidris 
et al., 
2008) 
 No No (meeting 
abstract) 
No Not 
included  
 
5 (Al Saad 
and 
Alsayed, 
2012) 
4 Perhaps 
 
Yes  Yes Included  2 
6 (Bedwani 
et al., 
1999) 
 No No (meeting 
abstract) 
No   
7 (Taha et 
al., 2013) 
 No     
8 (Corbex, 
2009) 
5 Perhaps Yes Yes Included  3 
9 (Corbex 
and 
McEwan, 
2010) 
6 Perhaps None retrievable  
10 (Doumit et 
al., 2010) 
 No     
11 (Weber et 
al., 2012) 
 No     
12 (Elzawawy, 
1999) 
7 Perhaps  Yes Yes Included  4 
13 (El-
Zawawy, 
1991) 
8 Perhaps Yes Yes Included  5 
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14 (Elzawawy, 
1987) 
9 Perhaps  None retrievable  
15 (Elzawawy 
et al., 
2008) 
10 Perhaps  Yes  No  No uni or 
multivariate 
analysis  
 
16 (Ermiah et 
al., 2012) 
11 Perhaps  Yes Yes Included  6 
17 (Fakhro et 
al., 1999) 
 No     
18 (Fink et al., 
2010) 
 No     
19 (Landolsi 
et al., 
2010) 
12 Perhaps Yes No No 
evidence of 
univariate 
or 
multivariate 
analysis 
 
20 (Lannin et 
al., 1998) 
 No     
21 (Maamri, 
2012) 
 No     
22 (McEwan 
et al., 
2014) 
13 Perhaps  Yes Yes Included  7 
23 (Montazeri 
et al., 
2010) 
 Perhaps Yes Yes Included  8 
24 (Montazeri 
et al., 
2010) 
 No Conference 
abstract 
   
25 (Mousa et 
al., 2011) 
14 Perhaps Yes Yes Included  9 
26 (Omar et 
al., 2003) 
 No     
27 (Otieno et 
al., 2010) 
 No     
28 (Otieno et 
al., 2010) 
 No     
29 (Rastad et 
al., 2012) 
15 Perhaps Yes Yes Included  10 
30 (Robinson 
et al., 
1986) 
 No     
31 (Shaheen et 
al., 2011) 
 No     
32 (Spenser et 
al., 1989) 
 No     
33 (Taha et 
al., 2012) 
 No     
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34 (Ahmad, 
2004) 
16 Perhaps  Yes  No No 
evidence of 
univariate 
or 
multivariate 
analysis 
 
35 (Harirchi et 
al., 2005) 
17 Perhaps Yes Yes Included  11 
36 (Stapleton 
et al., 
2011) 
18 Perhaps Yes Yes Included  12 
37 (Ismail et 
al., 2013) 
 Perhaps  No No No 
evidence of 
univariate 
or 
multivariate 
analysis 
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Appendix C: SNCR acceptance for the study  
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Appendix D: POM of factors associated with advanced breast 
cancer stages at diagnosis for 10663 female breast cancer patients. 
Factors 
Adjusted ordinal regression 
P POR, (95% CI) 
Age 
Unknown 0.131 0.487, (0.191–1.123) 
18-39 0.060 0.91, (0.838–1.003) 
40-49 0.002 0.870, (0.797–0.948) 
50+ 1 (Reference) 
Year of diagnosis 
1994-1996 0.000 1.615, (1.371–1.901) 
1997-1999 0.000 1.310, (1.180–1.454) 
2000-2002 0.249 1.057, (0.961–1.163) 
2003-2006 1 (Reference) 
Place of residence  
Unknown 0.017 1.233, (1.038–1.464) 
Other regions  0.000 1.21, (1.102–1.329) 
Regions with advanced oncology care 1 (Reference) 
Nationality 
Unknown 0.952 0.989, (0.702–1.393) 
Non-Saudi 0.000 0.855, (0.783–0.932) 
Saudi 1 (Reference) 
Marital status 
Unknown 0.000 0.788, (0.692–0.896) 
Unmarried 0.621 1.030, (0.913–1.162) 
Married 1 (Reference) 
Test for parallel lines: Chi-Square=324.647, df=24 & P=0.000 
Pseudo R
2
: Cox and Snell=0.010, Nagelkerke=0.011 & McFadden=0.005 
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Appendix E: Interview guide 
Before the interview started 
The researcher will introduce herself. I am Sultana Alhurishi, a PhD student at the University 
of Leeds. She will introduce the study ‘’ Understanding female breast cancer late 
presentation in Riyadh, Saudi Arabia, the role of interviewer, the confidentiality and options 
of tape recording will be also mentioned. After that the consent form will be obtained. 
 Firstly, the participant will be asked about her: 
 Age 
 Marital status 
 No. of children…… 
 Educational level 
 Employment status 
 Family history of breast cancer/cancer 
 
Secondly, she will be asked about the key themes to explore. Key themes are: 
(1) Experience and perceptions of body change(s)  
 Describe the nature of first symptom(s) noticed? 
 How did you discover the body changes? E.g. discover it yourself when you take a 
shower. 
 What did you think when you discovered these changes?  
o Probes: these symptoms were not serious, can go, are cancer, or require 
medical attention. 
 
(2) Knowledge and symptoms recognition 
 What do you think about breast cancer? 
 What did you know about breast cancer what you did not before you notice body 
changes? 
o Probes: Types of BC symptoms: lump or thickening, discharges from nipple, 
changes in breast size or shape of the breast, dimpling of the skin ,changes in 
the nipple shape, rash on the nipple or surrounding area, swelling or lump in 
the armpit. 
 What were the sources of you knowledge? 
 
(3) Health seeking behaviour 
 Who was the first medical person consulted? And why? 
 What encouraged you to seem medical care? 
o Probes: e.g. pain, symptoms become worse, others recommendation 
 What do you think the facilitators to go for medical services?  
o Probes: what motivate you/help you to visit the doctor? E.g. treatment 
availability.  
 What do you think barriers to go for health services immediately when notice 
symptoms change?  
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o Probes: e.g. of the barriers: competing priorities, fear of the diagnosis, 
fatalism of the disease 
(4) Social network 
 Did you share your symptom(s) or take about it with others? If yes, 
o Probes: talking with family or friends. 
 Who were they? 
 What were their advices? 
 What support they provided? 
 Do they help you to go for medical treatment 
(5) Symptoms management: 
 How did you manage these symptoms and deal with it? 
o Probes: what did you to manage these symptoms e.g. deny it/ignore it, use 
alternative medicine, or try to search for information about it. 
(6) Time line of seeking medical care (Estimation of the seeking health care period 
although the recall bias is expected) 
 When did you notice first body change? 
 When did you think that body change (s) is illness? 
 When did you decide to consult someone? 
 When did you contact health care? 
(7) Health care services 
 How do you think the health care services affect your decision to seek medical care? 
o Probes: Are they available, accessible, and acceptable at the time when you 
feel about body change. 
 Do you usually seek medical care when you notice body change? 
(8) Health promotion and education 
 What do you think is missing and could be done to improve the early presentation of 
breast cancer? 
 What are your suggestions for health education and promotional interventions to 
improve early presentation of breast cancer? 
 
Last question  
 Is there any think you want to add? 
 
 
Thanks for your time, and participation. 
 
Duration of the interview (start at: __________finish at: ___________)  
 
 
 
 - 652 -
 
 
 
 المقابلة دليل
: السعودية العربية بالمملكة الرياض في للنساء الثدي لسرطان المتأخر العرض فهم: الدراسة عنوان
 .نوعية دراسة
 مقدمة
 في للنساء الثدي لسرطان المتأخر العرض فهم: النوعية الدراسة في للمشاركات المقابلات في تطرح سوف التي للأسئلة النموذج هذا
 لتوضيح السؤال صياغة اعادة إمكانية مع المشاركات على شفهيا الأسئلة بطرح الباحثة فيه تقوم السعودية، العربية بالمملكة الرياض
 الباحثة، دور ، الدراسة عنوان بنفسها، الباحثة تعّرف سوف بالمقابلة البدء قبل و. ترتيبها تغيير أو الحاجة عند الأسئلة دمج و المعنى
 .المشاركة من الخطية الموافقة تؤخذ سوف ذلك بعد. الصوتي لتسجيلا خيار و المقابلة، سرية
 شخصية معلومات 
 العمر 5
 الاجتماعية الحالة 6
 الاطفال عدد 7
 التعليمي المستوى 8
 الوظيفة 9
 الثدي سرطان و للسرطان عائلي تاريخ وجود 
  2
 :التالية المواضيع عن سؤالها يتم سوف ذلك بعد 
 الجسم تغييرات ادراك و الخبرة
 لاحظته؟ عرض أول صفي الثدي في التغيرات ةبداي في -
 الاستحمام أثناء مثلا العرض؟ هذا اكتشفت كيف -
 شيء مرض الاعراض هذه: مثلا ؟)الاعراض أو( العرض هذا اكتشفت عندما ببالك خطرن التي الفكرة هي ما -
 .الطبية للرعاية تحتاج أعراض أو سرطان، هي طبيعي، شيء تذهب، أن الممكن من عارض،
 الأعراض تمييز و ارفالمع
 الثدي؟ سرطان عن لديك التي الفكرة ما -
 الأعراض مثلا تجهلينه؟ كنت الذي ما و الثدي سرطان عن لديك كانت التي المعلومات ما -
 .طبيب أو انترنت، صديقة، كتاب، محاضرة، مثلا عليها؟ حصلت أين من و  لديك المعلومات مصادر هي ما -
  3
 الصحية الرعاية طلب
  4
 جسمك؟ في تغيير أي ملاحظة عند الصحية الرعاية طلب دتكعا من هل -
 مثلا بالذات؟ اختياره تم لماذا و استشارته؟ طلبت) طبي مختص أو( طبيب أول هو من عرض، لأول ملاحظتك عند -
 .الصحي المركز في العام الطبيب
 .الآخرين توصية أو سوء، تزداد الأعراض الألم، مثلا الصحية؟ الرعاية لطلب شجعتك التي الأسباب ما -
 توفر مثلا ؟ أعراض أي ملاحظة عند مباشرة الصحية للمرافق الذهاب على المساعدة العوامل هي ما باعتقادك -
 العلاج
 ، الاولويات تحديد مثلا أعراض؟ أي ملاحظة عند الصحية المرافق إلى فورا الذهاب من تعيقك التي العوامل ما -
 .اكتشافه أو المرض من الخوف
 
 لاجتماعيةا الشبكة
  5
 أفراد أحد مثلا الأعراض؟ هذه عن الطبي المختص غير آخر شخص مع تحدثت هل الأعراض لاحظت عندما -
 بنعم الإجابة كانت إذا. الاصدقاء أو العائلة
 .هكذا و شخص ثاني ، شخص أول مثلا تكلمت؟ من مع -
 .هكذا و الثاني الأول، الشخص لك قال ماذا نصحك؟مثلا بماذا -
 ساعدك؟ كيف و للعلاج؟ للذهاب عدةمسا لك قدم هل -
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 الأعراض في التحكم
 تجاهلها، حاولت مثلا بها؟ قمت طبية استشارة أول حتى و للأعراض ملاحظتك منذ الثدي تغييرات مع تعاملت كيف 
 .الأعراض هذه عن معلومات عن البحث حاولت البديل، الطب علاجات استخدمت
 الصحية الرعاية لطلب الزمني الجدول
 ؟ الأعراض لاحظت متى منذ 
 صحية؟ مشكلة أنها أحسست متى 
 الطبي؟ الفريق استشرت متى 
 الطبي؟ الفريق آخرغير أحد استشارة قررت متى 
 
 الصحية الرعاية خدمات
 
 عندما متاحة متوفرة،:  ؟مثلا الصحي المرفق من الصحية الرعاية لطلب قرارك في الصحية الخدمات أثرت كيف -
 ؟جسمك في بتغييرات أحسست
 الصحي التثقيف و التعزيز
  المرض عن المعارف نقص مثلا الثدي؟ لسرطان المبكر الاكتشاف لتسهيل تحسينه يمكن و الموجود القصور ما برأيك -
 الثدي؟ لسرطان المبكر الاكتشاف لتحسين الصحة تعزيز و التثقيف لتدخلات مقترحاتك هي ما -
 سؤال آخر
 آخر؟ شيء أي إضافة في ترغبين هل -
 
 .مشاركتك و وقتك على شكرا
  :_______)انتهت:______  بدأت(  :المقابلة مدة
 
 
 
 
 
 
 
- 258 - 
 
 
 
Appendix F: The planned sampling frame 
Participants: Women diagnosed with breast cancer (Up to 24) 
Early stages 
(Up to 8) 
Advanced stages 
(Up to 16) 
≥50 
(Up to 8) 
Riyadh 
(At least 1) 
<50 
(Up to 8) 
≥50 
(Up to 4) 
<50 
(Up to 4) 
Non-Riyadh 
(At least 1) 
Riyadh 
(At least 1) 
Non-Riyadh 
(At least 1) 
Riyadh 
(At least 2) 
Non-Riyadh 
(At least 2) 
Riyadh 
(At least 2) 
Non-Riyadh 
(At least 2) 
Stage at diagnosis  
Age   
Region  
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Appendix G: Information sheet  
Date 29 April 2011  
        Version 3  
 
 
Participant Information Sheet 
 
Research title: Understanding female breast cancer late presentation in Riyadh, Saudi 
Arabia: a qualitative study  
 
Dear Participant,  
You are invited to participate in a Ph.D. research project. Before you decide, it is important 
for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully and discuss it with others if you wish. Ask 
the researcher if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part.  
Thank you for reading this information. If you decide to participate, you will be given a copy 
of this information sheet. 
Background  
Breast cancer is the commonest female cancer in Saudi Arabia and often diagnosed at 
advanced stages. It is not entirely known why some women are presenting their symptoms 
late while others early to the doctors. This study is attempting to investigate the factors 
affecting patients presenting themselves to the doctors after they discovered a breast lump or 
other symptoms.  
 
What is the purpose of this study?  
This study aims to understand the factors leading to breast cancer late presentation after self- 
recognition of breast cancer symptoms in Riyadh, with the intention to design health 
promotion intervention(s) to improve the early presentation of breast cancer.  
We will be carrying out face to face interviews with breast cancer patients who were recently 
diagnosed with the disease. 
 
Why I have been chosen?  
You have been chosen because of your diagnosis and your experience which might help us to 
understand how to improve the health services provided and plan health promotion 
interventions.  
 
Do I have to take part in this study?  
It is up to you to decide whether or not to take part. If you do decide to take part, you will be 
asked to sign a consent form. You can still withdraw at any time without this affecting your 
present or future care. You do not have to give a reason for your withdrawal.  
 
What will happen to me if I take part?  
If you decide to participate in the study you will be asked to be interviewed only once. The 
interview will be in a private place in the hospital during your hospital visit. Once you agreed 
to participate in this study, we will arrange a convenient time with you to conduct the 
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interview. We will obtain your consent to take part in this study before the start of the 
interview. The interview may last up to 90 minutes. During the interview you will be asked 
questions about when and how you discovered your breast cancer. You will also be asked 
about your experience from self-discovery of your illness until you first contacted your 
doctor.  
It is expected that you will help to agree on the date of the interview, and answer the 
questions about your experience of your illness. You have a right to refuse to answer any 
question or stop the interview at any time you decide.  
 
What are benefits from participating in this study?  
There is no immediate benefit for those who participated in this study. It is likely that this 
study will help in understanding the reasons women delay breast cancer presentation. This 
information is needed for designing and developing interventions to improve early 
presentation of breast cancer.  
 
What will happen to the result of the research study?  
The information that you give the researcher will be used to better understand the process of 
seeking medical care amongst breast cancer patients. The results will be written up in the 
form of a Ph.D. thesis and possibly published in research reports, journals or academic books. 
It may also be disseminated in seminars and conferences. 
  
Will my responses be kept confidential?  
All the information collected from you will be kept strictly confidential. All data collected 
will be anonymised and nobody will be able to identify you in any report or publication. 
Research data will be accessed only by the researcher and research supervisors. Paper copies 
will be kept in a locked file cabinet in a locked office and electronic data will be kept on 
encrypted and password protected computers.  
 
Will the interview be audio recorded?  
The interview can be audio recorded only with your approval. The recording is used because 
it eases data transcription. The recording will be destroyed immediately after all the 
interviews are transcribed.  
You can still participate even though you refuse to be audio-recorded. In this case the 
researcher will be handwriting your responses in notes during the interview. In any case, if 
you are not able to provide written consent, your consent will be taken using the audio-tape 
recorder. 
 
Who is organising this study?  
This study is a part of a Ph.D. at the University of Leeds.  
 
Who has reviewed this study?  
This study has been reviewed by the Ethics Committee at the University of Leeds and your 
hospital. If you have any questions, concerns or complaints contact the researcher or her lead 
supervisor.  
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Researcher  
 
Lead Supervisor  
Sultana Alhurishi  
Ph.D. student at the University of Leeds 
Leeds Institute of health Sciences 
Charles Thackrah Building, 
Room G.02 
University of Leeds 
101 Clarendon Road 
Leeds, LS2 9LJ 
UK 
Tel.00441133431688 
E mail ml07saah@leeds.ac.uk 
 
 
 
 
Dr. Jennifer Lim   
Leeds Institute of Health Sciences,  
School of Medicine  
University of Leeds  
Charles Thackrah Building  
101 Clarendon Road  
Leeds LS2 9LJ  
Tel: ++44 113 343 2702  
E mail  J.Lim@leeds.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 262 -
 
 
 
  2219ابريل 29لتاريخ 
                                                                                                      3  الاصدار:       
                                                                                                                           
                
  المشاِركة ورقة معلومات
  
عنوان الدراسة: فهم العرض المتأخر لسرطان الثدي للنساء في الرياض بالمملكة العربية 
 السعودية:دراسة نوعية
 
 عزيزتي المشاركة
انت مدعوة للمشاركة في لمشروع بحثي لمرحلة الدكتوراه. قبل أن تقرري، من المهم بالنسبة 
تفهمي لماذا أعد البحث وما الذي يشتمل عليه. يرجى أخذ الوقت الكافي لقراءة المعلومات لك أن 
التالية بعناية ومناقشته مع الآخرين إذا رغبتي. اسألي الباحثة إذا كان هناك أي شيء غير واضح 
أو إذا كنت ترغبين في مزيد من المعلومات. خذي الوقت الكافي حتى تقرري ما إذا كنت 
  في المشاركة او لا.ترغبين 
 شكرا لك على قراءة هذه المعلومات. إذا قررت المشاركة، سيتم إعطاؤك نسخة من هذه الورقة.
 
 تقديم
سرطان الثدي هو أكثر أنواع السرطان لدى النساء في المملكة العربية السعودية وغالبا ما يتم 
ض النساء للأطباء تشخيصه  في مراحل متقدمة. من غير المعروف تماما لماذا تعرض بع
أعراض المرض في وقت متأخر في حين أن اخريات منهن يعرضنها في وقت مبكر. هذه 
 الدراسة هي محاولة لاستقصاء العوامل التي تؤثر على المريضات الاتي 
 يقدمن أنفسهن للأطباء بعد اكتشاف وجود ورم في الثدي أو أعراض أخرى.
 
 ما الهدف من هذه الدراسة ؟
لدراسة إلى فهم العوامل التي تؤدي إلى عرض سرطان الثدي في وقت متأخر بعد تهدف هذه ا
الإدراك الذاتي له من قبل المريضة في الرياض، لغرض تصميم تدخلات لتعزيز الصحة 
 تهدف لتحسين العرض المبكر لسرطان الثدي.
هن وستجرى مقابلات وجها لوجه مع مريضات سرطان الثدي اللاتي تم تشخيص المرض لدي
 مؤخرا.
 
 لماذا تم اختياري؟
تم اختيارك بسبب التشخيص وخبرتك التي قد تساعدنا على فهم كيفية تحسين الخدمات الصحية 
 المقدمة وتصميم تدخلات لتعزيز الصحة.
 
 هل يجب علي المشاركة في البحث؟
منك الأمر متروك لك لتقرري ما إذا رغبت بالمشاركة او لا. إذا قررت المشاركة سوف يطلب 
التوقيع على استمارة الموافقة. يمكنك الإنسحاب في أي وقت دون أن يؤثر هذا على الرعاية 
 المستقبل. ولايجب عليك إعطاء سبب للانسحاب.المقدمة لك في الحاضر أو 
 
 شاركت في البحث؟  ماذا سيحدث لي إذا
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حدة فقط. وسوف إذا قررت المشاركة في هذه الدراسة سوف يطلب منك إجراء مقابلة مرة وا
على المشاركة في  ينقتوافتكون المقابلة في مكان خاص في المستشفى أثناء زيارتك لها. عندما 
هذه الدراسة، سوف يتم ترتيب وقت مناسب معك لهذه المقابلة. سوف نحصل على موافقتك على 
دقيقة.  60إلى المشاركة في هذه الدراسة قبل بدء المقابلة. المقابلة قد تستغرق وقتا ربما يصل 
خلال المقابلة سوف يتم سؤالك حول متى وكيف اكتشفت سرطان الثدي وعن تجربتك منذ ان 
  حتى أول اتصال لك بالطبيب. بشكل ذاتي اكتشفت المرض
وسيتم على الأحرى، الاتفاق معك على موعد المقابلة، والإجابة على الأسئلة حول تجربتك مع 
جابة عن أي سؤال أو التوقف عن المقابلة في أي وقت المرض. كما ان لك الحق في رفض الإ
  .شئت
 
 مالمنفعة من مشاركتي في هذا البحث؟
لا يوجد منفعة مباشرة لمن يشارك في هذه الدراسة . من المحتمل أن تساعد هذه الدراسة في فهم 
لتأخر عرض المريضات بسرطان الثدي انفسهن على الأطباء. وهذه  الاسباب المؤدية
 المعلومات نحتاجها لتصميم تدخلات لتحسين العرض المبكر لسرطان الثدي.
 
 ماذا سيحدث لنتيجة البحث؟
المعلومات التي سوف تدلين بها للباحثة سوف تساعد على فهم عملية طلب مريضات سرطان 
تب نتائج البحث في رسالة دكتوراه، كما أنه من المحتمل أن الثدي للرعاية الصحية. سوف تك
مجلات أو كتب علمية. ومن الممكن أيضا ًأن تنشر في مؤتمرات و  تنشر في تقارير بحثية أو
 حلقات المناقشة العلمية.
 
 هل ستحفظ استجاباتي بشكل سري؟
الهوية و لا  جميع البيانات التي سوف تجمع سوف تحفظ بسرية تامة. وسوف تكون مجهولة
صدار. بيانات البحث سوف تطلع عليها ا يستطيع أحد التعرف على هويتك في أي تقرير أو
. سيتم الإحتفاظ بالنسخ الورقية في درج مقفل في مكتب مقفل و فقط الباحثة و المشرفين عليها
  .البيانات الالكترونية سوف يحتفظ بها في حاسبات آلية مزودة ببرنامج حماية و كلمة سر
  
 هل ستسجل المقابلة صوتيا؟
في حال موافقتك سيتم تسجيل المقابلة صوتيا. الغرض من التسجيل الصوتي هو تسهيل عملية 
تفريغ البيانات. وهذا التسجيل سوف يتم التخلص منه مباشرة بعد تفريغ كل المقابلات. وممن 
لتك صوتيا وفي هذه الممكن أن تشاركي في البحث حتى لو لم ترغبي في أن يتم تسجيل مقاب
وفي حال عدم مقدرتك   الحالة سوف تقوم الباحثة بكتابة استجاباتك في مذكرات خلال المقابلة.
 على اعطاء موافقة خطيه لأي سبب سوف يتم تسجيل موافقتك صوتيا.
   
 من ينظم هذه الدراسة؟
  يل درجة الدكتوارة في جامعة ليدزهذه الدراسة جزء من رسالة لن
 
  راجعة هذه الدراسة؟من قام بم
روجعت هذه الدراسة من قبل لجنة اخلاقيات البحث في جامعة ليدز والمستشفى الذي تراجعين 
لديك أي اسئلة او استفسارات او شكاوى يمكنك الإتصال بالباحثة او  كان بها. وفي حال
 المشرف الرئيس.
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ةثحابلا 
 
سيئرلا فرشملا  
يشيرحلا ةناطلس 
 اط يف ةراوتكد ةبلزديل ةعماج   
Leeds Institute of health Sciences 
Charles Thackrah Building, 
Room G.02 
University of Leeds 
101 Clarendon Road 
Leeds, LS2 9LJ 
UK 
Tel. 00441133431688 
E mail ml07saah@leeds.ac.uk 
 
 
 
 ميل رفينيج.د 
Leeds Institute of Health Sciences,  
School of Medicine  
University of Leeds  
Charles Thackrah Building  
101 Clarendon Road  
Leeds LS2 9LJ  
Tel. ++44 113 343 2702  
E mailJ.Lim@leeds.ac.uk  
- 265 - 
 
 
 
Appendix H: Consent form  
Consent Form  
ثحبلا يف ةكراشملا ىلع ةقفاوملا جذومن 
Dated 29 April 2011  خيراتلا92 ليربا9122                                                                 
            Version: 3  :رادصلاا 3                                                                                
                                                                                                                           
                                                 
Research title: Understanding female breast cancer late 
presentation in Riyadh, Saudi Arabia: a qualitative study. 
رسل رخأتملا ضرعلا مهف :ةساردلا ناونع ةيبرعلا ةكلمملاب ضايرلا يف ءاسنلل يدثلا ناط
ةيعون ةسارد:ةيدوعسلا 
 
Initial the box if you agree with the statement to the left    
                      راسيلا ةهج يف ةمجرتملا ةرابعلا ىلع كتقفاوم ةلاح يف كمسا نم ىلولاا فورحلا بتكا 
Statement 
Initial 
 فورحلا
لااةيلو  
ةرابعلا 
1- I confirm that I have read and 
understood the information 
sheet (Dated 92/4/2011, 
version 3), explaining the 
above research project and I 
have had the opportunity to 
ask questions about the 
study. 
 1-  تامولعملا ةقرو تمهفو تأرق دق يننأب رقأ
ب(خيرات 92  /4 /9111 رادصلاا ،3 ،)
 تحيتاو ،هلاعأ يثحبلا عورشملا حرشت يتلا
.ةساردلا لوح ةلئسلأا حرطل ةصرفلا يل 
 
2- I understand that my 
participation is voluntary and 
that I am free to withdraw at 
any time without giving any 
reason and without there 
being any negative 
consequences. In addition, 
should I not wish to answer 
any particular question or 
questions, I am free to 
decline. 
 9-  لماك يل نأو ةيعوطت يتكراشم نأ مهفأ
 ءادبإ نود تقو يأ يف باحسنلاا يف ةيرحلا
 .ةيبلس بقاوع كانه نوكت نا نودو ببس يأ
ل ،كلذ ىلإ ةفاضلإابو يف ةيرحلا لماك يد
 يفةنيعم ةلئسأ وأ لاؤس يأ ىلع درلا مدع
.كلذ يف يتبغر مدع ةلاح 
 
3- I understand that my 
responses will be kept strictly 
confidential. I give 
permission for members of 
the research team to have 
access to my anonymised 
responses. I understand that 
 3-  ةيرسب اهب ظافتحلاا متيس يدودر نأب ملعأ
 لماكلا نذلإا ثحبلا قيرف يطعأو .ةمات
م اهيلع علاطلااب نأ مهفأ و.ةيوهلا ةلوهج
 هيلإ راشي نل و ثحبلا داومب طبتري نل يمسا
 ريرقتلا يف ىلع فرعتلا دحأ عيطتسي نل و
.ثحبلا نم جتنت يتلا ريراقتلا وأ 
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my name will not be linked 
with the research materials, 
and I will not be identified or 
identifiable in the report or 
reports that result from the 
research.   
4- I agree for the data collected 
from me to be used in the 
PhD study which is part of a 
doctoral thesis. 
 4- ست نأ ىلع قفاوأ مت يتلا تانايبلا مدخت
 دعت يتلا ةيثحبلا ةساردلا يف ينم اهعمج
.هاروتكدلا ةجرد لينل ةلاسر نم ءزج 
5- I agree for the interview to be 
audio-tape recorded. 
 5- .ايتوص ةلباقملا ليجست متي نا ىلع قفاوأ 
6- I agree to take part in the 
above research project. 
 6- لا ىلع قفاوأ روكذملا ثحبلا اذه يف ةكراشم
هلاعا. 
 
 
 
 
_________________________ _____________         _________________ 
Name of participant ةكراشملا مسا Date                       خيراتلا Signature           عيقوتلا
   
(or legal representative  ايمسر اهلثمي نم وأ ) 
_________________________ _____________         _________________ 
Name of person taking consent          Date                       خيراتلا Signature           عيقوتلا
   
 ةقفاوملا هذه ذخأ يذلا صخشلا مسا  
(if different from lead researcher ئرلا ثحابلا نع افلتخم ناك اذإسي ) 
To be signed and dated in presence of the participant   يف ةكراشملا روضحب خرؤت و عّقوت
       ثحبلا 
_________________________ _____________         _________________ 
 Lead researcher     سيئرلا ثحابلا Date                       خيراتلا Signature     عيقوتلا       
   
To be signed and dated in presence of the participant   يف ةكراشملا روضحب خرؤت و عّقوت
        ثحبلا 
 
Researcher ةثحابلا 
Sultana Alhurishi     يشيرحلا ةناطلس  
Leeds Institute of health Sciences 
Charles Thackrah Building 
Room G.02 
University of Leeds 
101 Clarendon Road 
Leeds 
LS2 9LJ 
UK 
E mail/ ليميلاا:   ml07saah@leeds.ac.uk 
Telephone  /فتاهلا :   00441133431688 
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Appendix I: KFSH&RC ethical approval  
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Appendix J: University of Leeds ethical research practice 
audit 
